[
  {
    "EudraCT Number": "2016-005078-37",
    "Sponsor Protocol Number": "SOPHOCLES-P4G",
    "Sponsor Name": "Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases",
    "Full Title": "Public health targeting of PrEP at HIV positives\u2019 bridging networks",
    "Start Date": "2017-05-26",
    "Medical condition": [
      "Healthy volunteers"
    ],
    "Disease": "Version: 19.1, SOC Term: 10022891 - Investigations, Classification Code: 10020187, Term: HIV test negative, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "GR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-005078-37"
  },
  {
    "EudraCT Number": "2017-005049-67",
    "Sponsor Protocol Number": "19762",
    "Sponsor Name": "Bayer HealthCare LLC",
    "Full Title": "A Randomized, Double-Blind, Placebo-Controlled Trial to Compare the Duration of Analgesic Efficacy and Safety of Naproxen Sodium Tablets and Ibuprofen Tablets in Postsurgical Dental Pain",
    "Start Date": "2018-08-29",
    "Medical condition": [
      "Pain relief"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004856, Classification Code: 10044049, Term: Dental pain and sensation disorders, Level: HLT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-005049-67"
  },
  {
    "EudraCT Number": "2019-002910-37",
    "Sponsor Protocol Number": "TEA",
    "Sponsor Name": "Erasmus MC",
    "Full Title": "Study on the pharmacokinetic interaction between green tea and tamoxifen in patients with breast cancer. \u201cthe TEA study\u201d",
    "Start Date": "2019-10-07",
    "Medical condition": [
      "Breast cancer"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002910-37"
  },
  {
    "EudraCT Number": "2020-001890-56",
    "Sponsor Protocol Number": "COVID-\u0393",
    "Sponsor Name": "Universidad Cat\u00f3lica de Murcia (UCAM)",
    "Full Title": "Double-blind randomized placebo-controlled clinical trial to evaluate the efficacy and safety of the use of intravenous gammaglobulins in the treatment of patients with COVID-19",
    "Start Date": "2020-06-10",
    "Medical condition": [
      "Patients with severe symptoms of COVID-19",
      "a disease caused by infection with the SARS-CoV-2 virus."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001890-56"
  },
  {
    "EudraCT Number": "2015-003106-16",
    "Sponsor Protocol Number": "B2",
    "Sponsor Name": "Antonis Valachis",
    "Full Title": "Immunogenicity of influenza vaccination among breast cancer patients treated with trastuzumab in adjuvant setting",
    "Start Date": "2016-08-03",
    "Medical condition": [
      "Efficacy of vaccination against influenza in patients with breast cancer"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "SE": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003106-16"
  },
  {
    "EudraCT Number": "2014-004915-35",
    "Sponsor Protocol Number": "CQBW276X2201",
    "Sponsor Name": "Novartis Pharma AG",
    "Full Title": "A randomized, double blind, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of inhaled QBW276 in patients with cystic fibrosis",
    "Start Date": "2017-07-26",
    "Medical condition": [
      "Cystic Fibrosis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10011762, Term: Cystic fibrosis, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Prematurely Ended"
      },
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-004915-35"
  },
  {
    "EudraCT Number": "2018-001013-32",
    "Sponsor Protocol Number": "CV-185-685",
    "Sponsor Name": "HOSPITAL CL\u00cdNIC BARCELONA",
    "Full Title": "ANTITHROMBOTIC THERAPY AFTER LEFT ATRIAL APPENDAGE OCCLUSION: DOUBLE ANTIPLATELET THERAPY VS. APIXABAN",
    "Start Date": "2018-11-08",
    "Medical condition": [
      "ATRIAL FIBRILLATION IN PATIENTS AFTER OCCLUSION OF THE LEFT ATRIAL APPENDAGE (LAAC)"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-001013-32"
  },
  {
    "EudraCT Number": "2018-003041-41",
    "Sponsor Protocol Number": "012507",
    "Sponsor Name": "Queen Mary University of London",
    "Full Title": "A pragmatic pilot randomised controlled trial of Prothrombin Complex Concentrate (PCC) versus Fresh Frozen Plasma (FFP) in adult patients who are undergoing Heart Surgery",
    "Start Date": "2018-11-16",
    "Medical condition": [
      "Major bleeding during cardiac surgery not related to vitamin K antagonists"
    ],
    "Disease": "Version: 21.1, SOC Term: 10042613 - Surgical and medical procedures, Classification Code: 10042609, Term: Surgery, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-003041-41"
  },
  {
    "EudraCT Number": "2018-004712-22",
    "Sponsor Protocol Number": "D18-02",
    "Sponsor Name": "GERCOR",
    "Full Title": "Peri-operative association of immunotherapy (pre-operative association of nivolumab and ipilimumab, post-operative nivolumab alone) in localized microsatellite instability (MSI) and/or deficient mi...",
    "Start Date": "2019-06-13",
    "Medical condition": [
      "oeso-gastric adenocarcinoma"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10001150, Term: Adenocarcinoma gastric, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-004712-22"
  },
  {
    "EudraCT Number": "2018-000157-41",
    "Sponsor Protocol Number": "UoL001343",
    "Sponsor Name": "The University of Liverpool",
    "Full Title": "NEO21-RS: A phase II randomised study of the cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with oestrogen suppression therapy versus oestrogen suppression therapy alone as neoadj...",
    "Start Date": "2019-06-07",
    "Medical condition": [
      "ER-positive",
      "HER2-negative breast cancer"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10070577, Term: Oestrogen receptor positive breast cancer, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-000157-41"
  },
  {
    "EudraCT Number": "2016-002738-55",
    "Sponsor Protocol Number": "69HCL16-0134",
    "Sponsor Name": "Hospices Civils de Lyon",
    "Full Title": "Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal Carcinosis ( IPOXA )",
    "Start Date": "2017-01-06",
    "Medical condition": [
      "Patients with peritoneal carcinosis of colorectal origin and uncertain resectability with an indication for systemic chemotherapy compatible with the FOLFIRI + bevacizumab combination."
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004864, Classification Code: 10052171, Term: Peritoneal carcinoma, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002738-55"
  },
  {
    "EudraCT Number": "2018-002978-52",
    "Sponsor Protocol Number": "CNTO1959HDS2002",
    "Sponsor Name": "Universitair Medisch Centrum Groningen",
    "Full Title": "Guselkumab for hidradenitis suppurativa, a mode of action study.",
    "Start Date": "2019-07-16",
    "Medical condition": [
      "Hidradenitis suppurativa"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-002978-52"
  },
  {
    "EudraCT Number": "2018-003484-56",
    "Sponsor Protocol Number": "BOLDOS-18",
    "Sponsor Name": "Miguel Caballero Campo",
    "Full Title": "Efficacy of corifolitropin alfa in double ovarian stimulation compared with two conventional ovarian stimulation cycles for embryo accmulation in low responder patients. Multicenter randomized cont...",
    "Start Date": "2019-12-26",
    "Medical condition": [
      "Infertility in patients requiring in vitro fertilization treatment with poor ovarian response profile",
      "defined by Bologna Criteria."
    ],
    "Disease": "Version: 21.0, SOC Term: 10038604 - Reproductive system and breast disorders, Classification Code: 10021926, Term: Infertility, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-003484-56"
  },
  {
    "EudraCT Number": "2014-004925-42",
    "Sponsor Protocol Number": "P04824",
    "Sponsor Name": "Schering-Plough Research Institute, a Division of Schering Corporation",
    "Full Title": "Efficacy and Safety of 200 mcg BID Mometasone Furoate Nasal Spray (MFNS) vs Placebo as Adjunctive Treatment to Antibiotics in Relief of Symptoms of Acute Bacterial Sinusitis",
    "Start Date": "2015-04-13",
    "Medical condition": [
      "Acute Bacterial Sinusitis"
    ],
    "Disease": "",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-004925-42"
  },
  {
    "EudraCT Number": "2015-003291-77",
    "Sponsor Protocol Number": "GLPG1837-CL-201",
    "Sponsor Name": "Galapagos NV",
    "Full Title": "A phase IIa, open label study of multiple doses of GLPG1837 in subjects with cystic fibrosis and the G551D mutation",
    "Start Date": "2016-02-02",
    "Medical condition": [
      "Cystic fibrosis with the G551D mutation"
    ],
    "Disease": "Version: 18.1, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10011762, Term: Cystic fibrosis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "IE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003291-77"
  },
  {
    "EudraCT Number": "2015-005553-13",
    "Sponsor Protocol Number": "CLS001-CO-PR-011",
    "Sponsor Name": "Cutanea Life Sciences",
    "Full Title": "A PHASE 2, RANDOMIZED, VEHICLE-CONTROLLED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO EXPLORE THE PHARMACODYNAMICS, SAFETY AND EFFICACY OF TOPICAL OMIGANAN IN PATIENTS WITH EXTERNAL GENITAL WARTS",
    "Start Date": "2016-05-11",
    "Medical condition": [
      "Patients with external genital warts"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004864, Classification Code: 10018182, Term: Genital warts, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005553-13"
  },
  {
    "EudraCT Number": "2014-004016-11",
    "Sponsor Protocol Number": "2305",
    "Sponsor Name": "University of Bristol",
    "Full Title": "What is the clinical and cost effectiveness of benzocaine/phenazone ear drops for reducing antibiotic consumption and ear pain in children aged between 6 months and 10 years presenting to primary c...",
    "Start Date": "2016-06-30",
    "Medical condition": [
      "Acute otitis media"
    ],
    "Disease": "Version: 20.1, SOC Term: 10013993 - Ear and labyrinth disorders, Classification Code: 10065838, Term: Middle ear inflammation, Level: PT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-004016-11"
  },
  {
    "EudraCT Number": "2018-004231-72",
    "Sponsor Protocol Number": "IBICCR2018-01",
    "Sponsor Name": "Fundaci\u00f3n P\u00fablica Andaluza para la Investigaci\u00f3n de M\u00e1laga en Biomedicina y Salud (FIMABIS)",
    "Full Title": "Randomized study of the detection of RAS / BRAF mutations by BEAMing technology in advance of the radiological diagnosis of progression in patients with metastatic colorectal cancer RAS / BRAF WT a...",
    "Start Date": "2019-06-27",
    "Medical condition": [
      "Median of the progression-free survival of patients with mCRC who maintains the treatment in conventional 1st line",
      "QT + anti-EFGR",
      "versus patients who withdraw anti-EGFR therapy after detection of..."
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10061451, Term: Colorectal cancer, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-004231-72"
  },
  {
    "EudraCT Number": "2015-005046-55",
    "Sponsor Protocol Number": "20151104",
    "Sponsor Name": "Ume\u00e5 University Hospital",
    "Full Title": "Evaluation of [68Ga]PSMA PET/MRI in intermediate and high risk prostate cancer \u2013 a comparison with mpMRI, [11C]ACE PET/CT and histopathological validation",
    "Start Date": "2016-08-23",
    "Medical condition": [
      "Medium and high risk prostate cancer"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "SE": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005046-55"
  },
  {
    "EudraCT Number": "2017-000391-28",
    "Sponsor Protocol Number": "951404713",
    "Sponsor Name": "INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON",
    "Full Title": "A PHASE II, DOUBLE-BLIND, CONTROLLED, PARALLEL-ARM TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INFUSION OF ALLOGENIC MESENCHYMAL STEM CELLS IN LUPUS  NEPHRITIS (LN)",
    "Start Date": "2017-09-20",
    "Medical condition": [
      "LUPUS NEPHRITIS"
    ],
    "Disease": "Version: 20.0, SOC Term: 10038359 - Renal and urinary disorders, Classification Code: 10025140, Term: Lupus nephritis, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000391-28"
  },
  {
    "EudraCT Number": "2012-003741-15",
    "Sponsor Protocol Number": "MSC_apceth_101/1",
    "Sponsor Name": "apceth GmbH & Co. KG",
    "Full Title": "Treatment of Advanced Gastrointestinal Cancer in a Phase I/II trial with modified autologous MSC_apceth_101. Open-label, multicentre, phase I/II.",
    "Start Date": "2013-06-27",
    "Medical condition": [
      "Patients suffering from advanced",
      "recurrent or metastatic gastrointestinal adenocarcinoma."
    ],
    "Disease": "Version: 18.1, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10017991, Term: Gastrointestinal neoplasms malignant and unspecified, Level: HLGT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-003741-15"
  },
  {
    "EudraCT Number": "2011-001795-19",
    "Sponsor Protocol Number": "Uni-Koeln-1341",
    "Sponsor Name": "University of Cologne",
    "Full Title": "STATIN RECAPTURE THERAPY BEFORE CORONARY ARTERY BYPASS GRAFTING  (ACRONYM: START-CABG TRIAL)",
    "Start Date": "2012-09-13",
    "Medical condition": [
      "Patients on a long term statin therapy with established coronary artery disease (CAD) scheduled for isolated surgical myocardial revascularisation (i.e. CABG)"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-001795-19"
  },
  {
    "EudraCT Number": "2012-000309-60",
    "Sponsor Protocol Number": "120101",
    "Sponsor Name": "G\u00f6teborgs universitet",
    "Full Title": "Biochemical and neuropsychological effects on Premenstrual Dysphoric Disorder after acute administration of escitalopram",
    "Start Date": "2016-03-30",
    "Medical condition": [
      "Premenstrual Dysphoric Disorder"
    ],
    "Disease": "Version: 18.1, SOC Term: 10038604 - Reproductive system and breast disorders, Classification Code: 10051537, Term: Premenstrual dysphoric disorder, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "SE": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-000309-60"
  },
  {
    "EudraCT Number": "2013-001722-25",
    "Sponsor Protocol Number": "ZonMw80-83600-98-10226",
    "Sponsor Name": "VU University Medical Center",
    "Full Title": "Cholinesterase inhibitors to slow progression of visual hallucinations in Parkinson\u2019s disease: a multi-center placebo-controlled trial (CHEVAL)",
    "Start Date": "2013-08-27",
    "Medical condition": [
      "Parkinson's disease"
    ],
    "Disease": "Version: 18.0, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10061536, Term: Parkinson's disease, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-001722-25"
  },
  {
    "EudraCT Number": "2012-001144-22",
    "Sponsor Protocol Number": "ML28337",
    "Sponsor Name": "ROCHE SAS",
    "Full Title": "A RANDOMIZED, OPEN-LABEL, PHASE II STUDY ASSESSING THE EFFICACY AND THE SAFETY OF BEVACIZUMAB IN NEOADJUVANT THERAPY IN PATIENTS WITH FIGO STAGE IIIC/IV OVARIAN, TUBAL OR PERITONEAL ADENOCARCINOMA,...",
    "Start Date": "2012-07-03",
    "Medical condition": [
      "Epithelial ovarian cancer"
    ]
  },
  {
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10033128, Term: Ovarian cancer, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-001144-22"
  },
  {
    "EudraCT Number": "2011-004368-31",
    "Sponsor Protocol Number": "I1F-MC-RHBC",
    "Sponsor Name": "Eli Lilly and Company",
    "Full Title": "A 12-Week Multicenter, Randomized, Double-Blind, Placebo Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients with Moderate to Severe Plaque Psorias...",
    "Start Date": "2012-09-13",
    "Medical condition": [
      "Moderate to severe plaque psoriasis"
    ],
    "Disease": "Version: 18.1, SOC Term: 100000004858, Classification Code: 10071117, Term: Plaque psoriasis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "BG": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-004368-31"
  },
  {
    "EudraCT Number": "2011-005279-18",
    "Sponsor Protocol Number": "RG_11-164",
    "Sponsor Name": "University of Birmingham",
    "Full Title": "A RandoMised study of best Available therapy versus JAK Inhibition in patients with high risk Polycythaemia Vera or Essential Thrombocythaemia who are resistant or intolerant to HydroxyCarbamide.",
    "Start Date": "2012-02-08",
    "Medical condition": [
      "Polycythaemia vera"
    ],
    "Disease": "Version: 19.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10015493, Term: Essential thrombocythaemia, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-005279-18"
  },
  {
    "EudraCT Number": "2009-014922-40",
    "Sponsor Protocol Number": "PT-171-503",
    "Sponsor Name": "Erasmus MC",
    "Full Title": "Carfilzomib in combination with Thalidomide and Dexamethasone for remission induction and consolidation of Multiple Myeloma at first presentation",
    "Start Date": "2010-07-07",
    "Medical condition": [
      "Multiple myeloma at first presentation"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2009-014922-40"
  },
  {
    "EudraCT Number": "2011-004187-30",
    "Sponsor Protocol Number": "CO17730",
    "Sponsor Name": "Avraham Pharmaceuticals Ltd.",
    "Full Title": "A 36-month, multi-centre, randomized double-blind placebo-controlled study to evaluate the safety and efficacy of low dose Ladostigil in patients with Mild Cognitive Impairment (MCI)",
    "Start Date": "2011-12-14",
    "Medical condition": [
      "Patient with Mild Cognitive Impairment"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004852, Classification Code: 10009846, Term: Cognitive impairment, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "AT": "Completed"
      },
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-004187-30"
  },
  {
    "EudraCT Number": "2013-003785-14",
    "Sponsor Protocol Number": "200249",
    "Sponsor Name": "Novartis Pharma Services AG",
    "Full Title": "A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and MK-3475 in Subjects with Advanced Renal Cell Carcinoma",
    "Start Date": "2014-03-03",
    "Medical condition": [
      "Renal Cell Carcinoma"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10050513, Term: Metastatic renal cell carcinoma, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-003785-14"
  },
  {
    "EudraCT Number": "2013-002505-62",
    "Sponsor Protocol Number": "STH16404",
    "Sponsor Name": "Sheffield Teaching Hospitals NHS Foundation Trust",
    "Full Title": "SarCaBon: A randomised phase II trial of Saracatinib versus placebo for cancer-induced bone pain",
    "Start Date": "2013-11-14",
    "Medical condition": [
      "Cancer-induced bone pain"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004864, Classification Code: 10049038, Term: Metastatic bone pain, Level: LLT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-002505-62"
  },
  {
    "EudraCT Number": "2013-003481-14",
    "Sponsor Protocol Number": "3004",
    "Sponsor Name": "National Institute of Diabetes and Digestive and Kidney Diseases",
    "Full Title": "Study of allopurinol to prevent GFR loss in type 1 diabetes",
    "Start Date": "2014-03-07",
    "Medical condition": [
      "Type 1 diabetes",
      "microalbuminuria or macroalbuminuria and mildly impaired kidney function."
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004848, Classification Code: 10037827, Term: Raised serum uric acid, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-003481-14"
  },
  {
    "EudraCT Number": "2013-003488-71",
    "Sponsor Protocol Number": "OVG-2013/04",
    "Sponsor Name": "University of Oxford",
    "Full Title": "A pilot study of the impact of BCG administration on the immunogenicity of serogroup C meningococcal conjugate vaccine in healthy infants",
    "Start Date": "2013-12-12",
    "Medical condition": [
      "Vaccine responses"
    ],
    "Disease": "",
    "Population Age": [
      "Newborns",
      "Infants and toddlers",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-003488-71"
  },
  {
    "EudraCT Number": "2013-004108-20",
    "Sponsor Protocol Number": "UMCN-AKF13.05",
    "Sponsor Name": "Radboud University Nijmegen Medical Centre",
    "Full Title": "Improving the tolerability of the oral targeted anti-cancer drug pazopanib by food intake (DIET)",
    "Start Date": "2014-03-17",
    "Medical condition": [
      "Patients  who are treated or will be treated with pazopanib."
    ]
  },
  {
    "Disease": "Version: 19.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10073145, Term: Soft tissue cancer, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-004108-20"
  },
  {
    "EudraCT Number": "2010-020841-29",
    "Sponsor Protocol Number": "ADAPT",
    "Sponsor Name": "King`s College London",
    "Full Title": "The role of anti-IgE (omalizumab) in the management of severe recalcitrant paediatric atopic eczema",
    "Start Date": "2011-07-07",
    "Medical condition": [
      "Severe eczema in children"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004858, Classification Code: 10014189, Term: Eczema allergic atopic, Level: LLT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-020841-29"
  },
  {
    "EudraCT Number": "2011-004735-32",
    "Sponsor Protocol Number": "SP001",
    "Sponsor Name": "SOTIO a.s.",
    "Full Title": "Randomized, open-label, parallel-group, multi-centre phase II clinical trial with active cellular immunotherapy DCVAC/PCa  in patients with castrate-resistant prostate cancer",
    "Start Date": "2012-01-11",
    "Medical condition": [
      "metastatic castrate-resistant prostate cancer"
    ],
    "Disease": "Version: 19.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10036909, Term: Prostate cancer metastatic, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "CZ": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-004735-32"
  },
  {
    "EudraCT Number": "2010-023878-40",
    "Sponsor Protocol Number": "2.3",
    "Sponsor Name": "Medical University Vienna",
    "Full Title": "Influence of intra-arterial cerebral Papaverine Hydrochloride on cerebral glucose, lactate, pyruvate, glycerol, and glutamate concentrations, cerebral oxygenation, angiographic vasospasm, delayed s...",
    "Start Date": "2011-12-22",
    "Medical condition": [
      "To demonstrate the influence of intra-arterial cerebral Papaverine Hydrochloride on cerebral glucose",
      "lactate",
      "pyruvate",
      "glycerol",
      "and glutamate concentrations and cerebral oxygenation in patients ..."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "AT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-023878-40"
  },
  {
    "EudraCT Number": "2011-003254-90",
    "Sponsor Protocol Number": "CLFG316A2204",
    "Sponsor Name": "Novartis Pharma Services AG",
    "Full Title": "A randomised, active-controlled, open-label, multiple-dose, proof-of-concept study of intravitreal LFG316 in patients with active non-infectious intermediate-, posterior-, or panuveitis requiring s...",
    "Start Date": "2012-05-14",
    "Medical condition": [
      "Active non-infectious intermediate-",
      "posterior-",
      "or panuveitis requiring systemic immunosuppressive therapy"
    ],
    "Disease": "Version: 20.0, SOC Term:  100000014975, Classification Code: 10066681, Term: Acute uveitis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-003254-90"
  },
  {
    "EudraCT Number": "2012-003023-38",
    "Sponsor Protocol Number": "GERMAIN",
    "Sponsor Name": "Friedrich-Schiller-Universit\u00e4t Jena",
    "Full Title": "Phase II study of Bortezomib, Melphalan, Prednisone (VMP) followed by Lenalidomide maintenance vs. VMP without maintenance in Myeloma patients not eligible to high-dose chemotherapy and autologous ...",
    "Start Date": "2013-10-30",
    "Medical condition": [
      "multiple myeloma"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004864, Classification Code: 10028228, Term: Multiple myeloma, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-003023-38"
  },
  {
    "EudraCT Number": "2012-000756-34",
    "Sponsor Protocol Number": "2012.001",
    "Sponsor Name": "NeuroVive Pharmaceutical AB",
    "Full Title": "Copenhagen Head Injury Ciclosporin (CHIC) Study:  An open-label, uncontrolled Phase II -study to investigate pharmacokinetics, safety and biomarkers of effectiveness of NeuroSTAT\u00ae (ciclosporin) i...",
    "Start Date": "2012-11-02",
    "Medical condition": [
      "Severe Traumatic Brain Injury"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-000756-34"
  },
  {
    "EudraCT Number": "2015-002222-40",
    "Sponsor Protocol Number": "U31287-A-U203",
    "Sponsor Name": "Daiichi Sankyo , Inc.",
    "Full Title": "Randomized, Placebo-Controlled, Double Blind Phase 2 Study of Patritumab (U3-1287) in Combination with Cetuximab plus Platinum Based Therapy in First Line Setting in Subjects with Recurrent or Meta...",
    "Start Date": "2015-11-11",
    "Medical condition": [
      "Squamous Cell Carcinoma of the Head and Neck"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10060121, Term: Squamous cell carcinoma of head and neck, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "HU": "Completed"
      },
      {
        "BE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002222-40"
  },
  {
    "EudraCT Number": "2015-002163-42",
    "Sponsor Protocol Number": "DRM04-HH06",
    "Sponsor Name": "Dermira, Inc.",
    "Full Title": "AN OPEN-LABEL STUDY ASSESSING LONG-TERM SAFETY OF DRM04 IN SUBJECTS WITH PRIMARY AXILLARY HYPERHIDROSIS",
    "Start Date": "2015-10-13",
    "Medical condition": [
      "Primary axillary hyperhidrosis"
    ],
    "Disease": "Version: 19.1, SOC Term: 10040785 - Skin and subcutaneous tissue disorders, Classification Code: 10020642, Term: Hyperhidrosis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002163-42"
  },
  {
    "EudraCT Number": "2015-000872-89",
    "Sponsor Protocol Number": "MK001",
    "Sponsor Name": "University of Oxford",
    "Full Title": "ANODE: a randomised controlled trial of prophylactic ANtibiotics to investigate the prevention of infection following Operative vaginal DElivery.",
    "Start Date": "2015-10-29",
    "Medical condition": [
      "Maternal infection in the first six weeks after operative vaginal delivery."
    ],
    "Disease": "",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-000872-89"
  },
  {
    "EudraCT Number": "2017-003669-87",
    "Sponsor Protocol Number": "M14-064",
    "Sponsor Name": "Abbvie Deutschland GmbH & Co. KG",
    "Full Title": "Phase 2 Study Comparing Efficacy and Safety of ABT-165 and  FOLFIRI vs Bevacizumab and FOLFIRI in Metastatic Colorectal Cancer Previously  Treated with Fluoropyrimidine/Oxaliplatin and Bevacizumab",
    "Start Date": "2018-03-19",
    "Medical condition": [
      "metastatic adenocarcinoma of the colon or rectum previously treated with a regimen containing fluoropyrimidine/oxaliplatin and bevacizumab"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "BE": "Prematurely Ended"
      },
      {
        "ES": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003669-87"
  },
  {
    "EudraCT Number": "2014-000814-73",
    "Sponsor Protocol Number": "RG_14-072",
    "Sponsor Name": "University of Birmingham",
    "Full Title": "National Lung Matrix Trial: Multi-drug, genetic marker-directed, non-comparative, multi-centre, multi-arm phase II trial in non-small cell lung cancer",
    "Start Date": "2016-07-15",
    "Medical condition": [
      "Metastatic or locally advanced non-small cell lung cancer (NSCLC)"
    ],
    "Disease": "Version: 21.1, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10061873, Term: Non-small cell lung cancer, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-000814-73"
  },
  {
    "EudraCT Number": "2016-002873-36",
    "Sponsor Protocol Number": "A3L31",
    "Sponsor Name": "Sanofi Pasteur SA",
    "Full Title": "Immunogenicity and Safety of Sanofi Pasteur's DTaP-IPV-Hep B-PRP-T Combined Vaccine at 2, 4, and 6 Months of Age versus Sanofi Pasteur's DTaP-IPV//PRP~T Combined Vaccine at 2, 4, and 6 Months of Ag...",
    "Start Date": "2016-07-08",
    "Medical condition": [
      "Diphtheria",
      "Tetanus",
      "Pertussis",
      "Haemophilus Influenzae Type b infection",
      "Poliomyelitis",
      "and Hepatitis B"
    ]
  },
  {
    "Disease": "",
    "Population Age": [
      "Infants and toddlers",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002873-36"
  },
  {
    "EudraCT Number": "2017-004070-34",
    "Sponsor Protocol Number": "PRECAVE",
    "Sponsor Name": "Servicio de Urolog\u00eda. Hospital Universitario La Paz",
    "Full Title": "RANDOMIZED CLINICAL TRIAL, OPEN, TO EVALUATE THE BLADDER INSTILLATION OF NEOADYUVANT CHEMOTHERAPY TO THE TRANSURETHAL RESECTION OF BLADDER FOR THE PREVENTION OF RECURRENCE OF NONMUSCLE-INVASIVE URO...",
    "Start Date": "2018-01-29",
    "Medical condition": [
      "Non-muscle-invasive urothelial carcinoma"
    ],
    "Disease": "",
    "Population Age": [
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004070-34"
  },
  {
    "EudraCT Number": "2018-000775-32",
    "Sponsor Protocol Number": "AB.OH.2018",
    "Sponsor Name": "Vall d'Hebron Institut de Recerca",
    "Full Title": "Phase IV, randomized, open, parallel groups clinical trial for evaluating the early Stop of antibiotic Treatment in febrile neutropenic Oncohematological Paediatric patients.",
    "Start Date": "2018-06-05",
    "Medical condition": [
      "Febrile neutrophenia in oncohematological pediatric patients."
    ],
    "Disease": "Version: 20.0, SOC Term: 10005329 - Blood and lymphatic system disorders, Classification Code: 10016288, Term: Febrile neutropenia, Level: PT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-000775-32"
  },
  {
    "EudraCT Number": "2018-003520-37",
    "Sponsor Protocol Number": "RG_18-220",
    "Sponsor Name": "University of Birmingham",
    "Full Title": "A multi-stage randomised trial of durvalumab (Medi4736) with chemoradiotherapy with 5-fluorouracil and mitomycin C in patients with muscle-invasive bladder cancer",
    "Start Date": "2020-02-07",
    "Medical condition": [
      "Muscle invasive bladder cancer"
    ],
    "Disease": "Version: 21.1, SOC Term: 100000004864, Classification Code: 10022877, Term: Invasive bladder cancer, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-003520-37"
  },
  {
    "EudraCT Number": "2016-000078-39",
    "Sponsor Protocol Number": "GEO-2014/01-HR",
    "Sponsor Name": "PLIVA Hrvatska d.o.o.",
    "Full Title": "A prospective, multicentre, uncontrolled study of Geonistin vaginal tablets effectiveness with pharmacokinetic evaluation for unspecific and mixed vulvovaginal infections characterized by vaginal d...",
    "Start Date": "2016-05-25",
    "Medical condition": [
      "Unspecific and mixed vulvovaginal infections characterized by vaginal discharge."
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "HR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000078-39"
  },
  {
    "EudraCT Number": "2015-005593-38",
    "Sponsor Protocol Number": "NN9924-4257",
    "Sponsor Name": "Novo Nordisk A/S",
    "Full Title": "Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation versus Sitagliptin in Subjects with Type 2 Diabetes Mellitus. A 52 week Randomised, Open-label,...",
    "Start Date": "2016-09-09",
    "Medical condition": [
      "Diabetes Mellitus",
      "Type 2"
    ],
    "Disease": "Version: 20.0, SOC Term:  100000072461, Classification Code: 10045242, Term: Type II diabetes mellitus, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "BE": "Completed"
      },
      {
        "AT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005593-38"
  },
  {
    "EudraCT Number": "2015-005614-30",
    "Sponsor Protocol Number": "SOAP2016",
    "Sponsor Name": "Uzsoki Utcai K\u00f3rh\u00e1z",
    "Full Title": "SOAP Antibiotic prophylaxis trial  Systemic versus combined systemic and Oral Antibiotic Prophylaxis in elective colorectal surgery",
    "Start Date": "2016-07-07",
    "Medical condition": [
      "In colorectal surgery wildely used bowel prep and systemic antibiotic prophylaxis. New data suggest that infective complications can be lowered if beside this regimen oral antibiotic profilaxis is ..."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005614-30"
  },
  {
    "EudraCT Number": "2016-004091-21",
    "Sponsor Protocol Number": "UCL/16/0587",
    "Sponsor Name": "University College London",
    "Full Title": "Nivolumab and ipilimumab treatment in prostate cancer with an immunogenic signature",
    "Start Date": "2017-08-23",
    "Medical condition": [
      "Metastatic castrate resistant prostate cancer (prostate adenocarcinoma)"
    ],
    "Disease": "Version: 21.0, SOC Term: 100000004864, Classification Code: 10001198, Term: Adenocarcinoma of the prostate metastatic, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004091-21"
  },
  {
    "EudraCT Number": "2017-001735-39",
    "Sponsor Protocol Number": "CMX001-999",
    "Sponsor Name": "Chimerix, Inc",
    "Full Title": "An Open-label, Randomized, Multi-center, Parallel Group, Two-arm Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir versus Standard of Care for Treatment of A...",
    "Start Date": "Information not available in EudraCT",
    "Medical condition": [
      "Treatment of adenovirus infections in high-risk  pediatric allogeneic hematopoietic cell transplant recipients"
    ],
    "Disease": "Version: 20.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10060931, Term: Adenovirus infection, Level: PT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IE": "Completed"
      },
      {
        "DE": "Prematurely Ended"
      },
      {
        "ES": "Prematurely Ended"
      },
      {
        "IT": "Prematurely Ended"
      },
      {
        "FR": "Completed"
      },
      {
        "NL": "Prematurely Ended"
      },
      {
        "GB": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-001735-39"
  },
  {
    "EudraCT Number": "2020-001157-48",
    "Sponsor Protocol Number": "20HH5896",
    "Sponsor Name": "Imperial College London",
    "Full Title": "Identifying a safe and tolerated dose of Imatinib for patients with Pulmonary Arterial Hypertension (PAH)",
    "Start Date": "2020-07-28",
    "Medical condition": [
      "Pulmonary Arterial Hypertension (Idiopathic",
      "heritable",
      "or assosicated with anorexigens)"
    ],
    "Disease": "Version: 20.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10050701, Term: Congenital pulmonary hypertension, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001157-48"
  },
  {
    "EudraCT Number": "2015-003331-36",
    "Sponsor Protocol Number": "FER-Loxapine-2015-01",
    "Sponsor Name": "FERRER INTERNACIONAL SA",
    "Full Title": "A Phase IV, Open-label, Non-randomized, Clinical Trial to Evaluate the Safety of self-administered ADASUVE(R) (Staccato loxapine for inhalation) in Agitated Patients outside the hospital setting",
    "Start Date": "2016-03-16",
    "Medical condition": [
      "Mild-to-moderate agitation in adult patients with schizophrenia or bipolar disorder"
    ],
    "Disease": "Version: 20.0, SOC Term: 10037175 - Psychiatric disorders, Classification Code: 10001497, Term: Agitation, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "AT": "Completed"
      },
      {
        "NO": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003331-36"
  },
  {
    "EudraCT Number": "2015-000630-30",
    "Sponsor Protocol Number": "AC-AD-003",
    "Sponsor Name": "AXON NEUROSCIENCE SE",
    "Full Title": "\u201cADAMANT\u201d A 24-months randomised, placebo-controlled, parallel group, double blinded, multi centre, phase 2 study to assess safety and efficacy of AADvac1 applied to patients with mild Alzheimer\u2019s ...",
    "Start Date": "2015-11-26",
    "Medical condition": [
      "Alzheimer\u2019s disease"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "AT": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "SE": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "SK": "Completed"
      },
      {
        "SI": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-000630-30"
  },
  {
    "EudraCT Number": "2016-002075-10",
    "Sponsor Protocol Number": "GN14NE598",
    "Sponsor Name": "NHS Greater Glasgow & Clyde",
    "Full Title": "Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis 2",
    "Start Date": "2016-09-21",
    "Medical condition": [
      "Acute ischaemic stroke"
    ],
    "Disease": "Version: 21.1, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10061256, Term: Ischaemic stroke, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002075-10"
  },
  {
    "EudraCT Number": "2016-002349-50",
    "Sponsor Protocol Number": "M16TGA",
    "Sponsor Name": "Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital (NKI-AVL)",
    "Full Title": "Phase I/II study with galunisertib (LY2157299) combined with capecitabine in patients with advanced chemotherapy resistant colorectal cancer and an activated TGF-\u03b2 signature",
    "Start Date": "2017-09-29",
    "Medical condition": [
      "colorectal carcinoma"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      },
      {
        "BE": "Prematurely Ended"
      },
      {
        "ES": "Prematurely Ended"
      },
      {
        "IT": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002349-50"
  },
  {
    "EudraCT Number": "2017-000495-28",
    "Sponsor Protocol Number": "132",
    "Sponsor Name": "Respiratory Research Unit, Bispebjerg University Hospital",
    "Full Title": "SIGNATURE - the 6-gene signature as a predictor of response to treatment in severe asthma and ACOS",
    "Start Date": "2017-05-18",
    "Medical condition": [
      "Severe asthma and astma-COPD overlap syndrome"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004855, Classification Code: 10068462, Term: Eosinophilic asthma, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000495-28"
  },
  {
    "EudraCT Number": "2013-003301-26",
    "Sponsor Protocol Number": "IAFIPF001",
    "Sponsor Name": "Newcastle Upon Tyne Hospitals NHS Foundation Trust",
    "Full Title": "A randomised placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis (IPF)",
    "Start Date": "2013-09-20",
    "Medical condition": [
      "Idiopathic Pulmonary Fibrosis (IPF)"
    ],
    "Disease": "Version: 19.0, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10021240, Term: Idiopathic pulmonary fibrosis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-003301-26"
  },
  {
    "EudraCT Number": "2014-003644-12",
    "Sponsor Protocol Number": "2014-003644-12",
    "Sponsor Name": "Neuromuscular Research Unit, Rigshospitalet",
    "Full Title": "The effect of Triheptanoin in adults with McArdle Disease (Glycogen Storage Disease Type V)",
    "Start Date": "2015-02-20",
    "Medical condition": [
      "McArdle Disease"
    ],
    "Also called": "Glycogen Storage Disease Type V or Myophosphorylase Deficiency",
    "Disease": "Version: 19.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10018462, Term: Glycogen storage disease type V, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-003644-12"
  },
  {
    "EudraCT Number": "2017-000494-36",
    "Sponsor Protocol Number": "AC-083-103",
    "Sponsor Name": "Idorsia Pharmaceuticals Ltd",
    "Full Title": "A Phase 2a, multi-center, single-blind, within-subject, placebo-controlled study to assess the pharmacodynamics of ACT-709478 in subjects with photosensitive epilepsy",
    "Start Date": "2017-07-26",
    "Medical condition": [
      "Photosensitive epilepsy"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "FR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000494-36"
  },
  {
    "EudraCT Number": "2014-003503-29",
    "Sponsor Protocol Number": "D5553C00003",
    "Sponsor Name": "AstraZeneca AB",
    "Full Title": "A 28-week, Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Study with a 24-week Extension Phase Followed by a 52-week Extension Phase to Evaluate the Efficacy and Safety of Simult...",
    "Start Date": "2014-12-16",
    "Medical condition": [
      "Diabetes Mellitus"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004860, Classification Code: 10012602, Term: Diabetes mellitus (incl subtypes), Level: HLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "SK": "Completed"
      },
      {
        "HU": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-003503-29"
  },
  {
    "EudraCT Number": "2014-004909-33",
    "Sponsor Protocol Number": "LCTU122",
    "Sponsor Name": "Manchester University NHS Foundation Trust",
    "Full Title": "Thrombin Inhibition Preoperatively in Early Breast Cancer",
    "Start Date": "2015-09-21",
    "Medical condition": [
      "Breast Cancer"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10057654, Term: Breast cancer female, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-004909-33"
  },
  {
    "EudraCT Number": "2015-005406-11",
    "Sponsor Protocol Number": "D1683C00005",
    "Sponsor Name": "Astrazeneca AB",
    "Full Title": "A Multi-Center, Randomized, Double-Blind, Active-Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin 5mg Co-administered with Dapagliflozin 5mg compared t...",
    "Start Date": "2016-05-25",
    "Medical condition": [
      "Type 2 diabetes mellitus",
      "inadequate glycaemic control"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "CZ": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005406-11"
  },
  {
    "EudraCT Number": "2013-005543-90",
    "Sponsor Protocol Number": "20130108",
    "Sponsor Name": "Amgen Inc",
    "Full Title": "A Randomized, Double-Blind Study to Compare Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of ABP 798 With Rituximab in Subjects With Moderate to Severe Rheumatoid Arthritis",
    "Start Date": "2014-08-26",
    "Medical condition": [
      "Rheumatoid arthritis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10028395 - Musculoskeletal and connective tissue disorders, Classification Code: 10039073, Term: Rheumatoid arthritis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "PL": "Completed"
      },
      {
        "BG": "Completed"
      },
      {
        "EE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-005543-90"
  },
  {
    "EudraCT Number": "2016-000376-26",
    "Sponsor Protocol Number": "ZPL521/101",
    "Sponsor Name": "Ziarco Pharma Ltd",
    "Full Title": "A Randomised, Adaptive Design, Double-Blind (3rd Party Open), Placebo Controlled, Sequential Group Study to  Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Applica...",
    "Start Date": "2016-05-09",
    "Medical condition": [
      "Atopic Dermatitis"
    ],
    "Disease": "Version: 18.1, SOC Term: 100000004858, Classification Code: 10003639, Term: Atopic dermatitis, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000376-26"
  },
  {
    "EudraCT Number": "2017-002449-31",
    "Sponsor Protocol Number": "ZP4207-16137",
    "Sponsor Name": "Zealand Pharma A/S",
    "Full Title": "A phase 3, randomized, double-blind, parallel trial to confirm the clinical efficacy and safety of dasiglucagon in the rescue treatment of hypoglycemia in subjects with type 1 diabetes mellitus (T1...",
    "Start Date": "2018-02-16",
    "Medical condition": [
      "Type 1 diabetes mellitus"
    ],
    "Disease": "Version: 20.0, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10027433, Term: Metabolism and nutrition disorders, Level: SOC",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "AT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002449-31"
  },
  {
    "EudraCT Number": "2020-001109-22",
    "Sponsor Protocol Number": "PBGM01-001",
    "Sponsor Name": "Passage Bio, Inc.",
    "Full Title": "A Phase 1/2 Open-Label, Multicenter, Dose Ranging and Confirmatory Study to Assess the Safety, Tolerability and Efficacy of a Single Dose of PBGM01 Delivered into the Cisterna Magna of Pediatric Su...",
    "Start Date": "Information not available in EudraCT",
    "Medical condition": [
      "GM1 gangliosidosis (GM1) is an autosomal recessive disorder that results from mutations in the human galactosidase beta 1 gene (GLB1)",
      "which encodes beta-galactosidase (\u03b2-gal)."
    ],
    "Disease": "",
    "Population Age": [
      "Infants and toddlers",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001109-22"
  },
  {
    "EudraCT Number": "2015-005674-37",
    "Sponsor Protocol Number": "COL-MIG-305(H8H-CD-LAHL)",
    "Sponsor Name": "Eli Lilly and Company",
    "Full Title": "An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)",
    "Start Date": "2016-11-01",
    "Medical condition": [
      "acute migraine"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10027607, Term: Migraine with aura, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005674-37"
  },
  {
    "EudraCT Number": "2016-000593-38",
    "Sponsor Protocol Number": "MR308-3502",
    "Sponsor Name": "Mundipharma Research GmbH & Co. KG",
    "Full Title": "A Randomized, Double-Blind, Multicenter, Placebo- and active Comparator-Controlled Study to evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Abdominal Hysterectomy Surgery...",
    "Start Date": "2016-12-05",
    "Medical condition": [
      "Acute pain after open total or subtotal abdominal hysterectomy"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004867, Classification Code: 10066714, Term: Acute pain, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Completed"
      },
      {
        "SK": "Completed"
      },
      {
        "LV": "Completed"
      },
      {
        "PL": "Completed"
      },
      {
        "BG": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000593-38"
  },
  {
    "EudraCT Number": "2013-004615-45",
    "Sponsor Protocol Number": "BPR-PIP-002",
    "Sponsor Name": "Basilea Pharmaceutica International Ltd",
    "Full Title": "A multicentre, randomized, investigator-blind, active-controlled study to evaluate the safety, tolerability, pharmacokinetics and efficacy of ceftobiprole versus intravenous standard-of-care cephal...",
    "Start Date": "2016-12-02",
    "Medical condition": [
      "Hospital-acquired pneumonia or community-acquired pneumonia requiring hospitalisation."
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004862, Classification Code: 10052596, Term: Nosocomial pneumonia, Level: LLT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      },
      {
        "BG": "Completed"
      },
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-004615-45"
  },
  {
    "EudraCT Number": "2017-001351-31",
    "Sponsor Protocol Number": "ED17/93260",
    "Sponsor Name": "University of Leeds",
    "Full Title": "A double-blind, randomized, placebo-controlled phase II pilot trial investigating efficacy, safety and feasibility of 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibition by AZD4017 to improve skin f...",
    "Start Date": "2017-09-04",
    "Medical condition": [
      "Type 2 diabetes"
    ],
    "Disease": "Version: 20.0, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10067585, Term: Type 2 diabetes mellitus, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-001351-31"
  },
  {
    "EudraCT Number": "2017-000724-10",
    "Sponsor Protocol Number": "60978",
    "Sponsor Name": "Academic Medical Center",
    "Full Title": "Targeting esophageal cancer with HDL nanoparticles: an imaging study",
    "Start Date": "2018-07-04",
    "Medical condition": [
      "Primary esophageal cancer"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000724-10"
  },
  {
    "EudraCT Number": "2016-001223-31",
    "Sponsor Protocol Number": "KAISII",
    "Sponsor Name": "King's College Hospital NHS Foundation Trust",
    "Full Title": "Incidence of Invasive Fungal Disease in Patients receiving Immunosuppressive Therapy, Intensive Chemotherapy or Reduced Intensity Haematopoietic Stem Cell Transplantation on Posaconazole Prophylaxis",
    "Start Date": "2016-10-11",
    "Medical condition": [
      "Aplastic Anaemia",
      "Myelodysplastic syndromes",
      "Acute Myeloid Leukaemia undergoing immunosuppression therapy",
      "high dose chemotherapy or reduced intensity stem cell transplantation"
    ],
    "Disease": "Version: 19.0, SOC Term: 10005329 - Blood and lymphatic system disorders, Classification Code: 10002967, Term: Aplastic anaemia, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001223-31"
  },
  {
    "EudraCT Number": "2016-001853-41",
    "Sponsor Protocol Number": "57698",
    "Sponsor Name": "Academic Medical Center",
    "Full Title": "Intensive endoscopic therapy versus conventional treatment for untreated benign anastomotic strictures after esophagectomy: a pilot and randomized controlled trial",
    "Start Date": "2018-09-19",
    "Medical condition": [
      "Benign esophagogastric anastomotic strictures after esophagectomy"
    ],
    "Disease": "Version: 20.0, SOC Term: 10042613 - Surgical and medical procedures, Classification Code: 10015460, Term: Esophagectomy, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001853-41"
  },
  {
    "EudraCT Number": "2014-002209-39",
    "Sponsor Protocol Number": "M14LTK",
    "Sponsor Name": "The Netherlands Cancer Institute",
    "Full Title": "Phase I/II study with lapatinib plus trametinib in patients with metastatic KRAS mutant non-small cell lungcancer",
    "Start Date": "2014-07-30",
    "Medical condition": [
      "non-small cell lung cancer"
    ]
  },
  {
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-002209-39"
  },
  {
    "EudraCT Number": "2016-004529-17",
    "Sponsor Protocol Number": "YO39609",
    "Sponsor Name": "F. Hoffman-La Roche Ltd",
    "Full Title": "A PHASE Ib/II, OPEN-LABEL, MULTICENTER, RANDOMIZED, UMBRELLA STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE IMMUNOTHERAPY-BASED TREATMENT COMBINATIONS IN PATIENTS WITH LOCALLY ADVANCED UNRESE...",
    "Start Date": "2018-07-17",
    "Medical condition": [
      "Locally advanced unresectable or Metastatic gastric or gastroesophageal junction cancer or esophageal cancer"
    ],
    "Disease": "Version: 21.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10030151, Term: Oesophageal cancer, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      },
      {
        "ES": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004529-17"
  },
  {
    "EudraCT Number": "2015-004898-32",
    "Sponsor Protocol Number": "SAM103848",
    "Sponsor Name": "GlaxoSmithKline Research & Development Ltd.",
    "Full Title": "Pediatric Asthma Clinical Effectiveness study (PEACE). A Randomized, Double-Blind, Double Dummy, Parallel Group comparative clinical study of Salmeterol/Fluticasone propionate Inhalation Powder (50...",
    "Start Date": "2016-12-08",
    "Medical condition": [
      "Asthma"
    ],
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004898-32"
  },
  {
    "EudraCT Number": "2016-000416-15",
    "Sponsor Protocol Number": "GS-US-342-2104",
    "Sponsor Name": "Gilead Sciences, Inc.",
    "Full Title": "A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination in Subjects with Chronic HCV Infection who have Received a Liver Transp...",
    "Start Date": "2016-07-14",
    "Medical condition": [
      "Chronic Hepatitis C virus infection"
    ],
    "Disease": "Version: 19.0, SOC Term: 10019805 - Hepatobiliary disorders, Classification Code: 10019754, Term: Hepatitis cholestatic, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000416-15"
  },
  {
    "EudraCT Number": "2017-001831-38",
    "Sponsor Protocol Number": "ENB-009-10",
    "Sponsor Name": "Alexion Pharma GmbH",
    "Full Title": "A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Concurrent Control Study of the Safety, Efficacy, and Pharmacokinetics of ENB-0040 (Human Recombinant Tissue-Nonspecific Alkaline...",
    "Start Date": "2017-05-09",
    "Medical condition": [
      "Hypophosphatasia"
    ],
    "Disease": "Version: 20.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10049933, Term: Hypophosphatasia, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-001831-38"
  },
  {
    "EudraCT Number": "2015-005495-19",
    "Sponsor Protocol Number": "RVT-101-2001",
    "Sponsor Name": "Axovant Sciences Inc.",
    "Full Title": "A Phase 2b, double-blind, randomized, placebo-controlled study of RVT-101 in subjects with dementia with Lewy bodies (DLB).",
    "Start Date": "2016-06-13",
    "Medical condition": [
      "Dementia with Lewy Bodies"
    ],
    "Disease": "Version: 19.0, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10067889, Term: Dementia with Lewy bodies, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Completed"
      },
      {
        "NL": "Completed"
      },
      {
        "IT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005495-19"
  },
  {
    "EudraCT Number": "2016-003962-24",
    "Sponsor Protocol Number": "6632-9050-04",
    "Sponsor Name": "Medice Arzneimittel P\u00fctter GmbH & Co. KG",
    "Full Title": "A multi-centre, randomized, placebo-controlled, double-blind, parallel-group study investigating safety and efficacy of a sore throat lozenge in the symptomatic treatment of patients with acute pha...",
    "Start Date": "2016-12-27",
    "Medical condition": [
      "Acute Pharyngitis"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003962-24"
  },
  {
    "EudraCT Number": "2017-002281-46",
    "Sponsor Protocol Number": "NN7008-4304",
    "Sponsor Name": "Novo Nordisk A/S",
    "Full Title": "Safety of turoctocog alfa for prophylaxis and treatment of bleeding episodes in previously treated patients with moderate or severe Haemophilia A in India.",
    "Start Date": "2018-02-20",
    "Medical condition": [
      "Haemophilia A"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004850, Classification Code: 10018938, Term: Haemophilia A (Factor VIII), Level: LLT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002281-46"
  },
  {
    "EudraCT Number": "2014-002266-71",
    "Sponsor Protocol Number": "GN14RE146",
    "Sponsor Name": "NHS Greater Glasgow and Clyde",
    "Full Title": "The role of Qutenza (topical capsaicin 8%) in treating neuropathic pain from arteriovenous fistulae in patients with end stage renal failure",
    "Start Date": "2015-01-02",
    "Medical condition": [
      "Chronic neuropathic pain from arteriovenous fistulae in patients with end stage renal failure"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004852, Classification Code: 10054095, Term: Neuropathic pain, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-002266-71"
  },
  {
    "EudraCT Number": "2019-004657-89",
    "Sponsor Protocol Number": "BIOS-16-001",
    "Sponsor Name": "Ethicon Inc",
    "Full Title": "A Prospective Study Evaluating the Safety and Effectiveness of EVARREST\u00ae Fibrin Sealant Patch in Controlling Mild or Moderate Hepatic Parenchyma or Soft Tissue Bleeding During Open, Abdominal, Retr...",
    "Start Date": "2020-12-14",
    "Medical condition": [
      "Mild or moderate hepatic parenchyma or soft tissue bleeding during"
    ],
    "Disease": "",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-004657-89"
  },
  {
    "EudraCT Number": "2016-002996-91",
    "Sponsor Protocol Number": "CB8025-21629",
    "Sponsor Name": "CymaBay Therapeutics, Inc.",
    "Full Title": "An 8-week, dose ranging, open label, randomized, Phase 2 study with a 44-week extension, to evaluate the safety and efficacy of MBX-8025 in subjects with Primary Biliary Cholangitis (PBC) and an in...",
    "Start Date": "2017-02-21",
    "Medical condition": [
      "Primary Biliary Cholangitis"
    ],
    "Disease": "Version: 20.1, SOC Term: 100000004871, Classification Code: 10036680, Term: Primary biliary cirrhosis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002996-91"
  },
  {
    "EudraCT Number": "2016-003408-29",
    "Sponsor Protocol Number": "5F9003",
    "Sponsor Name": "Gilead Sciences, Inc.",
    "Full Title": "A Phase 1b/2 Trial of Hu5F9-G4 in Combination with Rituximab or Rituximab + Chemotherapy in Patients with Relapsed/Refractory B-cell Non-Hodgkin\u2019s Lymphoma",
    "Start Date": "2019-11-04",
    "Medical condition": [
      "Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma."
    ],
    "Disease": "Version: 23.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10065856, Term: Non-Hodgkin's lymphoma unspecified histology indolent, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003408-29"
  },
  {
    "EudraCT Number": "2017-000406-38",
    "Sponsor Protocol Number": "DEX-09-08",
    "Sponsor Name": "Hospira Inc",
    "Full Title": "A Phase II/III, Open-Label, Multicenter, Safety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Neonates Ages \u2265 28 Weeks to \u2264 44 Weeks Gestational Age",
    "Start Date": "2017-02-27",
    "Medical condition": [
      "Initially intubated and mechanically ventilated preterm"
    ],
    "Disease": "",
    "Population Age": [
      "Infants and toddlers",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000406-38"
  },
  {
    "EudraCT Number": "2015-002449-71",
    "Sponsor Protocol Number": "LP0084-1193",
    "Sponsor Name": "LEO Pharma A/S",
    "Full Title": "Efficacy and Safety of LEO 43204 in Field Treatment of  Actinic Keratosis on Face or Chest including 12-month follow-up Part 1: 3-day treatment period including an 8-week follow-up period Part 2:...",
    "Start Date": "2015-12-23",
    "Medical condition": [
      "Actinic Keratosis"
    ],
    "Disease": "Version: 19.0, SOC Term: 10040785 - Skin and subcutaneous tissue disorders, Classification Code: 10000614, Term: Actinic keratosis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002449-71"
  },
  {
    "EudraCT Number": "2016-001278-13",
    "Sponsor Protocol Number": "PROSIBD",
    "Sponsor Name": "Taina Sipponen",
    "Full Title": "Immunologic, genetic and microbiomic predictors of the treatment response for TNFalpha-blocking drugs \u2013  prospective follow-up cohort of patients with Crohn\u2019s disease or ulcerative colitis",
    "Start Date": "2016-06-08",
    "Medical condition": [
      "Ulcerative colitis and Crohn's disease"
    ],
    "Disease": "Version: 19.0, SOC Term: 10017947 - Gastrointestinal disorders, Classification Code: 10011400, Term: Crohn's colitis, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FI": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001278-13"
  },
  {
    "EudraCT Number": "2016-001826-33",
    "Sponsor Protocol Number": "NA-1-007",
    "Sponsor Name": "NoNO Inc.",
    "Full Title": "A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Intravenous NA-1 in Subjects with Acute Ischemic Stroke Und...",
    "Start Date": "2017-07-07",
    "Medical condition": [
      "Acute Ischemic Stroke (AIS) in adult subjects with a large intracranial arterial occlusion",
      "a small ischemic core",
      "and good collaterals."
    ],
    "Disease": "Version: 20.1, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10074318, Term: Nonhemorrhagic stroke, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IE": "Completed"
      },
      {
        "GB": "Completed"
      },
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001826-33"
  },
  {
    "EudraCT Number": "2017-004047-20",
    "Sponsor Protocol Number": "NN1250-4419",
    "Sponsor Name": "Novo Nordisk A/S",
    "Full Title": "A randomised, cross-over, open-label, multi-centre trial comparing the effect of insulin degludec and insulin glargine 100U/mL, with or without OADs in subjects with type 2 diabetes using flash glu...",
    "Start Date": "2018-08-28",
    "Medical condition": [
      "Diabetes Mellitus",
      "Type 2"
    ],
    "Disease": "Version: 20.1, SOC Term: 100000004861, Classification Code: 10045242, Term: Type II diabetes mellitus, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "PL": "Completed"
      },
      {
        "SK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004047-20"
  },
  {
    "EudraCT Number": "2018-002532-24",
    "Sponsor Protocol Number": "0155/2018",
    "Sponsor Name": "HELM AG",
    "Full Title": "A phase III, multicentre, randomised, double-blind, parallel-group trial to evaluate the efficacy and safety of a generic gel (calcipotriol + betamethasone 50 \u03bcg/g + 0.5 mg/g gel) compared to origi...",
    "Start Date": "2018-12-27",
    "Medical condition": [
      "mild to moderate plaque-type psoriasis"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004858, Classification Code: 10071117, Term: Plaque psoriasis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-002532-24"
  },
  {
    "EudraCT Number": "2015-000700-26",
    "Sponsor Protocol Number": "178-CL-203",
    "Sponsor Name": "Astellas Pharma Europe B.V.",
    "Full Title": "A multicentre, open-label, single dose, phase 1 study to evaluate the pharmacokinetics, safety and tolerability of mirabegron oral suspension in pediatric subjects from 3 to less than 12 years of a...",
    "Start Date": "2015-09-23",
    "Medical condition": [
      "-neurogenic detrusor overactivity (NDO)"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004857, Classification Code: 10059617, Term: Overactive bladder, Level: LLT",
    "Population Age": [
      "Children",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-000700-26"
  },
  {
    "EudraCT Number": "2016-003658-34",
    "Sponsor Protocol Number": "9732",
    "Sponsor Name": "University Hospital of Montpellier",
    "Full Title": "Non-inferiority of intranasal fentanyl versus oral morphine sulfate in the treatment of pain in pediatric trauma : a controled randomized , single blind study",
    "Start Date": "Information not available in EudraCT",
    "Medical condition": [
      "traumatic pain"
    ],
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003658-34"
  },
  {
    "EudraCT Number": "2015-004066-28",
    "Sponsor Protocol Number": "AMLSG2415",
    "Sponsor Name": "University Hospital Ulm",
    "Full Title": "A Phase II Study with a Safety Run-in Phase Evaluating Vosaroxin With Azacitidine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia and Intermediate/Adverse Genetic Risk or Myelodysplas...",
    "Start Date": "2018-04-04",
    "Medical condition": [
      "Patients with confirmed diagnosis of acute myeloid leukemia (WHO 2016) and intermediate or adverse genetic risk (according to 2017 ELN recommendations); or patients with myelodysplastic syndrome wi..."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004066-28"
  },
  {
    "EudraCT Number": "2018-001067-23",
    "Sponsor Protocol Number": "PasHypo",
    "Sponsor Name": "Zealand University Hospital",
    "Full Title": "Pasireotide in the treatment of hypoglycemia following gastric bypass surgery",
    "Start Date": "2018-05-07",
    "Medical condition": [
      "Postprandial reactive hypoglycemia in patients with prior Roux-en-Y"
    ],
    "Disease": "Version: 20.1, SOC Term: 100000004861, Classification Code: 10059038, Term: Postprandial hypoglycemia, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-001067-23"
  },
  {
    "EudraCT Number": "2019-001314-41",
    "Sponsor Protocol Number": "69501",
    "Sponsor Name": "",
    "Full Title": "Kinetics of ivacaftor at Switch Orkambi Symkevi study",
    "Start Date": "2019-05-06",
    "Medical condition": [
      "Cystic fibrosis"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-001314-41"
  },
  {
    "EudraCT Number": "2020-001995-13",
    "Sponsor Protocol Number": "BREATH-19",
    "Sponsor Name": "Fundaci\u00f3n SEIMC-GESIDA",
    "Full Title": "A multicentre, open-label clinical trial to evaluate the effectiveness and safety of intravenous tocilizumab for treating patients with COVID-19 pneumonia: the BREATH-19 Study",
    "Start Date": "2020-05-15",
    "Medical condition": [
      "COVID-19 pneumonia"
    ],
    "Disease": "Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001995-13"
  },
  {
    "EudraCT Number": "2015-005275-24",
    "Sponsor Protocol Number": "TACPKPD",
    "Sponsor Name": "HOSPITAL UNIVERSITARI DE BELLVITGE",
    "Full Title": "Conversion pharmacodynamic study in stable renal transplant patients receiving tacrolimus two times a day to a new formulation of tacrolimus - LCP Tacro - 1 time a day.",
    "Start Date": "2016-03-18",
    "Medical condition": [
      "REJECTION PROPHYLAXIS IN RENAL TRANSPLANT PATIENTS"
    ],
    "Disease": "Version: 18.1, SOC Term: 10042613 - Surgical and medical procedures, Classification Code: 10038533, Term: Renal transplant, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005275-24"
  },
  {
    "EudraCT Number": "2014-004132-20",
    "Sponsor Protocol Number": "D9423C00001",
    "Sponsor Name": "AstraZeneca K.K.",
    "Full Title": "A multicentre, double-blind, randomised, parallel-group, Phase III study to assess efficacy and safety of D9421-C 9 mg versus Mesalazine 3 g in patients with active Crohn\u2019s Disease in Japan",
    "Start Date": "2016-07-28",
    "Medical condition": [
      "Active Crohn\u2019s Disease"
    ],
    "Disease": "Version: 19.0, SOC Term: 10017947 - Gastrointestinal disorders, Classification Code: 10011401, Term: Crohn's disease, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-004132-20"
  },
  {
    "EudraCT Number": "2017-000960-14",
    "Sponsor Protocol Number": "FM57",
    "Sponsor Name": "Futura Medical Developments Ltd.",
    "Full Title": "A Phase III, dose ranging, multi-centre, randomised, double blind, placebo controlled, home use, parallel group clinical trial of topically-applied glyceryl trinitrate (GTN) for the treatment of er...",
    "Start Date": "2018-12-19",
    "Medical condition": [
      "Erectile dysfunction"
    ],
    "Disease": "Version: 20.0, SOC Term: 10038604 - Reproductive system and breast disorders, Classification Code: 10052003, Term: Erectile dysfunction NOS, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "LV": "Prematurely Ended"
      },
      {
        "HU": "Prematurely Ended"
      },
      {
        "SK": "Completed"
      },
      {
        "PL": "Prematurely Ended"
      },
      {
        "CZ": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000960-14"
  },
  {
    "EudraCT Number": "2020-002011-21",
    "Sponsor Protocol Number": "MARACOVID",
    "Sponsor Name": "Fundaci\u00f3n para la Investigaci\u00f3n e Innovaci\u00f3n Biom\u00e9dica del Hospital Universitario Infanta Leonor y Sureste (FIIB)",
    "Full Title": "Bicentric, phase 2, randomized, open-label study to evaluate the efficacy and safety of maraviroc associated with standard treatment in hospitalized patients with pulmonary SARS-CoV-2 infection (CO...",
    "Start Date": "2020-06-02",
    "Medical condition": [
      "COVID-19 Pneumonia"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002011-21"
  },
  {
    "EudraCT Number": "2016-001238-89",
    "Sponsor Protocol Number": "FACE",
    "Sponsor Name": "Consorci Mar Parc de Salut de Barcelona (Parc de Salut MAR)",
    "Full Title": "IRON DEFICIENCY IN PATIENTS WITH COPD: IMPACT OF TOPPING WITH IRON CARBOXYMALTOSE. FACE STUDY (ASSESSMENT IN PATIENTS WITH FERINJECT AND IRON DEFICIENCY COPD TO IMPROVE EXERCISE TOLERANCE)",
    "Start Date": "2016-06-15",
    "Medical condition": [
      "Iron deficiency in Chronic obstructive pulmonary disease patients (COPD)"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001238-89"
  },
  {
    "EudraCT Number": "2016-001557-41",
    "Sponsor Protocol Number": "Adim-QIS-01",
    "Sponsor Name": "Adimmune Corporation",
    "Full Title": "A Phase III, Multi-center, Single-dose, Randomized, Double-blind, Non-inferiority and Lot-to-lot Consistency Study of Immunogenicity and Safety Evaluation of AdimFlu-S Quadrivalent Inactivated Infl...",
    "Start Date": "2016-09-09",
    "Medical condition": [
      "healthy volunteers"
    ],
    "Disease": "Version: 19.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10022000, Term: Influenza, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "BE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001557-41"
  },
  {
    "EudraCT Number": "2014-001290-14",
    "Sponsor Protocol Number": "EMR200136_583",
    "Sponsor Name": "MERCK ROMANIA SRL",
    "Full Title": "Prospective Phase IV Clinical Trial on Effectiveness of Rebif Treatment of CIS and RMS Patients in Romania using Electronic Device RebiSmart\u2122",
    "Start Date": "2014-10-24",
    "Medical condition": [
      "Clinical isolated syndrome and relapse multiple sclerosis"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "RO": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-001290-14"
  },
  {
    "EudraCT Number": "2017-003846-26",
    "Sponsor Protocol Number": "C-05-69",
    "Sponsor Name": "Alcon Research Ltd",
    "Full Title": "Safety Study of Olopatadine Nasal Spray",
    "Start Date": "2017-11-19",
    "Medical condition": [
      "perennial allergic rhinitis"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004855, Classification Code: 10034382, Term: Perennial allergic rhinitis, Level: LLT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003846-26"
  },
  {
    "EudraCT Number": "2017-004669-28",
    "Sponsor Protocol Number": "1704-GINFER-01-BMEC",
    "Sponsor Name": "CENTRO GINECOLOGICO GINFER",
    "Full Title": "A clinical tryal of the utility of ozone in patients with implantation failures",
    "Start Date": "2019-04-04",
    "Medical condition": [
      "Evaluate the action of ozone in the regulation",
      "concentration and activation of uterine NK."
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004669-28"
  },
  {
    "EudraCT Number": "2018-003510-41",
    "Sponsor Protocol Number": "CHDR1752-B",
    "Sponsor Name": "Centre for Human Drug Research",
    "Full Title": "Investigating anti-inflammatory effects of topical antibiotics in an LPS skin challenge model",
    "Start Date": "2018-10-11",
    "Medical condition": [
      "Inflamed skin"
    ]
  },
  {
    "Disease": "Version: 20.0, SOC Term: 100000004858, Classification Code: 10062249, Term: Skin inflammation, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-003510-41"
  },
  {
    "EudraCT Number": "2017-001117-86",
    "Sponsor Protocol Number": "16/0340",
    "Sponsor Name": "University College London",
    "Full Title": "A phase IV, prospective, randomised single-blind UK multicentre non-inferiority trial of low-dose versus standard dose rituximab for prevention of relapses in acquired TTP",
    "Start Date": "2017-07-25",
    "Medical condition": [
      "Acquired thrombotic thrombocytopenic purpura"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-001117-86"
  },
  {
    "EudraCT Number": "2015-003731-35",
    "Sponsor Protocol Number": "20130293",
    "Sponsor Name": "Amgen Inc",
    "Full Title": "A Randomized Double-blind Placebo Controlled Study Characterizing The Effects of PCSK9 Inhibition On Arterial Wall inflammation in Patients With Elevated Lp(a)",
    "Start Date": "2016-02-26",
    "Medical condition": [
      "Hypercholesterolemia"
    ],
    "Disease": "Version: 18.1, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10020603, Term: Hypercholesterolaemia, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003731-35"
  },
  {
    "EudraCT Number": "2015-004109-18",
    "Sponsor Protocol Number": "15SM2947",
    "Sponsor Name": "Imperial College London",
    "Full Title": "Self-Assessment Method for Statin side-effects Or Nocebo (SAMSON) trial.",
    "Start Date": "2015-11-05",
    "Medical condition": [
      "Primary and secondary prevention of hyperlideamia."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004109-18"
  },
  {
    "EudraCT Number": "2016-001764-11",
    "Sponsor Protocol Number": "PTC124-GD-030-DMD",
    "Sponsor Name": "PTC Therapeutics, Inc.",
    "Full Title": "A Phase 2 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Ataluren (PTC124\u00ae) in Patients Aged \u22652 to <5 Years Old With Nonsense Mutation Dystrophinopathy",
    "Start Date": "2020-01-21",
    "Medical condition": [
      "nonsense mutation dystrophinopathy"
    ],
    "Disease": "Version: 20.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10059117, Term: Becker's muscular dystrophy, Level: PT",
    "Population Age": [
      "Children",
      "Under 18"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001764-11"
  },
  {
    "EudraCT Number": "2014-003986-11",
    "Sponsor Protocol Number": "1401-MAD-004-IO",
    "Sponsor Name": "IVI Madrid",
    "Full Title": "Prospective, double-blinded, randomized clinical trial to evaluate the potential benefitial effect of resveratrol for preventing the ovarian hyperstimulation syndrome.",
    "Start Date": "2016-10-22",
    "Medical condition": [
      "Resveratrol may prevent the incidence of ovarian hyperstimulation syndrome by reducing the expression of VEGF and estradiol",
      "improving the haemoconcentration and ascitis Re"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-003986-11"
  },
  {
    "EudraCT Number": "2008-001876-67",
    "Sponsor Protocol Number": "B2061030",
    "Sponsor Name": "Pfizer Inc.",
    "Full Title": "A 6-Month Open-Label, Multicenter, Flexible-Dose Extension Study to the B2061032 Study to Evaluate the Safety, Tolerability and Efficacy of Desvenlafaxine Succinate Sustained-Release (DVS SR) in th...",
    "Start Date": "2016-07-27",
    "Medical condition": [
      "Major Depressive Disorder"
    ],
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-001876-67"
  },
  {
    "EudraCT Number": "2015-002176-25",
    "Sponsor Protocol Number": "1510150",
    "Sponsor Name": "Royal Devon and Exeter NHS Foundation Trust",
    "Full Title": "Do ultrasound guided botulinum A injections relieve pain in rotator cuff arthropathy?",
    "Start Date": "2016-04-01",
    "Medical condition": [
      "Rotator Cuff Tear Arthropathy"
    ],
    "Disease": "",
    "Population Age": [
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002176-25"
  },
  {
    "EudraCT Number": "2015-005347-14",
    "Sponsor Protocol Number": "H2020/PHRC-N/2014/GB-01",
    "Sponsor Name": "CHU DE NIMES",
    "Full Title": "Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for controlling neuro-inflammation in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients: A randomized, double-blind, pla...",
    "Start Date": "2016-08-25",
    "Medical condition": [
      "Amyotrophic Lateral Sclerosis (ALS)"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10002026, Term: Amyotrophic lateral sclerosis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005347-14"
  },
  {
    "EudraCT Number": "2016-003849-28",
    "Sponsor Protocol Number": "CLS001-CO-PR-014-CHDR1639",
    "Sponsor Name": "Cutanea Life Sciences",
    "Full Title": "A randomized, double-blind, placebo-controlled study to assess the pharmacodynamics, safety, tolerability and efficacy of omiganan BID in patients with mild to moderate atopic dermatitis",
    "Start Date": "2016-12-15",
    "Medical condition": [
      "Patients with mild to moderate atopic dermatitis"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004858, Classification Code: 10012435, Term: Dermatitis and eczema, Level: HLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003849-28"
  },
  {
    "EudraCT Number": "2016-005083-34",
    "Sponsor Protocol Number": "CAPI2017NL10",
    "Sponsor Name": "University Medical Center Utrecht",
    "Full Title": "Conestat alfa as prophylactic treatment for idiopathic non-histaminergic acquired angioedema",
    "Start Date": "2017-08-23",
    "Medical condition": [
      "The medical condition to be investigated is idiopathic non-histaminergic angioedema (InH-AAE). This disease is characterized by recurrent episodes with swelling of the subcutis and mucous membranes..."
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-005083-34"
  },
  {
    "EudraCT Number": "2015-002416-33",
    "Sponsor Protocol Number": "GLARGL07667",
    "Sponsor Name": "sanofi-aventis France",
    "Full Title": "An interventional, Open-label, single-arm, multicenter, 24 Weeks phase 4 study assessing the Efficacy and Safety of  Toujeo in patients with Type  2 Diabetes inadequately controlled with Basal Insulin",
    "Start Date": "2016-02-15",
    "Medical condition": [
      "Type 2 diabetes mellitus"
    ],
    "Disease": "Version: 19.0, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10067585, Term: Type 2 diabetes mellitus, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002416-33"
  },
  {
    "EudraCT Number": "2016-002691-27",
    "Sponsor Protocol Number": "690550",
    "Sponsor Name": "Academic Medical Center",
    "Full Title": "An open label exploratory analysis of the histological,  immunological and microbiome changes of the colonic mucosa during treatment with tofacitinib for moderate-severe ulcerative colitis",
    "Start Date": "2017-10-19",
    "Medical condition": [
      "Ulcerative colitis"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004856, Classification Code: 10045365, Term: Ulcerative colitis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002691-27"
  },
  {
    "EudraCT Number": "2017-003029-14",
    "Sponsor Protocol Number": "D9480C00006",
    "Sponsor Name": "AstraZeneca AB",
    "Full Title": "A phase 3b, multicenter, prospective, randomized, double blind, placebocontrolled study to reduce incidence of pre-dialysis hyperkalemia with Sodium Zirconium Cyclosilicate (DIALIZE)",
    "Start Date": "2018-02-09",
    "Medical condition": [
      "Hyperkalemia among patients on stable hemodialysis (pre-dialysis serum K >5.4 mmol/L after long inter-dialytic interval and >5.0 mmol/L after one short inter-dialytic interval)"
    ],
    "Disease": "Version: 20.1, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10020646, Term: Hyperkalaemia, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003029-14"
  },
  {
    "EudraCT Number": "2016-001440-18",
    "Sponsor Protocol Number": "IACI2016",
    "Sponsor Name": "university medical center utrecht",
    "Full Title": "Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in cystic fibrosis patients and healthy controls",
    "Start Date": "2018-05-30",
    "Medical condition": [
      "cystic fibrosis and healthy subjects"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001440-18"
  },
  {
    "EudraCT Number": "2018-004202-25",
    "Sponsor Protocol Number": "PI18/01297",
    "Sponsor Name": "Luis Nombela Franco",
    "Full Title": "Usefulness of amiodarone for the Prevention of new onset Atrial Fibrillation after transcatheter aortic valve implantation: a randomized controlled trial",
    "Start Date": "2019-06-05",
    "Medical condition": [
      "atrial fibrillation"
    ],
    "Disease": "Version: 20.0, SOC Term: 10007541 - Cardiac disorders, Classification Code: 10003658, Term: Atrial fibrillation, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-004202-25"
  },
  {
    "EudraCT Number": "2018-001133-40",
    "Sponsor Protocol Number": "AT1001-025",
    "Sponsor Name": "Amicus Therapeutics, Inc.",
    "Full Title": "An Open-label Study to Evaluate the Safety and Pharmacokinetics of Migalastat HCl in Fabry Subjects with Amenable GLA Variants and Severe Renal Impairment",
    "Start Date": "2020-01-06",
    "Medical condition": [
      "Fabry Subjects with Amenable GLA Variants and Severe Renal Impairment"
    ],
    "Disease": "Version: 20.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10016016, Term: Fabry's disease, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-001133-40"
  },
  {
    "EudraCT Number": "2012-003620-20",
    "Sponsor Protocol Number": "P101005",
    "Sponsor Name": "ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)",
    "Full Title": "Tamsulosin to prevent the failures of early bladder catheter removal after acute urinary retention in elderly women hospitalized for an acute medical problem",
    "Start Date": "2013-06-04",
    "Medical condition": [
      "urinary disorder"
    ],
    "Disease": "Version: 18.1, SOC Term: 100000004857, Classification Code: 10001055, Term: Acute retention of urine, Level: LLT",
    "Population Age": [
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-003620-20"
  },
  {
    "EudraCT Number": "2016-002109-20",
    "Sponsor Protocol Number": "AAV2-hRPE65v2-301",
    "Sponsor Name": "Spark Therapeutics, Inc.",
    "Full Title": "A Safety and Efficacy Study in Subjects with Leber Congenital Amaurosis (LCA) Using Adeno-Associated Viral Vector to Deliver the Gene for Human RPE65 to the Retinal Pigment Epithelium (RPE) [AAV2-h...",
    "Start Date": "2016-10-24",
    "Medical condition": [
      "Leber Congenital Amaurosis (LCA)"
    ],
    "Disease": "Version: 19.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10070667, Term: Leber's congenital amaurosis, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002109-20"
  },
  {
    "EudraCT Number": "2016-004936-39",
    "Sponsor Protocol Number": "SM2-KHT-2016",
    "Sponsor Name": "Department of Anesthesiology, N\u00e6stved Hospital",
    "Full Title": "The influence of different doses of local anaesthetics on the sensory distribution of lateral femoral cutaneous nerve block - a randomised, blinded, paired trial in heathy volunteers",
    "Start Date": "2017-02-01",
    "Medical condition": [
      "Healthy volunteers (treatment intended for pain treatment in patients after hip surgery)"
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004863, Classification Code: 10054711, Term: Postoperative pain, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004936-39"
  },
  {
    "EudraCT Number": "2015-004900-44",
    "Sponsor Protocol Number": "SF114570",
    "Sponsor Name": "GlaxoSmithKline Research & Development",
    "Full Title": "A Multi-center, Randomized, Double-blind, Vehicle-Controlled, Phase 2 Study of the Safety and Efficacy of Benzoyl peroxide/Clindamycin gel and Tazarotene cream when used in combination in the Treat...",
    "Start Date": "2016-12-21",
    "Medical condition": [
      "Acne Vulgaris"
    ],
    "Disease": "",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004900-44"
  },
  {
    "EudraCT Number": "2017-004564-35",
    "Sponsor Protocol Number": "205739",
    "Sponsor Name": "GlaxoSmithKline Research and Development Ltd.",
    "Full Title": "A Phase IIa Randomized, Placebo-Controlled, Double-Blind (Sponsor Open) Study to Investigate the Clinical Efficacy, Safety, and Tolerability of Nemiralisib (GSK2269557) in Symptomatic COPD Particip...",
    "Start Date": "2018-08-14",
    "Medical condition": [
      "Chronic Obstructive Pulmonary Disease (COPD)/chronic bronchitis and emphysema"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004855, Classification Code: 10010953, Term: COPD exacerbation, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "SE": "Completed"
      },
      {
        "NL": "Prematurely Ended"
      },
      {
        "ES": "Prematurely Ended"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004564-35"
  },
  {
    "EudraCT Number": "2019-002369-36",
    "Sponsor Protocol Number": "GECP19/01",
    "Sponsor Name": "Fundaci\u00f3n GECP",
    "Full Title": "Clinical Utility of Liquid Biopsy as a tool to assess the evolution of brigatinib treated patients with non-small cell lung cancer with EML4-ALK translocation: an exploratory study",
    "Start Date": "2020-04-18",
    "Medical condition": [
      "ALK+ non-small cell lung cancer"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004864, Classification Code: 10025055, Term: Lung cancer non-small cell stage IV, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002369-36"
  },
  {
    "EudraCT Number": "2016-001411-20",
    "Sponsor Protocol Number": "CQCC374X2201E1",
    "Sponsor Name": "Novartis Pharma AG",
    "Full Title": "Long-term, open label, multicenter, extension study to evaluate the safety and tolerability of QCC374 in patients with PAH",
    "Start Date": "2018-01-12",
    "Medical condition": [
      "Pulmonary arterial hypertension"
    ],
    "Disease": "Version: 20.0, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10064911, Term: Pulmonary arterial hypertension, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Prematurely Ended"
      },
      {
        "DE": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001411-20"
  },
  {
    "EudraCT Number": "2017-000263-32",
    "Sponsor Protocol Number": "V260-028",
    "Sponsor Name": "Merck & Co., Inc.",
    "Full Title": "A Double-Blind, Randomized, Placebo-Controlled, Safety and Tolerability Study of Live Pentavalent Human-Bovine Rotavirus Reassortant Vaccine in Chinese Healthy Adults, Children and Infants",
    "Start Date": "2017-03-07",
    "Medical condition": [
      "Prevention of Rotavirus Gastroenteritis Caused by Serotypes G1",
      "G2",
      "G3",
      "G4",
      "and G-Serotypes Associated With P1A [8] (e.g.",
      "G9) in Infants"
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004862, Classification Code: 10039232, Term: Rotavirus gastroenteritis, Level: LLT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000263-32"
  },
  {
    "EudraCT Number": "2017-002410-31",
    "Sponsor Protocol Number": "GEINO-1602",
    "Sponsor Name": "Grupo Espa\u00f1ol de Investigaci\u00f3n en Neurooncolog\u00eda (GEINO)",
    "Full Title": "Phase Ib/II Multicentric Study Combining Glasdegib with temozolomide in patients with newly diagnosed Glioblastoma, safety and preliminary efficacy for the combination.",
    "Start Date": "2018-02-06",
    "Medical condition": [
      "Glasdegib (SHH pathway inhibitor) is a rational therapeutic agent for patients with newly diagnosed Glioblastoma since inhibits SHH pathway interfering with cancer stem cells and endothelial migrat..."
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10018336, Term: Glioblastoma, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002410-31"
  },
  {
    "EudraCT Number": "2017-003008-30",
    "Sponsor Protocol Number": "16/0730",
    "Sponsor Name": "University College London",
    "Full Title": "A double-blind, randomised, placebo-controlled single-site study of high dose simvastatin treatment for secondary progressive multiple sclerosis: impact on vascular perfusion and oxidative damage",
    "Start Date": "2020-07-01",
    "Medical condition": [
      "Multiple Sclerosis (Secondary Progressive)"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004852, Classification Code: 10052785, Term: Multiple sclerosis acute and progressive, Level: HLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003008-30"
  },
  {
    "EudraCT Number": "2015-003943-20",
    "Sponsor Protocol Number": "DX-2930-03",
    "Sponsor Name": "Dyax Corp., an indirect, wholly-owned subsidiary of Shire plc.",
    "Full Title": "HELP Study\u2122: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate DX 2930 For Long-Term Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE)",
    "Start Date": "2016-03-31",
    "Medical condition": [
      "Hereditary angioedema (HAE)"
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004850, Classification Code: 10075280, Term: Hereditary angioedema attack, Level: LLT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "GB": "Completed"
      },
      {
        "IT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003943-20"
  },
  {
    "EudraCT Number": "2015-004429-15",
    "Sponsor Protocol Number": "GEM-1402",
    "Sponsor Name": "GRUPO ESPA\u00d1OL MULTICISPLINAR DE MELANOMA",
    "Full Title": "Phase II multicente, non randomized, open label trial of nivolumab in combination with ipilimumab in subjects with previously untreated metastatic uveal melanoma.",
    "Start Date": "2016-02-16",
    "Medical condition": [
      "Metastatic uveal melanoma non suitable for radical resection."
    ],
    "Disease": "Version: 18.1, SOC Term: 100000004864, Classification Code: 10053571, Term: Melanoma, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004429-15"
  },
  {
    "EudraCT Number": "2015-002061-29",
    "Sponsor Protocol Number": "08227",
    "Sponsor Name": "Consorci Sanitari de Terrassa",
    "Full Title": "Prospective randomized clinical trial comparing the effect of vaginal misoprostol synchronously with supracervical ball, versus only vaginal misoprostol for induction of labor.",
    "Start Date": "2016-03-21",
    "Medical condition": [
      "Pegnant women with a term singleton pregnancy",
      "cephalic presentation",
      "reassuring fetal heart rate pattern",
      "intact membranes and an unfavorable cervix (Bishop score less than 6)",
      "admitted to our ins..."
    ],
    "Disease": "Version: 18.1, SOC Term: 100000004865, Classification Code: 10055563, Term: Labor induction, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002061-29"
  },
  {
    "EudraCT Number": "2014-001102-17",
    "Sponsor Protocol Number": "CV181363",
    "Sponsor Name": "AstraZeneca AB",
    "Full Title": "A 26-week International, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel Group, Phase 3bTrial with a Blinded 26-week Long -term Extension Period to Evaluate the Efficacy and Safe...",
    "Start Date": "2015-03-27",
    "Medical condition": [
      "Type 2 Diabetes Mellitus"
    ],
    "Disease": "Version: 19.0, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10067585, Term: Type 2 diabetes mellitus, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-001102-17"
  },
  {
    "EudraCT Number": "2014-001417-79",
    "Sponsor Protocol Number": "DIAGNODE-1",
    "Sponsor Name": "Link\u00f6ping University",
    "Full Title": "Open Label Pilot Trial in patients with recent-onset T1D to evaluate the safety, diabetes status and immune response of GAD-antigen (Diamyd\u00ae) therapy administered into lymph nodes in combination wi...",
    "Start Date": "2018-02-05",
    "Medical condition": [
      "Type 1 diabetes"
    ],
    "Disease": "Version: 20.0, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10067584, Term: Type 1 diabetes mellitus, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "SE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-001417-79"
  },
  {
    "EudraCT Number": "2012-005723-33",
    "Sponsor Protocol Number": "amantadineSCEDI.",
    "Sponsor Name": "GGZ Oost Brabant",
    "Full Title": "Efficacy of amantadine on behavioural and emotional problems and impairment of executive functioning due to acquired brain injury to the frontal lobes: a series of single case experimental design s...",
    "Start Date": "2015-03-27",
    "Medical condition": [
      "behavioural and emotional problems and impairment of executive functioning due to acquired brain injury to the frontal lobes"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-005723-33"
  },
  {
    "EudraCT Number": "2016-002926-35",
    "Sponsor Protocol Number": "080716CT",
    "Sponsor Name": "Alder Hey Children's Foundation NHS Trust",
    "Full Title": "Pharmacokinetics of post-operative Cefuroxime in infants undergoing cardiac surgery",
    "Start Date": "2017-01-16",
    "Medical condition": [
      "post operative paediatric cardiac patients"
    ],
    "Disease": "Version: 19.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10053840, Term: Bacterial sepsis, Level: PT",
    "Population Age": [
      "Newborns",
      "Infants and toddlers",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002926-35"
  },
  {
    "EudraCT Number": "2019-000902-31",
    "Sponsor Protocol Number": "ECACOR19",
    "Sponsor Name": "OMEQUI",
    "Full Title": "Healing efficacy after impacted mandibular third molar surgery with the use of autologous platelet-rich fibrin: a randomized controlled clinical study",
    "Start Date": "2019-09-05",
    "Medical condition": [
      "If the addition of L-PRF reduces postoperative pain and inflammation",
      "as well as complications",
      "after extraction of lower third molars"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-000902-31"
  },
  {
    "EudraCT Number": "2016-000866-44",
    "Sponsor Protocol Number": "NC-6004-008",
    "Sponsor Name": "NanoCarrier Co, Ltd",
    "Full Title": "Phase I/II Clinical Trial of NC-6004 in Combination with 5-FU and Cetuximab as First-line Treatment in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of The Head and Neck",
    "Start Date": "2017-01-17",
    "Medical condition": [
      "Metastatic squamous cell carcinoma of the head and neck"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10063569, Term: Metastatic squamous cell carcinoma, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      },
      {
        "BG": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000866-44"
  },
  {
    "EudraCT Number": "2017-000608-13",
    "Sponsor Protocol Number": "MK-4117-201",
    "Sponsor Name": "Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.",
    "Full Title": "A phase III multicentre, parallel-group, randomized, placebo-controlled, double-blind clinical trial to study the efficacy and safety of MK-4117 in Japanese subjects with chronic urticaria.",
    "Start Date": "2017-02-09",
    "Medical condition": [
      "Chronic urticaria (a skin condition caused by an allergy)"
    ],
    "Disease": "Version: 19.1, SOC Term: 10040785 - Skin and subcutaneous tissue disorders, Classification Code: 10052568, Term: Urticaria chronic, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000608-13"
  },
  {
    "EudraCT Number": "2016-001365-92",
    "Sponsor Protocol Number": "1",
    "Sponsor Name": "Center for Diabetes Research, Gentofte Hospital",
    "Full Title": "Meal-time Administration of exenatide for Glycaemic control in type 1 diabetic Cases: A randomised, placebo-controlled trial",
    "Start Date": "2016-10-10",
    "Medical condition": [
      "Type 1 Diabetes"
    ],
    "Disease": "Version: 20.0, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10067584, Term: Type 1 diabetes mellitus, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001365-92"
  },
  {
    "EudraCT Number": "2016-002852-26",
    "Sponsor Protocol Number": "MS200588-0004",
    "Sponsor Name": "Merck KGaA",
    "Full Title": "A multicenter, randomized, double-blind, Phase III trial to evaluate the safety, immunogenicity, and efficacy of MSB11022 compared with Humira\u00ae in patients with moderately to severely active rheuma...",
    "Start Date": "2016-12-07",
    "Medical condition": [
      "moderately to severely active rheumatoid arthritis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10028395 - Musculoskeletal and connective tissue disorders, Classification Code: 10039073, Term: Rheumatoid arthritis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "CZ": "Completed"
      },
      {
        "GB": "Completed"
      },
      {
        "HU": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "LT": "Prematurely Ended"
      },
      {
        "BG": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002852-26"
  },
  {
    "EudraCT Number": "2016-002862-30",
    "Sponsor Protocol Number": "B7981006",
    "Sponsor Name": "Pfizer Inc 235 East 42nd Street, New York, NY10017 US",
    "Full Title": "A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY PROFILE OF PF-06651600 IN SUBJECTS WITH MODERATE TO SEVERE ACTIVE R...",
    "Start Date": "2017-01-31",
    "Medical condition": [
      "RHEUMATOID ARTHRITIS"
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004870, Classification Code: 10039075, Term: Rheumatoid arthritis and associated conditions, Level: HLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "SK": "Completed"
      },
      {
        "BG": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002862-30"
  },
  {
    "EudraCT Number": "2016-005004-26",
    "Sponsor Protocol Number": "ARC010",
    "Sponsor Name": "Aimmune Therapeutics, Inc.",
    "Full Title": "AR101 TRIAL IN EUROPE MEASURING ORAL IMMUNOTHERAPY SUCCESS IN PEANUT ALLERGIC CHILDREN (ARTEMIS)",
    "Start Date": "2017-04-12",
    "Medical condition": [
      "Peanut Allergy"
    ],
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "FR": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "ES": "Completed"
      },
      {
        "SE": "Completed"
      },
      {
        "IE": "Completed"
      },
      {
        "IT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-005004-26"
  },
  {
    "EudraCT Number": "2017-000188-33",
    "Sponsor Protocol Number": "MK-8616-146",
    "Sponsor Name": "Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.",
    "Full Title": "A Phase 4 Randomized, Active-Comparator Controlled Trial to Study the Efficacy and Safety of Sugammadex (MK-8616) for the Reversal of Neuromuscular Blockade Induced by Either Rocuronium Bromide or ...",
    "Start Date": "2017-10-27",
    "Medical condition": [
      "Reversal of neuromuscular blockade"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004865, Classification Code: 10018061, Term: General anesthesia, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      },
      {
        "BE": "Completed"
      },
      {
        "AT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000188-33"
  },
  {
    "EudraCT Number": "2015-002052-27",
    "Sponsor Protocol Number": "DRM04-HH04",
    "Sponsor Name": "Dermira, Inc.",
    "Full Title": "A PHASE 3, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED EFFICACY AND SAFETY STUDY OF DRM04 IN SUBJECTS WITH AXILLARY HYPERHIDROSIS",
    "Start Date": "2015-10-14",
    "Medical condition": [
      "Primary axillary hyperhidrosis"
    ],
    "Disease": "Version: 18.1, SOC Term: 10040785 - Skin and subcutaneous tissue disorders, Classification Code: 10020642, Term: Hyperhidrosis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002052-27"
  },
  {
    "EudraCT Number": "2015-002164-16",
    "Sponsor Protocol Number": "CPH-301-201030",
    "Sponsor Name": "CROMA-PHARMA GmbH",
    "Full Title": "Randomized double blind Phase 3 study to assess the efficacy and safety of BoNT/A-DP in the treatment of glabellar lines in comparison with placebo followed by an open label extension study",
    "Start Date": "2016-04-11",
    "Medical condition": [
      "Moderate to severe glabellar lines"
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004858, Classification Code: 10052609, Term: Glabellar frown lines, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002164-16"
  },
  {
    "EudraCT Number": "2015-004336-35",
    "Sponsor Protocol Number": "IDN-6556-12",
    "Sponsor Name": "Conatus Pharmaceuticals Inc.",
    "Full Title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan (IDN-6556), an Oral Caspase Inhibitor, in Subjects with Non-alcoholic Steatohepatitis (NASH) Fibrosis",
    "Start Date": "2016-05-20",
    "Medical condition": [
      ""
    ],
    "Disease": "Version: 18.1, SOC Term: 10019805 - Hepatobiliary disorders, Classification Code: 10053219, Term: Non-alcoholic steatohepatitis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004336-35"
  },
  {
    "EudraCT Number": "2016-000371-24",
    "Sponsor Protocol Number": "DOBO-01-16",
    "Sponsor Name": "Laboratorios Ordesa",
    "Full Title": "Multicenter pilot study for comparison of the efficacy of vaginal capsules with boric acid and L. gasseri and L. rhamnosus versus other vaginal drugs, in patients with bacterial or candida Vulvovag...",
    "Start Date": "2016-05-24",
    "Medical condition": [
      "Bacterial or candidiasic vulvovaginitis"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000371-24"
  },
  {
    "EudraCT Number": "2015-002145-63",
    "Sponsor Protocol Number": "INMiND-02",
    "Sponsor Name": "University of Southampton",
    "Full Title": "A double-blind, placebo-controlled study of the effect of a TNF alpha inhibitor, etanercept (Enbrel), on microglial activation in amyloid PET positive patients with Mild Cognitive Impairment due to...",
    "Start Date": "2015-10-15",
    "Medical condition": [
      "Mild Cognitive impairment- due to Alzheimer's disease- intermediate likelihood"
    ],
    "Disease": "Version: 18.1, SOC Term: 100000004852, Classification Code: 10001896, Term: Alzheimer's disease, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002145-63"
  },
  {
    "EudraCT Number": "2015-005051-28",
    "Sponsor Protocol Number": "20140336",
    "Sponsor Name": "Amgen Inc",
    "Full Title": "An Open-label, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Etelcalcetide (AMG 416) in Paediatric Subjects Aged 2 to less than 18 Years with Sec...",
    "Start Date": "2016-08-22",
    "Medical condition": [
      "Secondary Hyperparathyroidism (sHPT) Receiving Maintenance Haemodialysis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10014698 - Endocrine disorders, Classification Code: 10020708, Term: Hyperparathyroidism secondary, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "BE": "Completed"
      },
      {
        "LT": "Completed"
      },
      {
        "GB": "Completed"
      },
      {
        "PL": "Completed"
      },
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005051-28"
  },
  {
    "EudraCT Number": "2016-002069-77",
    "Sponsor Protocol Number": "RG101-05",
    "Sponsor Name": "Regulus Therapeutics Inc.",
    "Full Title": "An Observational Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Have Previously Received RG-101",
    "Start Date": "2016-12-01",
    "Medical condition": [
      "Hepatitis C Patients"
    ],
    "Disease": "Version: 19.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10047457, Term: Viral hepatitis C, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GR": "Completed"
      },
      {
        "HU": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002069-77"
  },
  {
    "EudraCT Number": "2016-004728-48",
    "Sponsor Protocol Number": "MK-1439-043",
    "Sponsor Name": "Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc.",
    "Full Title": "A Study to Evaluate the Comparative Bioavailability of the Investigational Oral Pediatric Minitablet Formulation of MK-1439 Compared to the Adult Formulation of MK-1439 in Healthy Adult Subjects",
    "Start Date": "2016-11-23",
    "Medical condition": [
      "HIV \u2013 Human Immunodeficiency Virus"
    ],
    "Disease": "Version: 19.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10020161, Term: HIV infection, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004728-48"
  },
  {
    "EudraCT Number": "2017-003411-19",
    "Sponsor Protocol Number": "CPU-003",
    "Sponsor Name": "Fakultn\u00ed nemocnice u sv. Anny v Brn\u011b",
    "Full Title": "Compatibility of clopidogrel prepared for administration through nasogastric tube with enteral nutrition (CPU-003)",
    "Start Date": "2017-11-09",
    "Medical condition": [
      "healthy volunteers"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "CZ": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003411-19"
  },
  {
    "EudraCT Number": "2016-004486-37",
    "Sponsor Protocol Number": "59812",
    "Sponsor Name": "University Medical Centre Utrecht",
    "Full Title": "FOsfomycin Randomised controlled trial for E.coli Complicated urinary tract infections as Alternative Stepdown Treatment",
    "Start Date": "2017-09-19",
    "Medical condition": [
      "Acute febrile urinary tract infection"
    ],
    "Disease": "Version: 20.0, SOC Term:  100000017512, Classification Code: 10046576, Term: Urinary tract infection, site not specified, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004486-37"
  },
  {
    "EudraCT Number": "2017-004348-39",
    "Sponsor Protocol Number": "1708155",
    "Sponsor Name": "CHU Saint-Etienne",
    "Full Title": "Association between methotrexate erythrocyte polyglutamate concentration and clinical response in rheumatoid arthritis patients treated with subcutaneous injectable methotrexate",
    "Start Date": "2018-02-15",
    "Medical condition": [
      "rheumatoid arthritis"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004859, Classification Code: 10042952, Term: Systemic rheumatoid arthritis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004348-39"
  },
  {
    "EudraCT Number": "2013-001790-25",
    "Sponsor Protocol Number": "FP01C-13-001",
    "Sponsor Name": "Foresee Pharmaceuticals Co., Ltd.",
    "Full Title": "An Open-Label, Single-Arm Study of the Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate for Injectable Suspension (LMIS 50 mg) in Subjects with Advanced Prostate Carcinoma",
    "Start Date": "2014-09-01",
    "Medical condition": [
      "Advanced Prostate Carcinoma"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004864, Classification Code: 10036921, Term: Prostate carcinoma, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "AT": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "SK": "Completed"
      },
      {
        "LT": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-001790-25"
  },
  {
    "EudraCT Number": "2016-001242-25",
    "Sponsor Protocol Number": "BBT120126032001",
    "Sponsor Name": "Blueberry Therapeutics Ltd.",
    "Full Title": "An Early Phase Development, Partly Blinded, Positive and Vehicle Controlled, Randomized, Non-inferiority Investigation of the Pharmacokinetics, Safety and Efficacy of BB2603 Cutaneous Hand-Pump Spr...",
    "Start Date": "2017-02-07",
    "Medical condition": [
      "Onychomycosis and associated Tinea Pedis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10030338, Term: Onychomycosis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001242-25"
  },
  {
    "EudraCT Number": "2017-000971-97",
    "Sponsor Protocol Number": "AL-X-01",
    "Sponsor Name": "ALK Abell\u00f3 A/S",
    "Full Title": "Safety and tolerability of shortened up-dosing with Alutard SQ",
    "Start Date": "2017-08-23",
    "Medical condition": [
      "Allergic rhinoconjunctivitis induced by grass pollen",
      "birch pollen and house dust mites"
    ],
    "Disease": "Version: 20.0, SOC Term:  100000014962, Classification Code: 10001728, Term: Allergic rhinoconjunctivitis, Level: LLT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "ES": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000971-97"
  },
  {
    "EudraCT Number": "2017-001185-20",
    "Sponsor Protocol Number": "167700-005CL",
    "Sponsor Name": "Proximagen Limited",
    "Full Title": "A Randomized, Double Dummy, Parallel Arm, Placebo  and Active Controlled, Double Blind, Study of the Safety and Efficacy of PRX167700 as Monotherapy in Adults with Moderate to Severe Knee Pain Due ...",
    "Start Date": "2017-12-05",
    "Medical condition": [
      "Moderate to Severe Knee Pain Due to Osteoarthritis in subjects who are Inappropriate for Oral Non steroidal Anti inflammatory Therapy"
    ],
    "Disease": "Version: 20.0, SOC Term: 10028395 - Musculoskeletal and connective tissue disorders, Classification Code: 10031166, Term: Osteoarthritis knees, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-001185-20"
  },
  {
    "EudraCT Number": "2014-000304-96",
    "Sponsor Protocol Number": "NL47648.029.14",
    "Sponsor Name": "VU University Medical Center (VUmc)",
    "Full Title": "Sentinel lymph node identification in colon cancer using a radioactive and fluorescent tracer",
    "Start Date": "2015-01-15",
    "Medical condition": [
      "Colon Carcinoma"
    ],
    "Disease": "Version: 18.1, SOC Term: 100000004864, Classification Code: 10009951, Term: Colon cancer NOS, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-000304-96"
  },
  {
    "EudraCT Number": "2015-004297-14",
    "Sponsor Protocol Number": "SLH2015001",
    "Sponsor Name": "Streeklaboratorium voor de volksgezondheid Kennemerland",
    "Full Title": "Effectiveness of fosfomycin versus nitrofurantoin in Dutch risk groups with cystitis: a pilot study (Uri-weg study)",
    "Start Date": "2016-06-08",
    "Medical condition": [
      "Cystitis without tissue invasion (uncomplicated cytitis)"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004297-14"
  },
  {
    "EudraCT Number": "2016-002826-35",
    "Sponsor Protocol Number": "EFC14835",
    "Sponsor Name": "Lexicon Pharmaceuticals, Inc.",
    "Full Title": "A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Added to a Sulfonylurea alone or in combination with Metformin...",
    "Start Date": "2017-04-24",
    "Medical condition": [
      "Type 2 diabetes mellitus"
    ],
    "Disease": "Version: 21.1, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10067585, Term: Type 2 diabetes mellitus, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "EE": "Completed"
      },
      {
        "SK": "Completed"
      },
      {
        "HU": "Completed"
      },
      {
        "GB": "Completed"
      },
      {
        "PL": "Completed"
      },
      {
        "BG": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002826-35"
  },
  {
    "EudraCT Number": "2017-000369-54",
    "Sponsor Protocol Number": "60725",
    "Sponsor Name": "University Medical Center Utrecht",
    "Full Title": "Intra-arterial Lutetium-177- dotatate for treatment of patients with neuroendocrine tumor liver metastases",
    "Start Date": "2018-06-27",
    "Medical condition": [
      "Patients with neuro-endocrine tumors with liver metastases with an indication for treatment with lutetium-177-dotatate"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000369-54"
  },
  {
    "EudraCT Number": "2017-000841-28",
    "Sponsor Protocol Number": "DC2017DECREASE01",
    "Sponsor Name": "VU University Medical Center",
    "Full Title": "Combined effects of SGLT2 inhibition and GLP-1 receptor agonism on food intake, body weight and central satiety and reward circuits in obese T2DM patients",
    "Start Date": "2017-08-14",
    "Medical condition": [
      "Type 2 diabetes mellitus"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000841-28"
  },
  {
    "EudraCT Number": "2015-005765-23",
    "Sponsor Protocol Number": "ESR-14-10083",
    "Sponsor Name": "VU Medical Centre",
    "Full Title": "Companion biomarker development for MEDI4736 treated non-small-cell lung cancer patients using 89Zirconium-labeled MEDI4736 \u2013 a feasibility study",
    "Start Date": "2017-10-10",
    "Medical condition": [
      "Stadium IV non-small-cell lung cancer"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005765-23"
  },
  {
    "EudraCT Number": "2017-000892-10",
    "Sponsor Protocol Number": "HS0001",
    "Sponsor Name": "UCB Biopharma SPRL",
    "Full Title": "A Phase 2 Multicenter, Investigator-blind, Subject-blind, Placebo-controlled Study of the Efficacy, Safety, and Pharmacokinetics of Bimekizumab in Subjects with Moderate to Severe Hidradenitis Supp...",
    "Start Date": "2017-11-22",
    "Medical condition": [
      "Hidradenitis Suppurativa"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004858, Classification Code: 10020041, Term: Hidradenitis suppurativa, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "BE": "Completed"
      },
      {
        "DK": "Completed"
      },
      {
        "GR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000892-10"
  },
  {
    "EudraCT Number": "2014-004036-19",
    "Sponsor Protocol Number": "Uni-Koeln-1754",
    "Sponsor Name": "University of Cologne",
    "Full Title": "GHSG-AFM13 An open-label, randomized, multicenter phase II trial with AFM13 in patients with relapsed or refractory Hodgkin Lymphoma",
    "Start Date": "2015-04-21",
    "Medical condition": [
      "Activity of AFM13 in patients with relapsed/refractory Hodgkin lymphoma after failure of standard therapy including the anti-CD30 immunoconjugate brentuximab vedotin (BV). In this heavily pretreate..."
    ],
    "Disease": "Version: 20.0, SOC Term: 10005329 - Blood and lymphatic system disorders, Classification Code: 10025319, Term: Lymphomas Hodgkin's disease, Level: HLGT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-004036-19"
  },
  {
    "EudraCT Number": "2013-004380-31",
    "Sponsor Protocol Number": "CM-2013-01",
    "Sponsor Name": "Cell Medica Inc.",
    "Full Title": "A Phase 2 open label study to investigate the efficacy of autologous EBV-specific T-cells for the treatment of patients with aggressive extranodal NK/T-cell lymphoma (ENKTCL).",
    "Start Date": "2015-01-22",
    "Medical condition": [
      "Aggressive EBV positive extranodal NK/T-cell lymphoma (ENKTCL)"
    ],
    "Disease": "Version: 19.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10034623, Term: Peripheral T-cell lymphoma unspecified, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "DE": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-004380-31"
  },
  {
    "EudraCT Number": "2015-005473-20",
    "Sponsor Protocol Number": "V121102015",
    "Sponsor Name": "UZ Leuven",
    "Full Title": "Pilot study on robot assisted retinal vein cannulation with ocriplasmin infusion for central retinal vein occlusion.",
    "Start Date": "2016-11-23",
    "Medical condition": [
      "Patients with central retinal vein occlusion (CRVO)"
    ],
    "Disease": "",
    "Population Age": [
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "BE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005473-20"
  },
  {
    "EudraCT Number": "2015-004155-43",
    "Sponsor Protocol Number": "PA-CL-PED-01",
    "Sponsor Name": "Vifor Fresenius Medical Care Renal Pharma France",
    "Full Title": "An Open-label, Randomised, Active-controlled, Parallel Group, Multicentre, Phase 3 Study to Investigate the Safety and Efficacy of PA21 (Velphoro\u00ae) and Calcium Acetate (Phoslyra\u00ae) in Paediatric and...",
    "Start Date": "2016-05-04",
    "Medical condition": [
      "Control of serum phosphorus levels in paediatric and adolescent subjects with chronic kidney disease (CKD)."
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004857, Classification Code: 10076412, Term: Chronic kidney disease stage 5, Level: LLT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "LT": "Prematurely Ended"
      },
      {
        "DE": "Prematurely Ended"
      },
      {
        "PL": "Prematurely Ended"
      },
      {
        "FR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004155-43"
  },
  {
    "EudraCT Number": "2015-004549-23",
    "Sponsor Protocol Number": "TV48125-CNS-30049",
    "Sponsor Name": "Teva Branded Pharmaceutical Products R&D, Inc.",
    "Full Title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for...",
    "Start Date": "2016-11-24",
    "Medical condition": [
      "Chronic Migraine"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004852, Classification Code: 10066636, Term: Chronic migraine, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "ES": "Completed"
      },
      {
        "FI": "Completed"
      },
      {
        "DK": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004549-23"
  },
  {
    "EudraCT Number": "2016-001891-31",
    "Sponsor Protocol Number": "PS0010",
    "Sponsor Name": "UCB Biopharma SPRL",
    "Full Title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose Ranging Study to Evaluate the Safety, Efficacy, Pharmacokinectics, and Pharmacodynamics of Bimekizumab in Adult sub...",
    "Start Date": "2016-10-27",
    "Medical condition": [
      "Chronic Plaque Psoriasis"
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004858, Classification Code: 10071117, Term: Plaque psoriasis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001891-31"
  },
  {
    "EudraCT Number": "2015-003536-12",
    "Sponsor Protocol Number": "CIGE025B1301E1",
    "Sponsor Name": "Novartis Pharmaceuticals",
    "Full Title": "An Extension Study to CIGE025B1301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children (6 - 15 Years) With Inadequately Controlled Allergic Asthma Despite...",
    "Start Date": "2016-02-16",
    "Medical condition": [
      "Allergic Asthma"
    ],
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003536-12"
  },
  {
    "EudraCT Number": "2017-000212-41",
    "Sponsor Protocol Number": "206246",
    "Sponsor Name": "GlaxoSmithKline, S.A.",
    "Full Title": "An Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2586881 in Participants with Pulmonary Arterial Hypertension.",
    "Start Date": "2017-08-10",
    "Medical condition": [
      "Pulmonary arterial hypertension"
    ],
    "Disease": "Version: 20.0, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10077740, Term: Pulmonary arterial hypertension WHO functional class II, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Completed"
      },
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000212-41"
  },
  {
    "EudraCT Number": "2017-003028-59",
    "Sponsor Protocol Number": "NL62684.091.17",
    "Sponsor Name": "Radboud University Medical Centre",
    "Full Title": "Treatment with Recombinant human Interleukin 1 receptor antagonist (Anakinra) in patients with Anaplastic Thyroid Cancer: a proof of concept study",
    "Start Date": "2018-06-06",
    "Medical condition": [
      "Anaplastic Thyroid Carcinoma"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003028-59"
  },
  {
    "EudraCT Number": "2015-005525-39",
    "Sponsor Protocol Number": "CCR4449",
    "Sponsor Name": "The Royal Marsden NHS Foundation Trust",
    "Full Title": "Proof-of-concept study of ibrutinib in c-MYC and HER2 amplified gastrooesophageal carcinoma",
    "Start Date": "2016-05-19",
    "Medical condition": [
      "Her2 or cMYC positive advanced oesophagogastric carcinomas"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005525-39"
  },
  {
    "EudraCT Number": "2017-001122-17",
    "Sponsor Protocol Number": "ISRCTN12771155",
    "Sponsor Name": "SILVIA GONZALEZ SANTOS",
    "Full Title": "\"ANALGESIC EFFICACY OF INTRADURAL MORPHINE VERSUS INTERCOSTAL LEVOBUPIVACAINE IN THE POSTOPERATIVE PERIOD OF MAJOR PULMONARY RESECTION BY VIDEOTHORASCOCOPY\"",
    "Start Date": "2017-11-13",
    "Medical condition": [
      "Control of the pain in surgery of major resection for videotoracoscopia"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-001122-17"
  },
  {
    "EudraCT Number": "2017-002411-34",
    "Sponsor Protocol Number": "20140315",
    "Sponsor Name": "Amgen Inc.",
    "Full Title": "Phase 3, Randomized, Open-label, Controlled, Multiple-Dose, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Etelcalcetide in Pediatric Subjects 28 days to < 18 Years of age With Sec...",
    "Start Date": "2019-01-28",
    "Medical condition": [
      "Secondary Hyperparathyroidism (sHPT) Receiving Maintenance"
    ],
    "Disease": "Version: 20.0, SOC Term: 10014698 - Endocrine disorders, Classification Code: 10020708, Term: Hyperparathyroidism secondary, Level: PT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002411-34"
  },
  {
    "EudraCT Number": "2020-004592-40",
    "Sponsor Protocol Number": "1",
    "Sponsor Name": "University of Edinburgh",
    "Full Title": "An open label exploratory study to assess the safety of using 100mg of methotrexate as a standard dose treatment for women with unruptured tubal ectopic pregnancy (OSPREY)",
    "Start Date": "2020-11-20",
    "Medical condition": [
      "Ectopic Pregnancy"
    ],
    "Disease": "Version: 20.0, SOC Term: 10036585 - Pregnancy, puerperium and perinatal conditions, Classification Code: 10014166, Term: Ectopic pregnancy, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004592-40"
  },
  {
    "EudraCT Number": "2015-003720-32",
    "Sponsor Protocol Number": "SPECTRE2015",
    "Sponsor Name": "NHS Greater Glasgow and Clyde",
    "Full Title": "Combined Suppression Of Cholesterol Bioavailability And Androgen Deprivation Therapy To Treat Castration Resistant Prostate Cancer",
    "Start Date": "2016-06-01",
    "Medical condition": [
      "Castration Resistant Prostate Cancer"
    ],
    "Disease": "Version: 18.1, SOC Term: 100000004864, Classification Code: 10007113, Term: Cancer of prostate, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003720-32"
  },
  {
    "EudraCT Number": "2015-005601-37",
    "Sponsor Protocol Number": "RBHP2015PICKERING4",
    "Sponsor Name": "CHU Clermont-Ferrand",
    "Full Title": "IMPACT OF 5% LIDOCAINE MEDICATED PLASTER ON ALLODYNIC SYMPTOMS OF LOCALIZED NEUROPATHIC PAIN AFTER KNEE SURGERY. A prospective, randomized, placebo controlled study in parallel groups.",
    "Start Date": "2016-02-24",
    "Medical condition": [
      "Post operative neuropathic pain (PONP)"
    ],
    "Disease": "Version: 18.1, SOC Term: 100000004852, Classification Code: 10054095, Term: Neuropathic pain, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005601-37"
  },
  {
    "EudraCT Number": "2015-003217-20",
    "Sponsor Protocol Number": "15073",
    "Sponsor Name": "University of Nottingham",
    "Full Title": "Management of recurrent pterygium to prevent visual impairment(REPEAT)",
    "Start Date": "2016-03-23",
    "Medical condition": [
      "RECURRENT PTERYGIUM"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003217-20"
  },
  {
    "EudraCT Number": "2016-001043-39",
    "Sponsor Protocol Number": "ML17225",
    "Sponsor Name": "F. Hoffmann-La Roche AG",
    "Full Title": "An Open-Label, Prospective, Randomized, Controlled, Multi-Center Study Assessing Fixed Dose Vs Concentration Controlled Cellcept Regimens For Patients Following A Single Organ Renal Transplantation...",
    "Start Date": "2016-10-03",
    "Medical condition": [
      "Renal Transplantation"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004865, Classification Code: 10023438, Term: Kidney transplant, Level: LLT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001043-39"
  },
  {
    "EudraCT Number": "2020-001971-33",
    "Sponsor Protocol Number": "CORIVER",
    "Sponsor Name": "Carmen Hidalgo",
    "Full Title": "Pragmatic study \"CORIVER\": Ivermectin as antiviral treatment for patients infected by SARS-COV2 (COVID-19)",
    "Start Date": "2020-06-02",
    "Medical condition": [
      "SARS-COV2"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001971-33"
  },
  {
    "EudraCT Number": "2013-002451-15",
    "Sponsor Protocol Number": "V102_15",
    "Sponsor Name": "GlaxoSmithKline Biologicals SA",
    "Full Title": "A Phase 2b, Randomized, Controlled, Observer-Blind, Multi-Center Study Assessing the Immunogenicity and Safety of GSK Meningococcal ABCWY Vaccine Administered at Different Schedules Compared to GSK...",
    "Start Date": "2014-09-19",
    "Medical condition": [
      "The current study is designed to assess immunological non-inferiority of the MenABCWY vaccine",
      "administered according to 0",
      "2 month schedule to healthy adolescents 10 to 18 years of age",
      "to those o..."
    ],
    "Disease": "Version: 19.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10027202, Term: Meningitis bacterial, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FI": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-002451-15"
  },
  {
    "EudraCT Number": "2015-000596-27",
    "Sponsor Protocol Number": "VAC52150EBL2001",
    "Sponsor Name": "Janssen Vaccines & Prevention BV",
    "Full Title": "A Randomized, Observer-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Prime-Boost Regimens of the Candidate Prophylactic Vaccines for Ebol...",
    "Start Date": "2015-05-18",
    "Medical condition": [
      "Ebola"
    ],
    "Disease": "Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10014071, Term: Ebola disease, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-000596-27"
  },
  {
    "EudraCT Number": "2020-002449-41",
    "Sponsor Protocol Number": "PRE-COVID",
    "Sponsor Name": "ANTONIO ANTELA LOPEZ",
    "Full Title": "Pilot trial on early treatment with hydroxychloroquine in patients with COVID-19 who do not have hospital admission at diagnosis.",
    "Start Date": "2020-06-15",
    "Medical condition": [
      "Patients diagnosed with COVID-19",
      "with positive PCR for SARS-CoV-2",
      "without criteria for hospital admission."
    ],
    "Disease": "Version: 23.0, SOC Term: 100000004862, Classification Code: 10084401, Term: COVID-19 respiratory infection, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002449-41"
  },
  {
    "EudraCT Number": "2015-003060-37",
    "Sponsor Protocol Number": "ANZUP1302",
    "Sponsor Name": "Cambridge University Hospitals NHS Foundation Trust",
    "Full Title": "UK P3BEP - A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours",
    "Start Date": "2017-04-05",
    "Medical condition": [
      "International germ cell classification catergory (IGCCC) intermediate or poor-risk metastatic germ cell tumours"
    ],
    "Disease": "Version: 21.1, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10068971, Term: Germ cell cancer metastatic, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003060-37"
  },
  {
    "EudraCT Number": "2011-001690-62",
    "Sponsor Protocol Number": "HE2016",
    "Sponsor Name": "University of Birmingham",
    "Full Title": "A randomised phase II clinical trial of conditioning cyclophosphamide and chemoembolisation with or without vaccination with dendritic cells pulsed with HepG2 lysate ex vivo in patients with Hepato...",
    "Start Date": "2014-09-16",
    "Medical condition": [
      "Hepatocellular carcinoma"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004864, Classification Code: 10049010, Term: Carcinoma hepatocellular, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-001690-62"
  },
  {
    "EudraCT Number": "2015-003866-96",
    "Sponsor Protocol Number": "BEMI-2015",
    "Sponsor Name": "ANGELA PUENTE",
    "Full Title": "Randomized controlled trial on the safety and efficacy of low molecular weight heparins in the prevention of thrombotic events in hospitalized cirrhotic patients",
    "Start Date": "2016-04-29",
    "Medical condition": [
      "Prevention of thrombosis in cirrhotic patients"
    ],
    "Disease": "Version: 18.1, SOC Term: 10047065 - Vascular disorders, Classification Code: 10014523, Term: Embolism and thrombosis, Level: HLGT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003866-96"
  },
  {
    "EudraCT Number": "2016-003110-27",
    "Sponsor Protocol Number": "21.07.2016",
    "Sponsor Name": "Bente Lomholt Langdahl, Dept. of Endocrinology and Internal Medicine, Aarhus University Hospital",
    "Full Title": "Bone turnover markers as predictors of treatment break outcome",
    "Start Date": "2016-10-03",
    "Medical condition": [
      "Osteoporosis"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004859, Classification Code: 10031289, Term: Osteoporosis, unspecified, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003110-27"
  },
  {
    "EudraCT Number": "2018-000368-27",
    "Sponsor Protocol Number": "MAN-ALG-18-001",
    "Sponsor Name": "FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE",
    "Full Title": "ND",
    "Start Date": "2018-10-22",
    "Medical condition": [
      "Fabry disease"
    ],
    "Disease": "Version: 20.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10010331, Term: Congenital, familial and genetic disorders, Level: SOC",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-000368-27"
  },
  {
    "EudraCT Number": "2016-000238-23",
    "Sponsor Protocol Number": "ExeBAT01",
    "Sponsor Name": "Leiden University Medical Center",
    "Full Title": "The effect of Exenatide on brown adipose tissue activity and energy expenditure in healthy young men",
    "Start Date": "2016-08-09",
    "Medical condition": [
      "Healthy volunteers",
      "intended indications: obesity and dyslipidemia"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000238-23"
  },
  {
    "EudraCT Number": "2017-002849-30",
    "Sponsor Protocol Number": "CCTL019B2101J/CHP-959",
    "Sponsor Name": "University of Pennsylvania",
    "Full Title": "A Phase I/IIA Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRzeta and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant Or Refractory CD19+ Leuk...",
    "Start Date": "2017-11-16",
    "Medical condition": [
      "Chemotherapy resistant or refractory CD19+ B-cell Leukemia and Lymphoma."
    ],
    "Disease": "Version: 20.0, SOC Term: 10005329 - Blood and lymphatic system disorders, Classification Code: 10025320, Term: Lymphomas non-Hodgkin's B-cell, Level: HLGT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002849-30"
  },
  {
    "EudraCT Number": "2015-003625-34",
    "Sponsor Protocol Number": "1311.5",
    "Sponsor Name": "Boehringer Ingelheim Finland Ky",
    "Full Title": "A randomised, double-blind, placebo-controlled, proof-of-concept, dose-ranging study of BI 655066 / ABBV-066 / risankiumab in patients with active psoriatic arthritis",
    "Start Date": "2016-04-13",
    "Medical condition": [
      "Active Psoriatic Arthritis"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004859, Classification Code: 10037160, Term: Psoriatic arthritis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FI": "Completed"
      },
      {
        "ES": "Completed"
      },
      {
        "NL": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "BE": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "FR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003625-34"
  },
  {
    "EudraCT Number": "2016-002112-41",
    "Sponsor Protocol Number": "2016-05-04",
    "Sponsor Name": "Region \u00d6sterg\u00f6tland",
    "Full Title": "Can Insuline improve the healing of dental implants?",
    "Start Date": "2016-07-16",
    "Medical condition": [
      "Missing teeth"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "SE": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002112-41"
  },
  {
    "EudraCT Number": "2016-001264-11",
    "Sponsor Protocol Number": "UMCM-2016EPI05",
    "Sponsor Name": "University Medical Center of the Johannes Gutenberg-University Mainz",
    "Full Title": "A phase IV, single-center, randomized, double-blind, placebo-controlled, parallel group study on the effects of empagliflozin on left ventricular diastolic function compared to usual care in indivi...",
    "Start Date": "2016-09-07",
    "Medical condition": [
      "Poorly controlled type 2 diabetes mellitus in adults"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001264-11"
  },
  {
    "EudraCT Number": "2016-003937-62",
    "Sponsor Protocol Number": "CLR_16_23",
    "Sponsor Name": "SUN Pharma Global FZE",
    "Full Title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Phase 2b Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects with Active Psoriatic Arthritis",
    "Start Date": "2017-03-20",
    "Medical condition": [
      "Psoriatic Arthritis"
    ],
    "Disease": "Version: 20.0, SOC Term:  100000018188, Classification Code: 10037160, Term: Psoriatic arthritis, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      },
      {
        "ES": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003937-62"
  },
  {
    "EudraCT Number": "2016-005111-40",
    "Sponsor Protocol Number": "CN138-178",
    "Sponsor Name": "Otsuka Pharmaceutical Development & Commercialization, Inc",
    "Full Title": "A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Flexible- Dosed Parallel-Group Study of Aripiprazole Flexibly Dosed in the Treatment of Children and Adolescents with Autistic Disorder",
    "Start Date": "2017-04-07",
    "Medical condition": [
      "Autistic Disorder"
    ],
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-005111-40"
  },
  {
    "EudraCT Number": "2017-000611-17",
    "Sponsor Protocol Number": "LTS12745",
    "Sponsor Name": "Alfresa Pharma Corporation and Sanofi KK",
    "Full Title": "A Long term study of M071754 - A open-label study in patients with infantile spasms.",
    "Start Date": "2017-08-28",
    "Medical condition": [
      "Patients diagnosed with infantile spasms"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10021750, Term: Infantile spasms, Level: PT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000611-17"
  },
  {
    "EudraCT Number": "2019-000608-14",
    "Sponsor Protocol Number": "1.0/170119",
    "Sponsor Name": "Tartu University Hospital",
    "Full Title": "Prospective validation of individualized Bayesian dose optimization tool DosOpt for Vancomycin treatment in neonates.",
    "Start Date": "Information not available in EudraCT",
    "Medical condition": [
      "In neonatal population wide inter-and intra-individual variability of pharmacokinetics makes extremely difficult to ensure optimal exposure of vancomycin with standard regimens. On average >50% of ..."
    ],
    "Disease": "",
    "Population Age": [
      "Preterm newborn infants",
      "Newborns",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "EE": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-000608-14"
  },
  {
    "EudraCT Number": "2016-000608-27",
    "Sponsor Protocol Number": "ProtokolSB2",
    "Sponsor Name": "Aarhus University Hospital",
    "Full Title": "The effect of subsartorial saphenous block on postoperative pain following major ankle and hind foot surgery",
    "Start Date": "2016-04-05",
    "Medical condition": [
      "Post-operative pain after four types of major ankle and hind foot surgery:"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004865, Classification Code: 10002540, Term: Ankle arthrodesis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000608-27"
  },
  {
    "EudraCT Number": "2014-003833-24",
    "Sponsor Protocol Number": "AGMT_HNO_PN",
    "Sponsor Name": "AGMT \u2013 Arbeitsgemeinschaft medikament\u00f6se Tumortherapie gemeinn\u00fctzige GmbH",
    "Full Title": "Randomized phase III study: Supplemental parenteral nutrition for patients with locally advanced inoperable tumors of the head and neck, receiving definitive radiotherapy with Cetuximab or Cisplatin",
    "Start Date": "2016-06-30",
    "Medical condition": [
      "Locally advanced inoperable tumors of the head and neck under definitive radiotherapy with Cetuximab or Cisplatin"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004864, Classification Code: 10023861, Term: Laryngeal squamous cell carcinoma stage IV, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "AT": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-003833-24"
  },
  {
    "EudraCT Number": "2016-000473-20",
    "Sponsor Protocol Number": "CLCZ696B3402",
    "Sponsor Name": "Novartis Pharma services AG",
    "Full Title": "A prospective evaluation of natriuretic peptide based referral of CHF patients in primary care",
    "Start Date": "2016-08-18",
    "Medical condition": [
      "Chronic heart failure with reduced ejection fraction"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004849, Classification Code: 10019279, Term: Heart failure, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HR": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000473-20"
  },
  {
    "EudraCT Number": "2017-003629-13",
    "Sponsor Protocol Number": "PROFIT",
    "Sponsor Name": "King's College London",
    "Full Title": "A Prospective, randomised placebo controlled feasibility trial of Faecal Microbiotica Transplantation in cirrhosis",
    "Start Date": "2018-01-31",
    "Medical condition": [
      "Cirrhosis of the liver"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004871, Classification Code: 10024667, Term: Liver cirrhosis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003629-13"
  },
  {
    "EudraCT Number": "2019-001974-27",
    "Sponsor Protocol Number": "STOPFLU",
    "Sponsor Name": "Centre Hospitalier Universitaire Vaudois (CHUV)",
    "Full Title": "Reducing the Burden of Influenza after Solid-Organ Transplantation: the STOP-FLU trial [Swiss Trial in solid Organ transplantation on Prevention of inFLUenza]",
    "Start Date": "2019-10-15",
    "Medical condition": [
      "Influenza in solid organ transplant patients"
    ],
    "Disease": "Version: 21.1, SOC Term: 10042613 - Surgical and medical procedures, Classification Code: 10059429, Term: Influenza immunisation, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-001974-27"
  },
  {
    "EudraCT Number": "2019-002956-18",
    "Sponsor Protocol Number": "ZWI-ZW25-202",
    "Sponsor Name": "Zymeworks Inc.",
    "Full Title": "Phase 2a Study of ZW25 in Combination with Palbociclib Plus Fulvestrant",
    "Start Date": "2020-03-25",
    "Medical condition": [
      "Breast cancer  patients including those with locally advanced (unresectable) or metastatic HER2-positive",
      "HR-positive breast cancer."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002956-18"
  },
  {
    "EudraCT Number": "2016-001586-87",
    "Sponsor Protocol Number": "RSLV-132-04",
    "Sponsor Name": "Resolve Therapeutics, LLC",
    "Full Title": "A Phase 2, Double Blind, Placebo Controlled Study of RSLV-132 in Subjects with Primary Sjogren\u2019s Syndrome",
    "Start Date": "2016-09-29",
    "Medical condition": [
      "Primary Sjogrens Syndrome"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001586-87"
  },
  {
    "EudraCT Number": "2016-003248-34",
    "Sponsor Protocol Number": "IMPAACTP1110",
    "Sponsor Name": "NIAID and NICHD",
    "Full Title": "A PHASE I TRIAL TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF RALTEGRAVIR IN HIV-1-EXPOSED NEONATES AT HIGH RISK OF ACQUIRING HIV-1 INFECTION",
    "Start Date": "2016-11-02",
    "Medical condition": [
      "New born babies at risk of acquiring HIV from their infected mothers."
    ],
    "Disease": "Version: 20.1, SOC Term: 100000004862, Classification Code: 10053529, Term: Vertical human immunodeficiency virus transmission, Level: LLT",
    "Population Age": [
      "Newborns",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003248-34"
  },
  {
    "EudraCT Number": "2017-000755-97",
    "Sponsor Protocol Number": "EPFL-CNBI-2017-01",
    "Sponsor Name": "Defitech Chair in Brain-Machine Interface, EPFL",
    "Full Title": "Brain-computer interface and neuromuscular stimulation for rehabilitation following chronic stroke",
    "Start Date": "2017-03-16",
    "Medical condition": [
      "I61 - Intracerebral haemorrhage"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000755-97"
  },
  {
    "EudraCT Number": "2017-004903-33",
    "Sponsor Protocol Number": "IBM4809",
    "Sponsor Name": "Orphazyme A/S",
    "Full Title": "Phase 2/3 Study of Arimoclomol in Inclusion Body Myositis (IBM) A Randomized, Double-blind, Placebo-Controlled Trial",
    "Start Date": "2018-06-18",
    "Medical condition": [
      "Sporadic Inclusion Body Myositis (sIBM)"
    ],
    "Disease": "Version: 21.1, SOC Term: 100000004859, Classification Code: 10075052, Term: Sporadic inclusion body myositis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004903-33"
  },
  {
    "EudraCT Number": "2019-003486-17",
    "Sponsor Protocol Number": "9-VPH-MVIH",
    "Sponsor Name": "CARMEN HIDALGO TENORIO",
    "Full Title": "Immunogenicity and safety of a 9-valent human papillomavirus vaccine in HIV-positive women",
    "Start Date": "2020-02-11",
    "Medical condition": [
      "New infection and lesions of papillomavirus in HIV-infected women"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-003486-17"
  },
  {
    "EudraCT Number": "2016-002598-36",
    "Sponsor Protocol Number": "16IC3372",
    "Sponsor Name": "Imperial College London",
    "Full Title": "Randomised Clinical Trial of Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer's Disease",
    "Start Date": "2017-03-03",
    "Medical condition": [
      "Alzheimer's Disease"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10001896, Term: Alzheimer's disease, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Temporarily Halted"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002598-36"
  },
  {
    "EudraCT Number": "2017-002641-29",
    "Sponsor Protocol Number": "INCB57643-101",
    "Sponsor Name": "Incyte Corporation",
    "Full Title": "A Phase 1/2, Open-Label, Dose-Escalation/Dose-Expansion, Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies",
    "Start Date": "2018-03-20",
    "Medical condition": [
      "Subjects with relapsed or refractory advanced or metastatic malignancies."
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004864, Classification Code: 10048683, Term: Advanced cancer, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002641-29"
  },
  {
    "EudraCT Number": "2014-003064-21",
    "Sponsor Protocol Number": "AAS",
    "Sponsor Name": "Hospital Universitari de Girona Dr. Josep Trueta",
    "Full Title": "THE USE OF ASPIRIN AS PRIMARY PREVENTION IN PATIENTS WITH DIABETES",
    "Start Date": "2015-01-15",
    "Medical condition": [
      "cardiovascular prevention in patients diagnosed in diabetes mellitus"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004860, Classification Code: 10012602, Term: Diabetes mellitus (incl subtypes), Level: HLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-003064-21"
  },
  {
    "EudraCT Number": "2014-000241-74",
    "Sponsor Protocol Number": "CNTO148AKS3001",
    "Sponsor Name": "Janssen Biologics, BV",
    "Full Title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNF\u03b1 Monoclonal Antibody, Administered Intravenously, in Subjects with Active Ankylosing Spondylitis",
    "Start Date": "2014-12-30",
    "Medical condition": [
      "Ankylosing spondylitis (AS)"
    ],
    "Disease": "Version: 19.0, SOC Term: 10028395 - Musculoskeletal and connective tissue disorders, Classification Code: 10002556, Term: Ankylosing spondylitis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-000241-74"
  },
  {
    "EudraCT Number": "2014-004616-12",
    "Sponsor Protocol Number": "CCDZ173X2203",
    "Sponsor Name": "Novartis Pharma Services AG",
    "Full Title": "A randomized, double-blind, placebo-controlled, parallel group study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of CDZ173 in patients with primary Sj\u00f6gren\u2019s syndrome",
    "Start Date": "2016-05-20",
    "Medical condition": [
      "Primary Sj\u00f6gren's syndrome"
    ],
    "Disease": "Version: 19.0, SOC Term: 10028395 - Musculoskeletal and connective tissue disorders, Classification Code: 10040767, Term: Sjogren's syndrome, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "HU": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-004616-12"
  },
  {
    "EudraCT Number": "2016-001387-12",
    "Sponsor Protocol Number": "CCLR325X2202",
    "Sponsor Name": "Novartis Pharma Services AG",
    "Full Title": "A randomized, subject and investigator-blind, placebo-controlled study of CLR325 in chronic stable heart failure patients.",
    "Start Date": "2016-10-11",
    "Medical condition": [
      "Stable Heart Failure"
    ],
    "Disease": "Version: 20.0, SOC Term: 10007541 - Cardiac disorders, Classification Code: 10007558, Term: Cardiac failure chronic, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "BE": "Completed"
      },
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001387-12"
  },
  {
    "EudraCT Number": "2016-002935-14",
    "Sponsor Protocol Number": "EMPRA",
    "Sponsor Name": "Medical University of Vienna, Internal Medicine III, Clinical Div. of Nephrology and Dialysis",
    "Full Title": "Effect of empagliflozin on the renin-angiotensin system in patients with chronic kidney disease with and without type 2 diabetes",
    "Start Date": "2016-11-22",
    "Medical condition": [
      "Chronic kidney disease with and without type 2 diabetes"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004857, Classification Code: 10076410, Term: Chronic kidney disease stage 3, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "AT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002935-14"
  },
  {
    "EudraCT Number": "2013-005099-17",
    "Sponsor Protocol Number": "GTI1306",
    "Sponsor Name": "Grifols Therapeutics Inc.",
    "Full Title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/ chromatography Purified (lGIV -C) as a Corticosteroi...",
    "Start Date": "2015-07-07",
    "Medical condition": [
      "Myasthenia Gravis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10028417, Term: Myasthenia gravis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "LT": "Completed"
      },
      {
        "EE": "Completed"
      },
      {
        "HU": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "BE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-005099-17"
  },
  {
    "EudraCT Number": "2017-000540-18",
    "Sponsor Protocol Number": "VX16-661-114",
    "Sponsor Name": "Vertex Pharmaceuticals Incorporated",
    "Full Title": "Phase 3b, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Safety, Efficacy, and Tolerability of Tezacaftor/Ivacaftor (TEZ/IVA) in an Orkambi-experienced Population ...",
    "Start Date": "Information not available in EudraCT",
    "Medical condition": [
      "Cystic Fibrosis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10011762, Term: Cystic fibrosis, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Completed"
      },
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000540-18"
  },
  {
    "EudraCT Number": "2013-003327-11",
    "Sponsor Protocol Number": "3623",
    "Sponsor Name": "University of Southampton",
    "Full Title": "Alternative Treatments of Adult female Urinary Tract Infection: a double blind, placebo controlled,factorial randomised trial of Uva ursi and open pragmatic trial of ibuprofen.",
    "Start Date": "2015-02-10",
    "Medical condition": [
      "Acute urinary tract infections."
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004862, Classification Code: 10000698, Term: Acute cystitis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-003327-11"
  },
  {
    "EudraCT Number": "2016-003376-49",
    "Sponsor Protocol Number": "MDCO-PCS-16-02",
    "Sponsor Name": "The Medicines Company",
    "Full Title": "An Open-Label, Single-Arm, Multicenter Pilot Study to Evaluate Safety, Tolerability, and Efficacy of ALN-PCSSC in Subjects with Homozygous Familial Hypercholesterolemia",
    "Start Date": "2017-06-20",
    "Medical condition": [
      "Homozygous Familial Hypercholesterolemia"
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004850, Classification Code: 10057080, Term: Homozygous familial hypercholesterolemia, Level: LLT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003376-49"
  },
  {
    "EudraCT Number": "2016-002571-10",
    "Sponsor Protocol Number": "MT-8554-E06",
    "Sponsor Name": "Mitsubishi Tanabe Pharma Corporation (MTPC)",
    "Full Title": "A Phase IIa, Multi-Centre, Randomised, Double-Blind, Cross-Over, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of MT-8554 in Subjects with Painful Diabetic Peripheral Neu...",
    "Start Date": "2017-06-12",
    "Medical condition": [
      "Painful Diabetic Peripheral Neuropathy (DPN)"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004852, Classification Code: 10012683, Term: Diabetic peripheral neuropathy, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      },
      {
        "PL": "Completed"
      },
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002571-10"
  },
  {
    "EudraCT Number": "2015-002506-37",
    "Sponsor Protocol Number": "SANNI-project:03",
    "Sponsor Name": "Region Skane",
    "Full Title": "Dexmedetomidine for analgosedation to newborn infants during neonatal intensive care \u2013 a prospective pharmacokinetic/ pharmacodynamic/ pharmacogenetic observational study.Cohort 3 in The SANNI Pr...",
    "Start Date": "2020-01-08",
    "Medical condition": [
      "Sick newborn infants in need of intensive care."
    ],
    "Disease": "",
    "Population Age": [
      "Newborns",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "SE": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002506-37"
  },
  {
    "EudraCT Number": "2020-001457-43",
    "Sponsor Protocol Number": "APHP200388",
    "Sponsor Name": "APHP",
    "Full Title": "Dexamethasone and oxygen support strategies in ICU patients with Covid-19 pneumonia",
    "Start Date": "2020-04-10",
    "Medical condition": [
      "acute hypoxemic respiratory failure (AHRF)"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001457-43"
  },
  {
    "EudraCT Number": "2020-001409-21",
    "Sponsor Protocol Number": "IMIB-DFC-2020-02",
    "Sponsor Name": "FFIS",
    "Full Title": "A prospective, multicenter, randomized, parallel, double-blind, placebo-controlled phase IIb clinical trial to evaluate intravenous infusion of Defibrotide in the prevention and treatment of respir...",
    "Start Date": "2020-04-01",
    "Medical condition": [
      "COVID-19"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001409-21"
  },
  {
    "EudraCT Number": "2015-002252-27",
    "Sponsor Protocol Number": "TED-C14-006",
    "Sponsor Name": "NPS Pharmaceuticals, Inc.",
    "Full Title": "A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age with Short Bowel Syndrome who are Dependent ...",
    "Start Date": "2016-09-19",
    "Medical condition": [
      "Short Bowel Syndrome"
    ],
    "Disease": "Version: 19.0, SOC Term: 10017947 - Gastrointestinal disorders, Classification Code: 10049416, Term: Short-bowel syndrome, Level: PT",
    "Population Age": [
      "Newborns",
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "IT": "Completed"
      },
      {
        "FI": "Completed"
      },
      {
        "BE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002252-27"
  },
  {
    "EudraCT Number": "2015-004904-50",
    "Sponsor Protocol Number": "GWEP15100",
    "Sponsor Name": "GW Research Ltd",
    "Full Title": "A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of Cannabidiol (GWP42003-P) in infants with Infantile Spasms following an initial open label pilot study.",
    "Start Date": "Information not available in EudraCT",
    "Medical condition": [
      "Infantile Spasms"
    ],
    "Disease": "Version: 20.1, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10021750, Term: Infantile spasms, Level: PT",
    "Population Age": [
      "Infants and toddlers",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004904-50"
  },
  {
    "EudraCT Number": "2016-000524-25",
    "Sponsor Protocol Number": "CAIN457A2318",
    "Sponsor Name": "Novartis Pharma Services AG",
    "Full Title": "A randomized, double-blind, placebo controlled, multicenter study of subcutaneous secukinumab, to demonstrate efficacy after twelve weeks of treatment and to assess safety, tolerability and long...",
    "Start Date": "2017-02-01",
    "Medical condition": [
      "Plaque psoriasis"
    ],
    "Disease": "Version: 20.0, SOC Term:  100000018190, Classification Code: 10050576, Term: Psoriasis vulgaris, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000524-25"
  },
  {
    "EudraCT Number": "2014-000331-16",
    "Sponsor Protocol Number": "C-935788-050",
    "Sponsor Name": "Rigel Pharmaceuticals Inc",
    "Full Title": "A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment of IgA Nephropathy",
    "Start Date": "2014-07-28",
    "Medical condition": [
      "IgA nephropathy (IgAN)"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "AT": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-000331-16"
  },
  {
    "EudraCT Number": "2014-003147-35",
    "Sponsor Protocol Number": "M14-567",
    "Sponsor Name": "AbbVie Deutschland GmbH & Co. KG",
    "Full Title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of the Co-Administration of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) With Sofosbuvir (SOF) With or Without Ribavirin (R...",
    "Start Date": "2014-12-16",
    "Medical condition": [
      "Chronic Hepatitis C Virus (HCV) Infection"
    ],
    "Disease": "Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10008912, Term: Chronic hepatitis C, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-003147-35"
  },
  {
    "EudraCT Number": "2016-000880-18",
    "Sponsor Protocol Number": "ESR-15-11524",
    "Sponsor Name": "Special Account for Research Funds-University of Patras",
    "Full Title": "A randomized, pharmacodynamic comparison of low dose ticagrelor to clopidogrel in patients with prior myocardial infarction",
    "Start Date": "2016-08-01",
    "Medical condition": [
      "The primary objective of the study is to compare the platelet inhibition of ticagrelor versus clopidogrel in post-MI patients in terms of  platelet reactivity at the end of the 2 study periods (pre..."
    ],
    "Disease": "Version: 19.0, SOC Term: 10007541 - Cardiac disorders, Classification Code: 10007649, Term: Cardiovascular disorder, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000880-18"
  },
  {
    "EudraCT Number": "2016-001008-49",
    "Sponsor Protocol Number": "NV22155",
    "Sponsor Name": "F. Hoffmann-La Roche AG",
    "Full Title": "A randomized, multicenter trial of oseltamivir doses of 75 mg for 5 or 10 days versus 150 mg for 5 or 10 days in influenza patients with pandemic (H1N1) 2009",
    "Start Date": "2016-09-30",
    "Medical condition": [
      "Influenza"
    ],
    "Disease": "Version: 19.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10022000, Term: Influenza, Level: PT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001008-49"
  },
  {
    "EudraCT Number": "2016-004952-30",
    "Sponsor Protocol Number": "E2080-J081-304",
    "Sponsor Name": "Eisai Co, Ltd.",
    "Full Title": "A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients",
    "Start Date": "2017-02-13",
    "Medical condition": [
      "Lennox-Gastaut Syndrome (LSG)"
    ]
  },
  {
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004952-30"
  },
  {
    "EudraCT Number": "2017-001737-85",
    "Sponsor Protocol Number": "80-84800-98-81014",
    "Sponsor Name": "academic medical centre",
    "Full Title": "Efficacy of AlbenDazole to inDuce mUcosal healing in Patients with Crohn's disease on anti-TNF monotherapy",
    "Start Date": "2018-07-17",
    "Medical condition": [
      "Crohn's disease"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004856, Classification Code: 10013099, Term: Disease Crohns, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-001737-85"
  },
  {
    "EudraCT Number": "2018-001136-21",
    "Sponsor Protocol Number": "B7451013",
    "Sponsor Name": "Pfizer Inc., 235 East 42nd Street, New York, NY 10017",
    "Full Title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Evaluate the Efficacy and Safety of PF-04965842 Monotherapy in Subjects Aged 12 Years and Older, with M...",
    "Start Date": "2018-10-22",
    "Medical condition": [
      "Moderate to severe atopic dermatitis"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004858, Classification Code: 10003639, Term: Atopic dermatitis, Level: LLT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "BG": "Completed"
      },
      {
        "HU": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "GB": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "PL": "Completed"
      },
      {
        "LV": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-001136-21"
  },
  {
    "EudraCT Number": "2016-001106-42",
    "Sponsor Protocol Number": "16-01/CalciBet-Gel",
    "Sponsor Name": "Dermapharm AG",
    "Full Title": "Double-blind, randomised clinical study comparing efficacy and safety of Calcipotriol 50 \u00b5g/g_Betamethasone 0.5 mg/g Gel (Test) vs. Daivobet(R) Gel (Reference) vs. Vehicle in patients with scalp ps...",
    "Start Date": "2016-09-19",
    "Medical condition": [
      "Psoriasis capitis"
    ],
    "Disease": "Version: 20.0, SOC Term:  100000018190, Classification Code: 10037157, Term: Psoriasis of scalp, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001106-42"
  },
  {
    "EudraCT Number": "2016-002408-13",
    "Sponsor Protocol Number": "NL58183.041.16",
    "Sponsor Name": "UMC Utrecht",
    "Full Title": "Bumetanide to Ameliorate Tuberous Sclerosis Complex Hyperexcitable Behaviors",
    "Start Date": "2017-02-07",
    "Medical condition": [
      "Tuberous Sclerosis Complex"
    ],
    "Disease": "Version: 20.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10045138, Term: Tuberous sclerosis, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002408-13"
  },
  {
    "EudraCT Number": "2017-002146-72",
    "Sponsor Protocol Number": "CC-5013-AML-002",
    "Sponsor Name": "Celgene Corporation",
    "Full Title": "A Phase 2, Multicenter, Single-arm, Open-label Study to Evaluate the Activity, Safety and Pharmacokinetics of Lenalidomide (REVLIMID\u00ae) in Pediatric Subjects from 1 to \u2264 18 Years of Age with Relapse...",
    "Start Date": "2017-07-03",
    "Medical condition": [
      "Leukemia",
      "Myeloid"
    ],
    "Disease": "Version: 20.0, SOC Term:  100000012984, Classification Code: 10000886, Term: Acute myeloid leukemia, Level: LLT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002146-72"
  },
  {
    "EudraCT Number": "2017-002189-39",
    "Sponsor Protocol Number": "161802",
    "Sponsor Name": "University of Oxford",
    "Full Title": "A randomised placebo-controlled trial to assess the effect of melatonin on circadian sleep-wake disturbances in ocular disease.",
    "Start Date": "2017-12-11",
    "Medical condition": [
      "circadian sleep-wake disturbances associated with ocular disease."
    ],
    "Disease": "Version: 21.1, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10009191, Term: Circadian rhythm sleep disorder, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002189-39"
  },
  {
    "EudraCT Number": "2018-000942-21",
    "Sponsor Protocol Number": "AIMS-2-CT1",
    "Sponsor Name": "Celso Arango",
    "Full Title": "A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents w...",
    "Start Date": "2019-07-24",
    "Medical condition": [
      "Autism Spectrum Disorder"
    ],
    "Disease": "Version: 21.1, SOC Term: 10037175 - Psychiatric disorders, Classification Code: 10063844, Term: Autism spectrum disorder, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-000942-21"
  },
  {
    "EudraCT Number": "2019-002085-13",
    "Sponsor Protocol Number": "KX-ORAX-010",
    "Sponsor Name": "Athenex, Inc",
    "Full Title": "A Pilot Study of Oraxol in Subjects with Cutaneous Angiosarcoma",
    "Start Date": "2019-12-30",
    "Medical condition": [
      "Study of Oraxol in Subjects with Cutaneous Angiosarcoma"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10002477, Term: Angiosarcoma metastatic, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002085-13"
  },
  {
    "EudraCT Number": "2016-001221-14",
    "Sponsor Protocol Number": "E.G.R.A.B.I.N.S1",
    "Sponsor Name": "Herlev Gentofte Hospital",
    "Full Title": "Effect of glucagon-like peptide 1 (GLP-1) based diabetes medication on blood flow velocity in persons without cerebrovascular disease.",
    "Start Date": "2016-06-17",
    "Medical condition": [
      "This is a healthy control group which is to be compared with patients with stroke."
    ],
    "Disease": "Version: 19.1, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10061256, Term: Ischaemic stroke, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001221-14"
  },
  {
    "EudraCT Number": "2016-002327-29",
    "Sponsor Protocol Number": "RGH-188-201",
    "Sponsor Name": "Gedeon Richter Plc.",
    "Full Title": "Open-Label, Multicentre, Multiple Dose Study to Evaluate Pharmacokinetics, Safety and Tolerability of Cariprazine in Adolescent Subjects with Schizophrenia, Schizoaffective- and Schizophreniform Di...",
    "Start Date": "2017-01-05",
    "Medical condition": [
      "Schizophrenia",
      "Schizoaffective- and Schizophreniform Disorders"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004873, Classification Code: 10039631, Term: Schizophrenia NEC, Level: HLT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "BG": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002327-29"
  },
  {
    "EudraCT Number": "2016-004656-30",
    "Sponsor Protocol Number": "MK-1439-052",
    "Sponsor Name": "Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.",
    "Full Title": "A Study of the Comparative Bioavailability of Two Second-Generation Investigational Pediatric Oral Granule Formulations of MK-1439 Compared to the Adult Formulation.   Additional PIP decision nu...",
    "Start Date": "2016-11-16",
    "Medical condition": [
      "HIV-1 Infection"
    ],
    "Disease": "Version: 19.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10020161, Term: HIV infection, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004656-30"
  },
  {
    "EudraCT Number": "2016-003018-29",
    "Sponsor Protocol Number": "2016-003018-29",
    "Sponsor Name": "Herlev and Gentofte Hospital",
    "Full Title": "Apremilast as anti-pruritic treatment in patients with prurigo nodularis",
    "Start Date": "2017-05-31",
    "Medical condition": [
      "Prurigo nodularis"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003018-29"
  },
  {
    "EudraCT Number": "2016-004691-22",
    "Sponsor Protocol Number": "RCT-004",
    "Sponsor Name": "Rechon Life Science AB",
    "Full Title": "A Randomised, Open, Parallel-group Phase III Biosimilarity Study to Assess the Long-term Safety, Focusing on Immunogenicity, of Rechon Insulin Human Soluble in Type 1 Diabetic Patients.",
    "Start Date": "2017-11-21",
    "Medical condition": [
      "Type 1 Diabetes"
    ],
    "Disease": "Version: 20.0, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10012601, Term: Diabetes mellitus, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004691-22"
  },
  {
    "EudraCT Number": "2018-002245-11",
    "Sponsor Protocol Number": "NAM2",
    "Sponsor Name": "UMC Utrecht",
    "Full Title": "Assessing penetration of high dose Nicotinamide (Vitamin B3) in synovial fluid",
    "Start Date": "2019-01-16",
    "Medical condition": [
      "Juvenile Idiopathic Arthritis (JIA)"
    ],
    "Disease": "",
    "Population Age": [
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-002245-11"
  },
  {
    "EudraCT Number": "2017-002154-36",
    "Sponsor Protocol Number": "CIGE025F1301",
    "Sponsor Name": "Novartis Pharma KK",
    "Full Title": "A 12 Week, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Omalizumab in Adult and Adolescent Patients With Inadequately Controlled...",
    "Start Date": "2019-02-13",
    "Medical condition": [
      "Severe Japanese cedar pollinosis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10038738, Term: Respiratory, thoracic and mediastinal disorders, Level: SOC",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002154-36"
  },
  {
    "EudraCT Number": "2019-001318-40",
    "Sponsor Protocol Number": "SN38-SPL9111-001",
    "Sponsor Name": "Starpharma Pty Ltd",
    "Full Title": "A phase 1/2 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of SN38-SPL9111 (DEP\u00ae-SN38), a SN38 dendrimer conjugate, in patients with advanced ...",
    "Start Date": "2019-08-07",
    "Medical condition": [
      "Advanced solid tumours."
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004864, Classification Code: 10007050, Term: Cancer, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-001318-40"
  },
  {
    "EudraCT Number": "2016-004799-23",
    "Sponsor Protocol Number": "BP39642",
    "Sponsor Name": "F. HOFFMANN - LA ROCHE LTD.",
    "Full Title": "A PHASE II, SINGLE ARM, MULTICENTER, PROOF OF MECHANISM STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, EFFICACY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF BITOPERTIN (RO4917838) IN ADULTS WITH NON-...",
    "Start Date": "2017-09-04",
    "Medical condition": [
      "\u03b2-Thalassemia"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004850, Classification Code: 10074356, Term: Non-transfusion dependent thalassemia, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IT": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004799-23"
  },
  {
    "EudraCT Number": "2015-002296-18",
    "Sponsor Protocol Number": "CaTo-ROC",
    "Sponsor Name": "Vejle Hospital, Department of Oncology",
    "Full Title": "Cabazitaxel in patients with Recurrent Ovarian Cancer after failure of standard therapy- A phase II trial",
    "Start Date": "2015-07-30",
    "Medical condition": [
      ""
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004864, Classification Code: 10033130, Term: Ovarian cancer NOS, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002296-18"
  },
  {
    "EudraCT Number": "2017-000605-20",
    "Sponsor Protocol Number": "FFIS/2017/01/SLT",
    "Sponsor Name": "Fundaci\u00f3n para la Formaci\u00f3n e Investigaci\u00f3n Sanitarias de la Regi\u00f3n de Murcia",
    "Full Title": "PERIPHERAL TRANSCUTANEOUS NEUROMODULATION OF THE POST-TIBIAL NERVE (T-PTNS) FOR SOLIFENACIN 10mg. IN THE TREATMENT OF HYPERACTIVE BLADDER SYNDROME: NON-INFERIORITY  PHASE IV RANDOMIZED CLINICAL TRIAL",
    "Start Date": "2017-07-26",
    "Medical condition": [
      "Overactive Bladder Syndrome"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000605-20"
  },
  {
    "EudraCT Number": "2018-000307-17",
    "Sponsor Protocol Number": "69HCL16_0743",
    "Sponsor Name": "Hospices Civils de Lyon",
    "Full Title": "Microcirculatory and Macrocirculatory Effects of Landiolol on Postoperative Atrial Fibrillation: a Randomized Study. MMELPOAF study.",
    "Start Date": "2018-07-19",
    "Medical condition": [
      "Postoperative Atrial Fibrillation"
    ],
    "Disease": "Version: 20.0, SOC Term: 10007541 - Cardiac disorders, Classification Code: 10003658, Term: Atrial fibrillation, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-000307-17"
  },
  {
    "EudraCT Number": "2014-004961-26",
    "Sponsor Protocol Number": "12-009",
    "Sponsor Name": "McMaster University",
    "Full Title": "Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY): A Multi-Center Randomized Controlled Study Comparing Alternative Antibiotic Regimens in Patients Undergoing Tumor Resections with Endopro...",
    "Start Date": "2015-12-15",
    "Medical condition": [
      "?\tPatients with a primary bone malignancy or soft-tissue sarcoma that has invaded a lower extremity bone that are undergoing surgical treatment to resect the tumor and functionally reconstruct the ..."
    ],
    "Disease": "Version: 18.1, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10006007, Term: Bone sarcoma, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      },
      {
        "AT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-004961-26"
  },
  {
    "EudraCT Number": "2015-005742-58",
    "Sponsor Protocol Number": "204813",
    "Sponsor Name": "GlaxoSmithKline Biologicals",
    "Full Title": "A phase II, randomised, observer-blind, controlled, study to assess the reactogenicity and safety of a single intramuscular dose of GlaxoSmithKline (GSK) Biologicals\u2019 investigational respiratory sy...",
    "Start Date": "2016-03-31",
    "Medical condition": [
      "Healthy volunteers (prevention of severe RSV disease in infants by transfer of maternal antibodies following active single dose immunisation of pregnant women)."
    ],
    "Disease": "Version: 18.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10035692, Term: Pneumonia due to respiratory syncytial virus, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "BE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005742-58"
  },
  {
    "EudraCT Number": "2015-004136-36",
    "Sponsor Protocol Number": "1002-040",
    "Sponsor Name": "Esperion Therapeutics, Inc.",
    "Full Title": "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER LONG-TERM SAFETY AND TOLERABILITY STUDY OF ETC-1002 IN PATIENTS WITH HYPERLIPIDEMIA AT HIGH CARDIOVASCULAR RISK WHO ARE NOT ADEQUATELY C...",
    "Start Date": "2016-06-14",
    "Medical condition": [
      "Treatment of high cardiovascular risk patients (heterozygous familial hypercholesterolemia [HeFH] and atherosclerotic cardiovascular diseases [ASCVD]) with hyperlipidemia"
    ],
    "Disease": "Version: 20.0, SOC Term:  100000012386, Classification Code: 10057079, Term: Heterozygous familial hypercholesterolemia, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Completed"
      },
      {
        "GB": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004136-36"
  },
  {
    "EudraCT Number": "2016-000502-11",
    "Sponsor Protocol Number": "EKOS-12",
    "Sponsor Name": "EKOS Corporation",
    "Full Title": "Study of the Optimum Duration of Acoustic Pulse Thrombolysis (APT) Procedure in the Treatment of Acute Submassive Pulmonary Embolism (OPTALYSE PE).",
    "Start Date": "2016-07-21",
    "Medical condition": [
      "Submassive pulmonary embolism"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000502-11"
  },
  {
    "EudraCT Number": "2020-003410-12",
    "Sponsor Protocol Number": "RG_19-169",
    "Sponsor Name": "University of Birmingham",
    "Full Title": "Pregnancy ANtihypertensive Drugs: which Agent is best?",
    "Start Date": "2020-12-16",
    "Medical condition": [
      "Hypertension in pregnancy (chronic hypertension",
      "gestational hypertension or pre-eclampsia)"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003410-12"
  },
  {
    "EudraCT Number": "2015-004551-43",
    "Sponsor Protocol Number": "CS-BM32-004",
    "Sponsor Name": "Biomay AG",
    "Full Title": "Study to evaluate the effect of different pre-seasonal  BM32 dosing schedules on the induction of a protective allergen-specific IgG Immune response",
    "Start Date": "2016-01-29",
    "Medical condition": [
      "Grass pollen allergy"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "AT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004551-43"
  },
  {
    "EudraCT Number": "2016-001800-49",
    "Sponsor Protocol Number": "EFC14834",
    "Sponsor Name": "Sanofi-aventis Recherche & D\u00e9veloppement",
    "Full Title": "A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Added to Metformin in Patients with Type 2 Diabetes Mellitus W...",
    "Start Date": "2016-11-29",
    "Medical condition": [
      "Type 2 diabetes mellitus"
    ],
    "Disease": "Version: 20.0, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10067585, Term: Type 2 diabetes mellitus, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      },
      {
        "SK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001800-49"
  },
  {
    "EudraCT Number": "2015-005439-41",
    "Sponsor Protocol Number": "PLRG-10/ML29157",
    "Sponsor Name": "Polish Lymphoma Research Group (PLRG)",
    "Full Title": "EVALUATION OF EFFICACY AND SAFETY OF OBINUTUZUMAB PREEMPTIVE TREATMENT AT THE TIME OF THE MOLECULAR RELAPSE AFTER FIRST LINE IMMUNOCHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN MANTLE C...",
    "Start Date": "2017-08-13",
    "Medical condition": [
      "Molecular relapse after the first line immunochemotherapy with autologous stem cell transplantation in mantle cell lymphoma (MCL) patients"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10061275, Term: Mantle cell lymphoma, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "PL": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005439-41"
  },
  {
    "EudraCT Number": "2017-000384-32",
    "Sponsor Protocol Number": "MS200527-0060",
    "Sponsor Name": "Merck KGaA",
    "Full Title": "A Phase IIb, Randomized, Double blind Study in Subjects with Rheumatoid Arthritis Evaluating the Safety and Efficacy of Evobrutinib Compared with Placebo in Subjects with an Inadequate Response to ...",
    "Start Date": "2017-11-02",
    "Medical condition": [
      "Rheumatoid Arthritis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10028395 - Musculoskeletal and connective tissue disorders, Classification Code: 10039073, Term: Rheumatoid arthritis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "BG": "Completed"
      },
      {
        "CZ": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000384-32"
  },
  {
    "EudraCT Number": "2018-002076-41",
    "Sponsor Protocol Number": "0667",
    "Sponsor Name": "University of Leicester",
    "Full Title": "A RANDOMISED CONTROLLED TRIAL OF PRE-SURGERY SODIUM VALPROATE, FOR THE PREVENTION OF ORGAN INJURY IN CARDIAC SURGERY: Val-CARD",
    "Start Date": "2018-08-23",
    "Medical condition": [
      "Reduction of myocardial and kidney injury risk of post cardiac surgery by increasing the expression of genes that promote myocardial mitochondrial homeostasis via effects on chromatin histone deace..."
    ],
    "Disease": "Version: 20.1, SOC Term: 100000004849, Classification Code: 10057768, Term: Post-cardiac injury syndrome, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-002076-41"
  },
  {
    "EudraCT Number": "2012-002993-29",
    "Sponsor Protocol Number": "M13-625",
    "Sponsor Name": "Abbott Laboratories GmbH",
    "Full Title": "A Randomized, Open-label, Two-arm, Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg daily versus Crinone 8% intravaginal progesterone gel  90 mg daily ...",
    "Start Date": "2015-07-15",
    "Medical condition": [
      "Treatment for the luteal support in in-vitro fertilization (IVF)."
    ],
    "Disease": "Version: 18.1, SOC Term: 100000004865, Classification Code: 10021572, Term: In vitro fertilization, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "BE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-002993-29"
  },
  {
    "EudraCT Number": "2015-003198-14",
    "Sponsor Protocol Number": "VP-VEC-162-3106",
    "Sponsor Name": "Vanda Pharmaceuticals Inc",
    "Full Title": "A multicenter, randomized, double-blind, placebo-controlled, parallel study to investigate the efficacy and safety of multiple oral doses of tasimelteon and matching placebo in travelers with Jet L...",
    "Start Date": "2015-12-21",
    "Medical condition": [
      ""
    ],
    "Disease": "Version: 18.1, SOC Term: 10037175 - Psychiatric disorders, Classification Code: 10040984, Term: Sleep disorder, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003198-14"
  },
  {
    "EudraCT Number": "2015-001006-34",
    "Sponsor Protocol Number": "2015C104",
    "Sponsor Name": "University Medical Centre Groningen (UMCG)",
    "Full Title": "Groningen Intervention study for the Preservation of cardiac function with sodium thiosulfate after ST-segment elevation myocardial infarction",
    "Start Date": "2016-10-25",
    "Medical condition": [
      "ST-segment elevated myocardial infarction",
      "decompensatio cordis"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-001006-34"
  },
  {
    "EudraCT Number": "2015-005527-12",
    "Sponsor Protocol Number": "55868",
    "Sponsor Name": "",
    "Full Title": "Sirolimus for the treatment of severe intestinal polyposis in patients with familial adenomatous polyposis (FAP); a pilot study",
    "Start Date": "2016-12-02",
    "Medical condition": [
      "Familial adenomatous polyposis"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005527-12"
  },
  {
    "EudraCT Number": "2015-002190-37",
    "Sponsor Protocol Number": "P140302",
    "Sponsor Name": "ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)",
    "Full Title": "A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in patients with Beh\u00e7et disease : STELABEC",
    "Start Date": "2015-10-30",
    "Medical condition": [
      "Beh\u00e7et disease"
    ],
    "STELABEC-1": "patients with oral ulcers",
    "STELABEC-2": "patients with active posterior uveitis or panuveitis",
    "Disease": "Version: 18.1, SOC Term: 100000004866, Classification Code: 10004212, Term: Behcet's disease, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002190-37"
  },
  {
    "EudraCT Number": "2015-005019-34",
    "Sponsor Protocol Number": "CTMT212X2106",
    "Sponsor Name": "Novartis Pharma Services AG",
    "Full Title": "A phase I/II study of safety and efficacy of ribociclib (LEE011) in combination with trametinib (TMT212) in patients with metastatic or advanced solid tumors",
    "Start Date": "2016-05-24",
    "Medical condition": [
      "Solid tumors",
      "Pancreatic Cancer",
      "Colorectal Cancer"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10033604, Term: Pancreatic cancer, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Prematurely Ended"
      },
      {
        "BE": "Prematurely Ended"
      },
      {
        "ES": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005019-34"
  },
  {
    "EudraCT Number": "2016-004680-39",
    "Sponsor Protocol Number": "AUTO3-PA1",
    "Sponsor Name": "Autolus Limited",
    "Full Title": "A Single Arm, Open-Label, Multi-Centre, Phase I/II Study Evaluating the Safety and Clinical Activity of AUTO3, a CAR T Cell Treatment Targeting CD19 and CD22 in Paediatric and Adult Patients with R...",
    "Start Date": "2017-06-21",
    "Medical condition": [
      "Acute lymphoblastic leukaemia (ALL)"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004864, Classification Code: 10063625, Term: Acute lymphoblastic leukemia recurrent, Level: LLT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004680-39"
  },
  {
    "EudraCT Number": "2008-000144-14",
    "Sponsor Protocol Number": "N01276",
    "Sponsor Name": "UCB Inc",
    "Full Title": "An international, double-blind, randomized, multi-center, parallel group, historical-control conversion to monotherapy study to evaluate the efficacy and safety of brivaracetam in subjects (\u2265 16 to...",
    "Start Date": "2008-07-14",
    "Medical condition": [
      "Partial onset seizures with or without secondary generalization."
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10015037, Term: Epilepsy, Level: LLT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "BE": "Completed"
      },
      {
        "CZ": "Prematurely Ended"
      },
      {
        "DE": "Prematurely Ended"
      },
      {
        "SE": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-000144-14"
  },
  {
    "EudraCT Number": "2007-001913-41",
    "Sponsor Protocol Number": "C87085",
    "Sponsor Name": "UCB Celltech",
    "Full Title": "A phase IIIb, multinational, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of certolizumab pegol, a pegylated Fab' fragment of a humanized anti-TNF-alpha mono...",
    "Start Date": "2007-12-12",
    "Medical condition": [
      "Crohn`s disease"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10011401, Term: Crohn's disease, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FI": "Prematurely Ended"
      },
      {
        "HU": "Completed"
      },
      {
        "LV": "Completed"
      },
      {
        "BE": "Completed"
      },
      {
        "EE": "Completed"
      },
      {
        "IT": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "AT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-001913-41"
  },
  {
    "EudraCT Number": "2005-003749-15",
    "Sponsor Protocol Number": "RES/0186/7211",
    "Sponsor Name": "Merck, Sharp & Dohme-Clinical Pharmacology,Europe",
    "Full Title": "Investigation of the effectiveness of oral lorazepam in managing preoperative dental anxiety in phobic dental patients-A pilot study",
    "Start Date": "2006-02-02",
    "Medical condition": [
      "Pre operative dental anxiety",
      "in phobic dental patients."
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-003749-15"
  },
  {
    "EudraCT Number": "2005-003750-10",
    "Sponsor Protocol Number": "NA",
    "Sponsor Name": "V\u00e4straG\u00f6taland",
    "Full Title": "Growth hormone and androgens in the treatment of glucocorticoid induced protein catabolism",
    "Start Date": "2005-09-12",
    "Medical condition": [
      "Chronic treatment with glucocorticoids (GCs) regardless of indication leads to marked protein catabolism that causes substantial debilitation which includes muscle wasting",
      "weakness",
      "skin fragility..."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "SE": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-003750-10"
  },
  {
    "EudraCT Number": "2007-005755-42",
    "Sponsor Protocol Number": "GEIS 15",
    "Sponsor Name": "Grupo Espa\u00f1ol de Investigaci\u00f3n en Sarcomas",
    "Full Title": "ENSAYO CL\u00cdNICO FASE II DE TRATAMIENTO NEOADYUVANTE CON IFOSFAMIDA A DOSIS ALTAS Y RADIOTERAPIA CONCOMITANTE EN SARCOMAS DE PARTES BLANDAS E IDENTIFICACION DE MARCADORES PREDICTORES DE RESPUESTA",
    "Start Date": "2008-01-28",
    "Medical condition": [
      "Sarcomas de Partes Blandas de tronco y extremidades"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10041299, Term: Soft tissue sarcomas, Level: HLGT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-005755-42"
  },
  {
    "EudraCT Number": "2007-005777-57",
    "Sponsor Protocol Number": "NE-01",
    "Sponsor Name": "Hospital Errikos Dunant- Department of Hematology",
    "Full Title": "A comparative study of low molecular weight IV iron dextran (CosmoFer\u00ae) versus per os iron for the treatment of anaemia in patients with haematological malignancies receiving epoietin treatment",
    "Start Date": "2008-05-13",
    "Medical condition": [
      "Fe deficiency anaemia"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10002034, Term: Anaemia, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GR": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-005777-57"
  },
  {
    "EudraCT Number": "2005-005581-36",
    "Sponsor Protocol Number": "309821",
    "Sponsor Name": "Schering AG",
    "Full Title": "Randomized phase II study to investigate the efficacy, safety and tolerability of ZK 230211 (25 mg vs. 100 mg) as second-line endocrine therapy for postmenopausal women with hormone receptor-positi...",
    "Start Date": "2006-05-24",
    "Medical condition": [
      "Metastatic breast cancer"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "AT": "Prematurely Ended"
      },
      {
        "GB": "Completed"
      },
      {
        "DE": "Prematurely Ended"
      },
      {
        "ES": "Completed"
      },
      {
        "IT": "Prematurely Ended"
      },
      {
        "FI": "Prematurely Ended"
      },
      {
        "SE": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-005581-36"
  },
  {
    "EudraCT Number": "2004-002168-59",
    "Sponsor Protocol Number": "AGLU017-02",
    "Sponsor Name": "GENZYME",
    "Full Title": "An Open-Label, Multicenter, Multinational, Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Acid alpha- Glucosidase (rhGAA) Treatment in Patients > 6 and <...",
    "Start Date": "2004-10-14",
    "Medical condition": [
      "Treatment for Type II Glycogenosis"
    ],
    "Disease": "Version: 6.1, SOC Term: , Classification Code: 10053185, Term: , Level: PT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2004-002168-59"
  },
  {
    "EudraCT Number": "2007-005468-28",
    "Sponsor Protocol Number": "CQAB149B2340",
    "Sponsor Name": "Novartis Pharma Services AG",
    "Full Title": "A Phase III, randomized, double-blind, placebo controlled, multicenter, 3-period, 14 day crossover study to determine the 24-h lung function profile of indacaterol (300 \u03bcg o.d.) in patients with mo...",
    "Start Date": "2008-01-18",
    "Medical condition": [
      "moderate to severe chronic obstructive pulmonary disease (COPD)."
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10010952, Term: COPD, Level: LLT",
    "Population Age": [
      ""
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "BE": "Completed"
      },
      {
        "ES": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-005468-28"
  },
  {
    "EudraCT Number": "2006-002392-40",
    "Sponsor Protocol Number": "LCH-A1",
    "Sponsor Name": "VU University Medical Center",
    "Full Title": "LCH-A1, first international study for Langerhans Cell Histiocytosis in adults",
    "Start Date": "2007-10-05",
    "Medical condition": [
      "Langerhans Cell Histiocytosis in adults with single system disease with  multifocal bonelesions or with lesions in the craniofacial bones with brain extension or in the vertebral bones with intrasp..."
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10020117, Term: Histiocytosis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      },
      {
        "IT": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-002392-40"
  },
  {
    "EudraCT Number": "2006-002395-18",
    "Sponsor Protocol Number": "2006-1",
    "Sponsor Name": "Aarhus Universitetshospital, Aarhus Sygehus THG",
    "Full Title": "Intervention studier med steviol til belysning af dosis respons forhold samt langtidseffekt hos personer med type 2 diabetes",
    "Start Date": "2006-10-18",
    "Medical condition": [
      "Inkluderede patienter er  type 2 diabetiske patienter"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-002395-18"
  },
  {
    "EudraCT Number": "2004-004214-16",
    "Sponsor Protocol Number": "FS014",
    "Sponsor Name": "Committee of Management, Common Services Agency T/A Scottish National Blood Transfusion Service",
    "Full Title": "A randomised control clinical study to determine whether SNBTS Fibrin Sealant promotes wound healing in patients undergoing cardiac surgery.",
    "Start Date": "2005-01-19",
    "Medical condition": [
      "In patients undergoing cardiac surgery the saphenous leg vein is used to replace veins used in coronary artery bypass grafts (CABG) surgery."
    ],
    "Disease": "Version: 7.1, SOC Term: , Classification Code: 10006894, Term: , Level: LLT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2004-004214-16"
  },
  {
    "EudraCT Number": "2004-004226-28",
    "Sponsor Protocol Number": "ATS K016",
    "Sponsor Name": "Takeda Pharma GmbH",
    "Full Title": "Effects of Pioglitazone in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease at High Risk for Cardiovascular Complications",
    "Start Date": "2005-01-17",
    "Medical condition": [
      "Type 2 Diabetes mellitus"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2004-004226-28"
  },
  {
    "EudraCT Number": "2007-007882-19",
    "Sponsor Protocol Number": "MI2-STAR2-2006",
    "Sponsor Name": "AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA",
    "Full Title": "A pilot, randomized trial to evaluate the lipid profile after antiretroviral  regimens including nevirapine or atazanavir boosted with ritonavir in HIV-positive patients naive for antiretrovirals",
    "Start Date": "2006-10-09",
    "Medical condition": [
      "immunodefic syndrome - patients naive antiretroviral therapy"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10000565, Term: Acquired immunodeficiency syndrome, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IT": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-007882-19"
  },
  {
    "EudraCT Number": "2005-000395-41",
    "Sponsor Protocol Number": "ICORG 05-01",
    "Sponsor Name": "All Ireland co-operative Oncology Research Group",
    "Full Title": "Phase II Study to Assess the Safety, Efficacy, and Tolerability of Combination Therapy with Velcade\uf0d4 (Bortezomib), Adriamycin, and Dexamethasone (PAD) as Therapy for Patients with relapsed or refra...",
    "Start Date": "2005-05-27",
    "Medical condition": [
      "Relapsed or refractory Multiple Myeloma"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      },
      {
        "IE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-000395-41"
  },
  {
    "EudraCT Number": "2006-005649-12",
    "Sponsor Protocol Number": "SUCPAT1_CTR0026",
    "Sponsor Name": "Regent Medical",
    "Full Title": "A 96 hour (4-application) patch test and TEWL assessment in healthy volunteers to investigate the comparative skin irritation potential of six antiseptics and two controls following cutaneous patch...",
    "Start Date": "2006-12-20",
    "Medical condition": [
      "This trial will be carried out on healthy volunteers.  Patches containing 0.2mls of each test product will be used. Each volunteer will have a single patch per product and the patches will be remov..."
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-005649-12"
  },
  {
    "EudraCT Number": "2006-005657-30",
    "Sponsor Protocol Number": "2006-24",
    "Sponsor Name": "Assistance Publique Hopitaux de marseille",
    "Full Title": "Etude pharmacocin\u00e9tique, prospective, ouverte, de la diffusion de l\u2019Ertap\u00e9n\u00e8me dans le muscle par microdialyse chez des patients de r\u00e9animation sous ventilation m\u00e9canique, recevant ou non des vasop...",
    "Start Date": "2007-03-14",
    "Medical condition": [
      "Reanimation par ventillation mecanique"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-005657-30"
  },
  {
    "EudraCT Number": "2006-005681-39",
    "Sponsor Protocol Number": "FAR-0201",
    "Sponsor Name": "FARMIGEA",
    "Full Title": "A RANDOMIZED, DOUBLE-BLIND, MULTICENTER PARALLEL GROUP STUDY ON EFFICACY AND SAFETY OF KETOTIFEN FUMARATE 0.05  OPHTHALMIC SOLUTION VERSUS KETOTIFEN FUMARATE 0.025",
    "Start Date": "2007-01-22",
    "Medical condition": [
      "Patients with seasonal allergic conjunctivitis  and history of ocular allergies for at least 2 years."
    ],
    "Disease": "Version: 6.1, SOC Term: , Classification Code: 10010744, Term: , Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-005681-39"
  },
  {
    "EudraCT Number": "2005-005725-64",
    "Sponsor Protocol Number": "CAGEM",
    "Sponsor Name": "AZIENDA SANITARIA OSPEDALIERA  S. GIOVANNI BATTISTA DI TORINO",
    "Full Title": "PHASE II CLINICAL AND PHARMACOKINETIC STUDY OF PEGYLATED LIPOSOMAL DOXORUBICIN AND GEMCITABINE IN ADVANCED OVARIAN CARCINOMA",
    "Start Date": "2006-01-20",
    "Medical condition": [
      "OVARIAN ADENOCARCINOMA"
    ],
    "Disease": "Version: 6.1, SOC Term: , Classification Code: 10061328, Term: , Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "IT": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-005725-64"
  },
  {
    "EudraCT Number": "2005-005749-20",
    "Sponsor Protocol Number": "64210/H",
    "Sponsor Name": "Richter Gedeon Vegy\u00e9szeti Gy\u00e1r Rt",
    "Full Title": "Amlodipint \u00e9s lisinoprilt tartalmaz\u00f3 fix gy\u00f3gyszerkombin\u00e1ci\u00f3 (Lisonorm\u00ae) hat\u00e1soss\u00e1g\u00e1nak \u00e9s biztons\u00e1goss\u00e1g\u00e1nak vizsg\u00e1lata essentialis hypertoni\u00e1s betegeken (ALFESS)",
    "Start Date": "2006-05-03",
    "Medical condition": [
      "essentialis hypert\u00f3nia"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-005749-20"
  },
  {
    "EudraCT Number": "2006-004834-33",
    "Sponsor Protocol Number": "ROB 803-09-002",
    "Sponsor Name": "OxyPharma AB",
    "Full Title": "A Phase II, Randomised, Double-blind, International, Multicentre, Placebo-controlled, Dose-ranging, Parallel-group Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 when Adde...",
    "Start Date": "2007-07-05",
    "Medical condition": [
      "Rheumatiod Arthritis"
    ],
    "Disease": "Version: 8.1, SOC Term: , Classification Code: 10039073, Term: Rheumatoid arthritis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "LT": "Completed"
      },
      {
        "LV": "Completed"
      },
      {
        "GB": "Completed"
      },
      {
        "BE": "Completed"
      },
      {
        "BG": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-004834-33"
  },
  {
    "EudraCT Number": "2006-004840-21",
    "Sponsor Protocol Number": "RISED_C_00935",
    "Sponsor Name": "sanofi-aventis Netherlands B.V.",
    "Full Title": "Bone Histomorphometry, Microarchitecture and Matrix Structure and Properties in Patients Receiving Long-term Risedronate Treatment",
    "Start Date": "2007-04-23",
    "Medical condition": [
      "The objective of this study is to collect data on bone histomorphometry",
      "architecture",
      "turnover and material properties from iliac crest biopsies taken from postmenopausal women after > 5 year rise..."
    ],
    "Disease": "Version: 8.1, SOC Term: , Classification Code: 10031285, Term: Osteoporosis postmenopausal, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "AT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-004840-21"
  },
  {
    "EudraCT Number": "2006-004849-42",
    "Sponsor Protocol Number": "88/2006/O/Sper",
    "Sponsor Name": "AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI",
    "Full Title": "Cetuximab + Irinotecano vs chemoterapia standard nel carcinoma colo-rettale avanzato pretrattato non resecabile esprimente EGFR",
    "Start Date": "2006-11-02",
    "Medical condition": [
      "carcinoma colo-rettale avanzato"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10010023, Term: Colorectal neoplasms malignant, Level: HLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IT": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-004849-42"
  },
  {
    "EudraCT Number": "2008-002002-19",
    "Sponsor Protocol Number": "MODAGE MO 169",
    "Sponsor Name": "BIOCODEX",
    "Full Title": "Effets du moclob\u00e9mide sur le profil d'activation c\u00e9r\u00e9brale de patients d\u00e9pressifs \u00e2g\u00e9s lors de t\u00e2ches cognitives et \u00e9motionnelles, en r\u00e9f\u00e9rence \u00e0 des sujets t\u00e9moins. Etude ouverte, multicentrique, ...",
    "Start Date": "2008-06-11",
    "Medical condition": [
      ""
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-002002-19"
  },
  {
    "EudraCT Number": "2007-005033-11",
    "Sponsor Protocol Number": "SRx-501-01",
    "Sponsor Name": "CombinatoRx, Inc",
    "Full Title": "A Comparison Of The Safety And Bioavailability Of Modified-Release Formulations Of Levodopa-Carbidopa In Subjects With Parkinson\u2019s Disease",
    "Start Date": "2008-03-27",
    "Medical condition": [
      "Patients with Parkinson's Disease"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-005033-11"
  },
  {
    "EudraCT Number": "2008-000905-12",
    "Sponsor Protocol Number": "CCD-0802-PR-0029",
    "Sponsor Name": "CHIESI",
    "Full Title": "A single dose, randomized, double blind, double dummy, placebo  controlled, three-period crossover clinical study, comparing  the onset of relief from methacholine induced bronchoconstriction with ...",
    "Start Date": "2008-08-20",
    "Medical condition": [
      "Ashtma"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10003553, Term: Asthma, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IT": "Completed"
      },
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-000905-12"
  },
  {
    "EudraCT Number": "2008-000928-71",
    "Sponsor Protocol Number": "GOIRC02/2008-TWIST",
    "Sponsor Name": "GRUPPO ONCOLOGICO ITALIANO DI RICERCA",
    "Full Title": "\u0093TWIST\u0094. RANDOMIZED PROSPECTIVE PHASE II STUDY OF TEMSIROLIMUS WITH OR WITHOUT LOW-DOSE INTERFERON ALPHA IN METASTATIC NON-CLEAR RENAL CELL CARCINOMA: GOIRC STUDY 02/2008",
    "Start Date": "2008-11-14",
    "Medical condition": [
      "Patients with advanced non-clear Cell Renal Carcinoma."
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10038414, Term: Renal cell carcinoma stage IV, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IT": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-000928-71"
  },
  {
    "EudraCT Number": "2008-000942-29",
    "Sponsor Protocol Number": "6520-0650-13",
    "Sponsor Name": "Medice Arnzneimittel P\u00fctter GmbH & Co. KG",
    "Full Title": "Quality assurance of methylphenidate administration in adults with ADHS",
    "Start Date": "2008-06-23",
    "Medical condition": [
      "Aufmerksamkeitsdefizit/Hyperaktivit\u00e4tsst\u00f6rungen (ADHS) bei Erwachsenen"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-000942-29"
  },
  {
    "EudraCT Number": "2007-000259-33",
    "Sponsor Protocol Number": "06-AnIt-06",
    "Sponsor Name": "Department of Anesthesiology and Intensive Care, University Hospital M\u00fcnster",
    "Full Title": "Perioperative protective effects of lidocaine - clinical study on the route and timing of administration",
    "Start Date": "2007-08-16",
    "Medical condition": [
      "patients",
      "scheduled for major elective colorectal surgery"
    ],
    "Disease": "Version: 14.0, SOC Term: 10042613 - Surgical and medical procedures, Classification Code: 10044447, Term: Transverse colectomy, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-000259-33"
  },
  {
    "EudraCT Number": "2007-000271-42",
    "Sponsor Protocol Number": "11012007",
    "Sponsor Name": "Matti Eskelinen",
    "Full Title": "OKSIKODONIN ANALGEETTINEN PITOISUUS PLASMASSA YHDESS\u00c4 PARASETAMOLIN 1g TAI 2g IV KANSSA ANNETTUNA MAHAKIRURGISILLA POTILAILLA",
    "Start Date": "2007-05-08",
    "Medical condition": [
      "Tutkimukseen otetaan 24 sappileikkaukseen tulevaa perustervett\u00e4 aikuispotilasta."
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10017641, Term: Gallbladder disease, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FI": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-000271-42"
  },
  {
    "EudraCT Number": "2007-002542-38",
    "Sponsor Protocol Number": "CAEB071A2210",
    "Sponsor Name": "Novartis Pharma Services AG",
    "Full Title": "A randomized, double blind, placebo controlled, parallel group design study to explore the efficacy, safety and tolerability of AEB071 in patients with active, moderate to severe ulcerative colitis.",
    "Start Date": "2007-11-28",
    "Medical condition": [
      "Ulcerative colitis"
    ],
    "Disease": "Version: 14.0, SOC Term: 10017947 - Gastrointestinal disorders, Classification Code: 10045365, Term: Ulcerative colitis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Prematurely Ended"
      },
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-002542-38"
  },
  {
    "EudraCT Number": "2006-005254-68",
    "Sponsor Protocol Number": "GEL/TAMO-2006",
    "Sponsor Name": "GEL/TAMO (Cooperative Spanish Group of Lymphoma/Autologous bone marrow transplant).",
    "Full Title": "Treatment with R-MegaCHOP and early rescue with R-IFE and autologous stem cells transplant (ASCT) according response measured by positron emission tomography (PET) in patients with diffuse large B-...",
    "Start Date": "2007-04-13",
    "Medical condition": [
      "Diffuse Large B-Cell Lymphoma (DLBCL)"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-005254-68"
  },
  {
    "EudraCT Number": "2007-005152-16",
    "Sponsor Protocol Number": "BV-2007/04",
    "Sponsor Name": "OM Pharma SA",
    "Full Title": "Multicentre, randomised, double-blind, placebo-controlled study of the efficacy and safety of Broncho-Vaxom in adults suffering from chronic rhinosinusitis",
    "Start Date": "2008-10-07",
    "Medical condition": [
      "Chronic rhinosinusitis"
    ],
    "Disease": "Version: 14.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10052106, Term: Rhinosinusitis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "AT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-005152-16"
  },
  {
    "EudraCT Number": "2007-005163-94",
    "Sponsor Protocol Number": "BAY81-8781/12946",
    "Sponsor Name": "Bayer HealthCare AG",
    "Full Title": "A prospective, randomized, verum controlled, open label, parallel group multi-center phase III clinical trial to demonstrate the superiority of 500 or 250 mg Aspirin\u00ae i.v. (BAY 81-8781) treatment v...",
    "Start Date": "2010-10-08",
    "Medical condition": [
      "Acute coronary syndrome (ACS)"
    ],
    "Disease": "Version: 14.1, SOC Term: 10007541 - Cardiac disorders, Classification Code: 10051592, Term: Acute coronary syndrome, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-005163-94"
  },
  {
    "EudraCT Number": "2007-005164-27",
    "Sponsor Protocol Number": "260981",
    "Sponsor Name": "research office urology VUmc",
    "Full Title": "Botulinum toxin A intravesical injections in the treatment of Bladder Pain Syndrome/ Interstitial Cystitis",
    "Start Date": "2008-02-22",
    "Medical condition": [
      "Interstitial Cystitis (IC) is a syndrome characterized by bladder pain associated with urgency",
      "frequency",
      "nocturia",
      "dysuria and sterile urine. The patho-physiology remains largely unclear. No univ..."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-005164-27"
  },
  {
    "EudraCT Number": "2007-005169-36",
    "Sponsor Protocol Number": "NKV110721",
    "Sponsor Name": "GlaxoSmithKline Research and Development Limited",
    "Full Title": "NKV110721, A Study of Single Dose Intravenous Casopitant in Combination with Ondansetron and Dexamethasone for the Prevention of Oxaliplatin-Induced Nausea and Vomiting",
    "Start Date": "2008-02-07",
    "Medical condition": [
      "Prevention of nausea and vomiting due to first cycle of oxaliplatin based chemotherapy in patients with colorectal cancer receiving a combination with 5-fluorouracil and leucovorin",
      "or in combinati..."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "BE": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "HU": "Completed"
      },
      {
        "IT": "Completed"
      },
      {
        "SK": "Completed"
      },
      {
        "BG": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-005169-36"
  },
  {
    "EudraCT Number": "2005-002494-75",
    "Sponsor Protocol Number": "CL3-12911-018",
    "Sponsor Name": "Institut de Recherches Internationales Servier",
    "Full Title": "The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 3 years in the treatment of knee osteoarthritis. A prospective multicentre, int...",
    "Start Date": "2006-04-26",
    "Medical condition": [
      "Osteoarthritis"
    ],
    "Disease": "Version: 7.0, SOC Term: , Classification Code: 10031161, Term: , Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "AT": "Completed"
      },
      {
        "BE": "Completed"
      },
      {
        "GB": "Completed"
      },
      {
        "ES": "Completed"
      },
      {
        "IT": "Completed"
      },
      {
        "DK": "Completed"
      },
      {
        "PT": "Completed"
      },
      {
        "LT": "Completed"
      },
      {
        "EE": "Completed"
      },
      {
        "CZ": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-002494-75"
  },
  {
    "EudraCT Number": "2007-000971-41",
    "Sponsor Protocol Number": "GGCP032/07",
    "Sponsor Name": "Grupo Gallego de C\u00e1ncer de Pulm\u00f3n",
    "Full Title": "Estudio fase II de bevacizumab en combinaci\u00f3n con vinorelbina y cisplatino, como tratamiento de primera l\u00ednea de pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico,no epidermoide, estadio IIIB con derra...",
    "Start Date": "2007-07-03",
    "Medical condition": [
      "C\u00e1ncer de pulm\u00f3n no microc\u00edtico(CPNM)",
      "no epidermoide",
      "estadio IIIB con derrame pleural o IV / on-small cell",
      "non-squamous lung cancer",
      "stage IIIb with pleural effusion or stage IV."
    ],
    "Disease": "Version: 14.1, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10029521, Term: Non-small cell lung cancer stage IIIB, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-000971-41"
  },
  {
    "EudraCT Number": "2004-002218-13",
    "Sponsor Protocol Number": "25289",
    "Sponsor Name": "INDUSTRIA FARMACEUTICA SERONO",
    "Full Title": "A phase III, multicenter, randomized, open, comparative study to evaluate if the addition of r-hLH (Luveris) ti FSH from day 8 of ovarian stimulation is able to decrease total FSH dose and to impro...",
    "Start Date": "2004-11-09",
    "Medical condition": [
      "Reduction of the FSH dose needed to obtain/retrieve each oocyte after administration of Luveris to FSH at day 8 of ovarian stimulation."
    ],
    "Disease": "Version: 6.1, SOC Term: , Classification Code: 10021928, Term: , Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "IT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2004-002218-13"
  },
  {
    "EudraCT Number": "2007-004553-29",
    "Sponsor Protocol Number": "ML21287",
    "Sponsor Name": "Roche",
    "Full Title": "Essai en ouvert, randomis\u00e9 et multicentrique \u00e9valuant l\u2019efficacit\u00e9 et la tol\u00e9rance de l\u2019association de l\u2019Enfuvirtide en cure d\u2019induction de 3 mois \u00e0 un traitement optimis\u00e9 (TO) comprenant au moins ...",
    "Start Date": "2007-10-23",
    "Medical condition": [
      "Patients s\u00e9ropositifs VIH-1 en \u00e9chec de lignes de traitements antir\u00e9troviraux ant\u00e9rieurs"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10020161, Term: HIV infection, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-004553-29"
  },
  {
    "EudraCT Number": "2017-000994-35",
    "Sponsor Protocol Number": "06032017",
    "Sponsor Name": "Hospital General Universitario de Alicante",
    "Full Title": "Study of  tolerability of iron liposome compared to ferrous sulphate in pregnant women with iron deficiency anemia.",
    "Start Date": "2018-08-02",
    "Medical condition": [
      "Iron deficiency anaemia"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004851, Classification Code: 10002042, Term: Anaemia deficiencies, Level: HLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000994-35"
  },
  {
    "EudraCT Number": "2014-005510-34",
    "Sponsor Protocol Number": "MMV_DSM265_14_01",
    "Sponsor Name": "Medicines for Malaria Venture",
    "Full Title": "Evaluation of the prophylactic antimalarial activity of a single dose of DSM265 in non-immune healthy adult volunteers by controlled human malaria infection with PfSPZ Challenge",
    "Start Date": "2015-09-30",
    "Medical condition": [
      "Healthy volunteers; controlled human malaria infection with PfSPZ"
    ],
    "Disease": "Version: 18.1, SOC Term: 10042613 - Surgical and medical procedures, Classification Code: 10025494, Term: Malaria prophylaxis, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-005510-34"
  },
  {
    "EudraCT Number": "2014-000727-25",
    "Sponsor Protocol Number": "47582",
    "Sponsor Name": "Isala Klinieken",
    "Full Title": "The effect of ARTISS on latissimus dorsi donor site seroma formation after breast reconstruction: a randomised controlled trial.",
    "Start Date": "2017-03-28",
    "Medical condition": [
      "The aim of this study is to investigate the effect of the fibrin sealant ARTISS compared with our standard care on total volume of donor site seroma after harvesting a LD in immediate breast recons..."
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-000727-25"
  },
  {
    "EudraCT Number": "2015-002955-85",
    "Sponsor Protocol Number": "AVICCI001",
    "Sponsor Name": "Imperial College London",
    "Full Title": "A feasibility study to assess the effects of AntiretroViral Intensification with Cenicriviroc for the management of HIV-associated Cognitive Impairment. The AVICCI study",
    "Start Date": "2016-01-21",
    "Medical condition": [
      "Human Immunodeficiency Virus"
    ],
    "Disease": "Version: 19.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10020161, Term: HIV infection, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002955-85"
  },
  {
    "EudraCT Number": "2017-002729-39",
    "Sponsor Protocol Number": "C-07-40",
    "Sponsor Name": "Alcon Research Ltd",
    "Full Title": "An Evaluation of the Safety and Efficacy of Moxifloxacin AF Ophthalmic Solution 0.5% for the Treatment of Bacterial Conjunctivitis in the USA",
    "Start Date": "2017-11-07",
    "Medical condition": [
      "Bacterial conjunctivitis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10061784, Term: Conjunctivitis bacterial, Level: PT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002729-39"
  },
  {
    "EudraCT Number": "2018-003426-89",
    "Sponsor Protocol Number": "E2020-J081-345",
    "Sponsor Name": "Eisai Co., Ltd. (Japan)",
    "Full Title": "A Double-blind, Placebo-controlled Comparative Study and Open-label Extension Study to Confirm the Efficacy and Safety of E2020 in Subjects With Down Syndrome Having Regression Symptoms and Disable...",
    "Start Date": "2018-10-18",
    "Medical condition": [
      "Down syndrome",
      "regression symptoms and disabled activities of daily living"
    ],
    "Disease": "",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-003426-89"
  },
  {
    "EudraCT Number": "2018-000454-22",
    "Sponsor Protocol Number": "CCR4825",
    "Sponsor Name": "The Royal Marsden NHS Foundation Trust",
    "Full Title": "A translational phase II study of single agent Olaparib in the treatment of advanced oesophagogastric cancer",
    "Start Date": "2019-02-01",
    "Medical condition": [
      "Advanced Oesophago-gastric cancer"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-000454-22"
  },
  {
    "EudraCT Number": "2013-002516-27",
    "Sponsor Protocol Number": "P121006",
    "Sponsor Name": "ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)",
    "Full Title": "",
    "Start Date": "2014-03-06",
    "Medical condition": [
      ""
    ],
    "Disease": "Version: 18.0, SOC Term: 100000004873, Classification Code: 10009817, Term: Cocaine dependence, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "FR": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-002516-27"
  },
  {
    "EudraCT Number": "2015-004901-18",
    "Sponsor Protocol Number": "LAM107844",
    "Sponsor Name": "GlaxoSmithKline Research & Development",
    "Full Title": "Clinical Evaluation of lamotrigine in Epilepsy",
    "Start Date": "2016-08-03",
    "Medical condition": [
      "Epilepsy"
    ],
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004901-18"
  },
  {
    "EudraCT Number": "2015-004870-14",
    "Sponsor Protocol Number": "LOC114220",
    "Sponsor Name": "GlaxoSmithKline Research & Development Ltd",
    "Full Title": "A multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study to determine the efficacy and safety of nebulized fluticasone propionate 1mg twice daily compared with...",
    "Start Date": "2016-08-03",
    "Medical condition": [
      "Asthma"
    ],
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004870-14"
  },
  {
    "EudraCT Number": "2015-004888-37",
    "Sponsor Protocol Number": "FFR111158",
    "Sponsor Name": "GlaxoSmithKline Research and Development Ltd",
    "Full Title": "A Pilot, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study to Evaluate the Efficacy and Safety of Once-daily Intranasal Administration of Fluticasone Furoate Nasal Spr...",
    "Start Date": "2016-08-03",
    "Medical condition": [
      "Irritant (non-allergic) rhinitis"
    ],
    "Disease": "",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004888-37"
  },
  {
    "EudraCT Number": "2017-000071-90",
    "Sponsor Protocol Number": "AGO/2017/002",
    "Sponsor Name": "Ghent University Hospital",
    "Full Title": "Effect of sevoflurane and propofol on hepato-splanchnic pressure and flow during hepatobiliary surgery.",
    "Start Date": "2017-03-15",
    "Medical condition": [
      "patients scheduled for hepato-biliary surgery."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "BE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000071-90"
  },
  {
    "EudraCT Number": "2017-000251-74",
    "Sponsor Protocol Number": "SFY10718",
    "Sponsor Name": "Sanofi",
    "Full Title": "An open-label, uncontrolled 4-week study to assess the safety, efficacy and pharmacokinetics of Allegra\u00ae (dry syrup formulation) 15 mg or 30 mg twice daily in pediatric patients with atopic dermat...",
    "Start Date": "2017-03-20",
    "Medical condition": [
      "Atopic dermatitis"
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004858, Classification Code: 10003639, Term: Atopic dermatitis, Level: LLT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000251-74"
  },
  {
    "EudraCT Number": "2017-002876-26",
    "Sponsor Protocol Number": "2017-002876-26",
    "Sponsor Name": "South Tees Hospitals NHS Foundation Trust",
    "Full Title": "Telomerase ACTivator to reverse Immunosenescence in Acute Coronary Syndrome: a double-blind, phase II, pilot randomised controlled trial (TACTIC)",
    "Start Date": "2018-10-19",
    "Medical condition": [
      "Immunosenescence in patients who have had an acute coronary syndrome diagnosed within the last 6 months."
    ],
    "Disease": "Version: 20.1, SOC Term: 10021428 - Immune system disorders, Classification Code: 10011968, Term: Decreased immune responsiveness, Level: PT",
    "Population Age": [
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002876-26"
  },
  {
    "EudraCT Number": "2016-003736-21",
    "Sponsor Protocol Number": "ACE-LY-110",
    "Sponsor Name": "Acerta Pharma BV",
    "Full Title": "A Phase 1/2 Proof-of-Concept Study of the Combination of Acalabrutinib and Vistusertib in Subjects with Relapsed/Refractory B-cell Malignancies",
    "Start Date": "2017-06-07",
    "Medical condition": [
      "Part 1: De novo Diffuse large B-cell lymphoma (DLBCL)",
      "Transformed DLBCL and Richter syndrome (RS)."
    ],
    "Part 2": "De novo Germinal center B-cell (GCB) DLBCL and De novo non-GCB DLBCL",
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10058728, Term: Richter's syndrome, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003736-21"
  },
  {
    "EudraCT Number": "2015-005445-32",
    "Sponsor Protocol Number": "LA-II-02",
    "Sponsor Name": "BIOrest, Ltd.",
    "Full Title": "The BLADE-PCI Trial (PHASE IIB LIPOSOMAL ALENDRONATE STUDY):  Biorest Liposomal Alendronate Administration for Diabetic Patients Undergoing Drug-Eluting Stent Percutaneous Coronary Intervention",
    "Start Date": "2016-06-24",
    "Medical condition": [
      "PCI (percutaneous coronary intervention) for angina",
      "silent ischemia or non-STEMI in patients with diabetes mellitus."
    ],
    "Disease": "Version: 18.1, SOC Term: 100000004866, Classification Code: 10051615, Term: Atherosclerotic cardiovascular disease, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005445-32"
  },
  {
    "EudraCT Number": "2016-003625-42",
    "Sponsor Protocol Number": "GS-US-342-4062",
    "Sponsor Name": "Gilead Sciences, Inc.",
    "Full Title": "A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir for 12 Weeks in Subjects with Chronic HCV Infection Who are on Dialysis for End Stage Renal Di...",
    "Start Date": "2017-03-24",
    "Medical condition": [
      "Chronic Hepatitis C virus infection"
    ],
    "Disease": "Version: 19.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10008912, Term: Chronic hepatitis C, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "ES": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003625-42"
  },
  {
    "EudraCT Number": "2016-003141-28",
    "Sponsor Protocol Number": "CCR4500",
    "Sponsor Name": "The Institute of Cancer Research",
    "Full Title": "ACE: Proof of concept Phase I/II trial of the CXCR2 antagonist AZD5069, administered in combination with enzalutamide, in patients with metastatic castration resistant prostate cancer(mCRPC)",
    "Start Date": "2017-04-04",
    "Medical condition": [
      "Metastatic castration resistant prostate cancer"
    ],
    "Disease": "",
    "Population Age": [
      ""
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003141-28"
  },
  {
    "EudraCT Number": "2016-004459-65",
    "Sponsor Protocol Number": "SEP-RES-2016-01",
    "Sponsor Name": "Respira. Fundaci\u00f3n Espa\u00f1ola del Pulm\u00f3n (SEPAR)",
    "Full Title": "Reslizumab in patients with severe asthma who failed to respond to omalizumab: a pilot study",
    "Start Date": "2017-03-20",
    "Medical condition": [
      "Severe asthma"
    ],
    "Disease": "Version: 19.1, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10003553, Term: Asthma, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004459-65"
  },
  {
    "EudraCT Number": "2016-000308-28",
    "Sponsor Protocol Number": "ICL670F1102",
    "Sponsor Name": "Novartis",
    "Full Title": "A randomized, open label, six sequences, cross-over study in healthy Japanese subjects to evaluate the pharmacokinetic comparability of deferasirox granule formulation with the reference dispersibl...",
    "Start Date": "2016-03-09",
    "Medical condition": [
      "Healthy adult subjects"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000308-28"
  },
  {
    "EudraCT Number": "2017-001678-40",
    "Sponsor Protocol Number": "CACZ885N2301E2",
    "Sponsor Name": "Novartis pharma AG",
    "Full Title": "An extension study of safety of canakinumab in Japanese patients with periodic fever syndromes",
    "Start Date": "2017-05-15",
    "Medical condition": [
      "Three disease of periodic fever syndromes",
      "TNF receptor Associated Periodic Syndrome (TRAPS)",
      "Hyper IgDSyndrome (HIDS)/ Mevalonate Kinase Deficiency (MKD) and Familial Mediterranean Fever (FMF"
    ],
    "Disease": "Version: 20.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10010331, Term: Congenital, familial and genetic disorders, Level: SOC",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-001678-40"
  },
  {
    "EudraCT Number": "2016-004318-82",
    "Sponsor Protocol Number": "CTBM100CUS03",
    "Sponsor Name": "Novartis Pharmaceuticals Corporation",
    "Full Title": "Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles",
    "Start Date": "2017-05-15",
    "Medical condition": [
      "Cystic Fibrosis"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004862, Classification Code: 10021860, Term: Infection Pseudomonas aeruginosa, Level: LLT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004318-82"
  },
  {
    "EudraCT Number": "2020-001364-29",
    "Sponsor Protocol Number": "AdiQure/COVID-19",
    "Sponsor Name": "Red Andaluza de Dise\u00f1o y Traslaci\u00f3n de Terapias Avanzadas-Fundaci\u00f3n Progreso y Salud",
    "Full Title": "Phase I/II clinical trial to evaluate the safety and efficacy of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded in patients with severe COVID-19 pneumonia",
    "Start Date": "2020-04-20",
    "Medical condition": [
      "Severe COVID-19 pneumonia"
    ],
    "Disease": "Version: 21.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10035737, Term: Pneumonia viral, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001364-29"
  },
  {
    "EudraCT Number": "2016-003820-22",
    "Sponsor Protocol Number": "2016-Longterm-OX",
    "Sponsor Name": "Dutch Growth Research Foundation",
    "Full Title": "Intranasal administration of oxytocin in children with Prader-Willi Syndrome. A randomized, open-label, cross-over trial of different treatment regimens of oxytocin administration. Effects on eatin...",
    "Start Date": "2016-12-22",
    "Medical condition": [
      "Prader-Willi syndrome"
    ],
    "Disease": "Version: 19.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10036476, Term: Prader-Willi syndrome, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Not Authorised"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003820-22"
  },
  {
    "EudraCT Number": "2016-000556-95",
    "Sponsor Protocol Number": "LP0053-1004",
    "Sponsor Name": "LEO Pharma A/S",
    "Full Title": "LEO 90100 twice weekly maintenance regimen for psoriasis vulgaris",
    "Start Date": "2017-01-03",
    "Medical condition": [
      "Psoriasis vulgaris"
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004858, Classification Code: 10050576, Term: Psoriasis vulgaris, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "FR": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000556-95"
  },
  {
    "EudraCT Number": "2016-002543-41",
    "Sponsor Protocol Number": "64041757LUC2002",
    "Sponsor Name": "Janssen-Cilag International NV",
    "Full Title": "An Open-label Randomized Phase 1b/2 Study of the Efficacy and Safety of JNJ-64041757, a Live Attenuated Listeria monocytogenes Immunotherapy, in Combination with Nivolumab Versus Nivolumab Monother...",
    "Start Date": "2018-02-20",
    "Medical condition": [
      "Advanced adenocarcinoma of the lung"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004864, Classification Code: 10001165, Term: Adenocarcinoma lung stage IV, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Prematurely Ended"
      },
      {
        "BE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002543-41"
  },
  {
    "EudraCT Number": "2019-004791-19",
    "Sponsor Protocol Number": "CACN00177-100D",
    "Sponsor Name": "Aeglea Biotherapeutics, Inc.",
    "Full Title": "A Phase 1/2 Multiple Ascending-Dose Study in Subjects With Homocystinuria Due to Cystathionine \u03b2-Synthase (CBS) Deficiency to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of ACN00177",
    "Start Date": "2020-05-11",
    "Medical condition": [
      "Homocystinuria Due to Cystathionine \u03b2-Synthase (CBS) Deficiency"
    ],
    "Disease": "Version: 20.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10020365, Term: Homocystinuria, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-004791-19"
  },
  {
    "EudraCT Number": "2015-005540-34",
    "Sponsor Protocol Number": "CLR_14_12",
    "Sponsor Name": "Sun Pharma Advanced Research Company, Ltd. (SPARC)",
    "Full Title": "A Multi-Center, Investigator-Masked, Randomized, Crossover, Equivalence Study of the Safety and Efficacy of Once Daily Brimonidine Tartrate 0.35% Ophthalmic Suspension Compared with Brimonidine Tar...",
    "Start Date": "2016-07-19",
    "Medical condition": [
      "Open-angle glaucoma",
      "chronic angle closure glaucoma with patent iridotomy",
      "pseudoexfoliation",
      "pigment dispersion",
      "or ocular hypertension"
    ],
    "Disease": "Version: 19.1, SOC Term: 10015919 - Eye disorders, Classification Code: 10018304, Term: Glaucoma, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "BG": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005540-34"
  },
  {
    "EudraCT Number": "2015-003537-99",
    "Sponsor Protocol Number": "ML28249",
    "Sponsor Name": "F. Hoffmann-La Roche AG",
    "Full Title": "A PHASE IV MULTICENTER, RANDOMIZED, OPEN LABEL, TWO-PERIOD CROSSOVER STUDY IN PATIENTS WITH CYSTIC FIBROSIS TO EVALUATE THE COMPARABLE EFFICACY AND SAFETY OF PULMOZYME\u00ae DELIVERED BY THE ERAPID\u2122 NEB...",
    "Start Date": "2016-07-05",
    "Medical condition": [
      "Cystic Fibrosis"
    ],
    "Disease": "Version: 19.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10011762, Term: Cystic fibrosis, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003537-99"
  },
  {
    "EudraCT Number": "2016-005023-92",
    "Sponsor Protocol Number": "4658-203",
    "Sponsor Name": "Sarepta Therapeutics, Inc.",
    "Full Title": "An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of\u00a0Eteplirsen\u00a0in Early Stage Duchenne Muscular Dystrophy",
    "Start Date": "2017-03-28",
    "Medical condition": [
      "Patients with Duchenne Muscular Dystropy Amenable to Exon 51 Skipping"
    ],
    "Disease": "Version: 19.1, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10013801, Term: Duchenne muscular dystrophy, Level: PT",
    "Population Age": [
      "Children",
      "Under 18"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-005023-92"
  },
  {
    "EudraCT Number": "2017-002183-41",
    "Sponsor Protocol Number": "METc2017.174",
    "Sponsor Name": "UMCG",
    "Full Title": "PET for Registration of Inflammation in the Vascular wall of Intracranial Aneurysms",
    "Start Date": "2020-08-27",
    "Medical condition": [
      "intracranial aneurysm"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002183-41"
  },
  {
    "EudraCT Number": "2017-004527-67",
    "Sponsor Protocol Number": "DT-DP-DFU-CR-04",
    "Sponsor Name": "DermaTools Biotech GmbH",
    "Full Title": "A Randomised Dose Finding Study Comparing The Safety And Efficacy Of three blinded doses of Diperoxochloric Acid (DPOCl, DermaPro\u00ae) and A Standard Moist Wound Dressing In Patients With Non-Healing...",
    "Start Date": "2018-08-06",
    "Medical condition": [
      "Diabetic foot ulcer with mean diameter between 1.5 and 4 cm after d\u00e9bridement  if  indicated)",
      ""
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "LV": "Completed"
      },
      {
        "EE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004527-67"
  },
  {
    "EudraCT Number": "2016-000754-35",
    "Sponsor Protocol Number": "R118528",
    "Sponsor Name": "The University of Manchester",
    "Full Title": "The effect of Denosumab on Pain and bone Marrow Lesions in symptomatic Knee Osteo-arthritis: A Randomised Double Blind Placebo controlled Clinical Trial",
    "Start Date": "2017-07-18",
    "Medical condition": [
      "Knee osteoarthritis"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004859, Classification Code: 10023476, Term: Knee osteoarthritis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000754-35"
  },
  {
    "EudraCT Number": "2020-003280-26",
    "Sponsor Protocol Number": "IMB101-005",
    "Sponsor Name": "Imbria Pharmaceuticals, Inc.",
    "Full Title": "A Dose-Ranging Pharmacodynamic Study to Evaluate the Effects of IMB-1018972 on Myocardial Energetics, Metabolism, and Function in Patients with Type 2 Diabetes",
    "Start Date": "2020-11-09",
    "Medical condition": [
      "Diabetic Cardiomyopathy (DbCM)"
    ],
    "Disease": "Version: 20.0, SOC Term: 10007541 - Cardiac disorders, Classification Code: 10012647, Term: Diabetic cardiomyopathy, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003280-26"
  },
  {
    "EudraCT Number": "2017-004376-64",
    "Sponsor Protocol Number": "EURO17-09",
    "Sponsor Name": "Eurocine Vaccines AB",
    "Full Title": "A Phase I/II, randomised, multicentre, placebo-controlled, partially-blinded, parallel-group study to assess the safety, tolerability and immune response following vaccination with ImmunoseTM FLU i...",
    "Start Date": "2018-01-10",
    "Medical condition": [
      "Influenza"
    ],
    "Disease": "Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10022000, Term: Influenza, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "SE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004376-64"
  },
  {
    "EudraCT Number": "2018-000019-26",
    "Sponsor Protocol Number": "D5670C00013",
    "Sponsor Name": "MedImmune Limited, a wholly owned subsidiary of AstraZeneca",
    "Full Title": "A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MEDI0382 in Subjects with Type 2 Diabetes Mellitus and Renal Impairment",
    "Start Date": "2018-05-04",
    "Medical condition": [
      "Type 2 Diabetes Mellitus"
    ],
    "Disease": "Version: 20.0, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10067585, Term: Type 2 diabetes mellitus, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-000019-26"
  },
  {
    "EudraCT Number": "2015-002613-30",
    "Sponsor Protocol Number": "GH-3899",
    "Sponsor Name": "Novo Nordisk A/S",
    "Full Title": "A 12-month, open-labelled, randomised, parallel-group, multi-centre, interventional trial to evaluate the efficacy and safety of recombinant human growth hormone (hGH) (Norditropin\u00ae Nordilet\u00ae) ther...",
    "Start Date": "2016-04-25",
    "Medical condition": [
      "Idiopathic short stature"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004859, Classification Code: 10066333, Term: Idiopathic short stature, Level: LLT",
    "Population Age": [
      "Children",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002613-30"
  },
  {
    "EudraCT Number": "2015-004745-70",
    "Sponsor Protocol Number": "55438",
    "Sponsor Name": "Academic Medical Center (AMC)",
    "Full Title": "Efficacy of intranasal ketamine on acute suicidality, a double blind randomized placebo-controlled trial (Ketamine Trial Amsterdam, KETA)",
    "Start Date": "2018-11-06",
    "Medical condition": [
      "Acute suicidality",
      "which is a rapid increase in suicidal ideation or behaviour from the patient's 'baseline' in the last 24 hours."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004745-70"
  },
  {
    "EudraCT Number": "2019-003135-36",
    "Sponsor Protocol Number": "CYD67",
    "Sponsor Name": "Sanofi Pasteur SA",
    "Full Title": "Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially with Gardasil\u00ae in Healthy Subjects Aged 9 to 13 Years in Malaysia",
    "Start Date": "2019-10-31",
    "Medical condition": [
      "Dengue Fever"
    ]
  },
  {
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-003135-36"
  },
  {
    "EudraCT Number": "2016-000623-73",
    "Sponsor Protocol Number": "LIDO",
    "Sponsor Name": "FUNDACI\u00d3N INVESTIGACI\u00d3N BIOM\u00c9DICA HOSPITAL PUERTA DE HIERRO",
    "Full Title": "LIDOCAINE IN ISCHEMIA-REPERFUSION INJURY FROM MICROSURGICAL BREAST RECONSTRUCTION. RANDOMISED UNICENTRIC, DOUBLE-BLIND, CLINICAL, CONTROLLED TRIAL.",
    "Start Date": "2016-09-29",
    "Medical condition": [
      "Ischemia-reperfusion injury from breast reconstruction microsurgical flaps."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000623-73"
  },
  {
    "EudraCT Number": "2020-001449-38",
    "Sponsor Protocol Number": "CW002",
    "Sponsor Name": "Chelsea and Westminster Hospital NHS Foundation Trust",
    "Full Title": "A Randomised Controlled Trial of Early Intervention in Patients HospItalised with COVID-19: Favipiravir verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaRe",
    "Start Date": "2020-04-29",
    "Medical condition": [
      "COVID-19 Infection"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004862, Classification Code: 10051905, Term: Coronavirus infection, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001449-38"
  },
  {
    "EudraCT Number": "2015-004543-40",
    "Sponsor Protocol Number": "ONC-2015-001/ML29968",
    "Sponsor Name": "IRCCS ISTITUTO CLINICO HUMANITAS",
    "Full Title": "A SINGLE ARM, PHASE II, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF VISMODEGIB AND RADIOTHERAPY IN PATIENTS WITH HIGH RISK OR LOCALLY ADVANCED BASAL CELL CARCINOMA NOT AMENABLE TO RADICA...",
    "Start Date": "2016-09-20",
    "Medical condition": [
      "HIGH RISK OR LOCALLY ADVANCED BASAL CELL CARCINOMA NOT AMENABLE TO RADICAL SURGERY"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10004146, Term: Basal cell carcinoma, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IT": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004543-40"
  },
  {
    "EudraCT Number": "2018-001402-28",
    "Sponsor Protocol Number": "EII_Prep",
    "Sponsor Name": "Hospital Universitario La Paz",
    "Full Title": "PROTOCOL FOR THE OPTIMIZATION OF THE PREPARATION FOR THE COLONOSCOPY IN PATIENTS WITH INTESTINAL INFLAMMATORY DISEASE",
    "Start Date": "2019-01-28",
    "Medical condition": [
      "preparation in patients with inflammatory bowel disease who will undergo an endoscopy"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-001402-28"
  },
  {
    "EudraCT Number": "2018-002763-26",
    "Sponsor Protocol Number": "814-PM-02",
    "Sponsor Name": "NeRRe Therapeutics Ltd,",
    "Full Title": "A DOUBLE-BLIND, RANDOMISED, PLACEBO CONTROLLED, ADAPTIVE DESIGN STUDY OF THE EFFICACY, SAFETY AND PHARMACOKINETICS OF NT-814 IN FEMALE SUBJECTS WITH MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED...",
    "Start Date": "2019-01-17",
    "Medical condition": [
      "Hot flushes (vasomotor symptoms) in menopausal women"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004872, Classification Code: 10027311, Term: Menopause flushing, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-002763-26"
  },
  {
    "EudraCT Number": "2008-003733-24",
    "Sponsor Protocol Number": "EPO2008-02",
    "Sponsor Name": "Abertawe Bro Morgannwg University NHS Trust",
    "Full Title": "A randomised study to assess the effects of Epoetin Beta on renal function in patients with critical illness(with or without multi-organ failure)",
    "Start Date": "2009-05-29",
    "Medical condition": [
      "Sepsis/Acute renal failure"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-003733-24"
  },
  {
    "EudraCT Number": "2007-003364-21",
    "Sponsor Protocol Number": "MCI-196-E11",
    "Sponsor Name": "Mitsubishi Tanabe Pharma Corporation",
    "Full Title": "A Phase III, Multicentre, Double-blind, Double-Dummy, Randomised, Flexible-dose, Comparative Study of MCI-196 versus Simvastatin for the Treatment of Dyslipidaemia in Subjects with Chronic Kidney D...",
    "Start Date": "2009-06-22",
    "Medical condition": [
      "Dislipidaemia in subjects with Chronic Kidney Disease on Dialysis."
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10058108, Term: Dyslipidaemia, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "LT": "Completed"
      },
      {
        "LV": "Completed"
      },
      {
        "DK": "Completed"
      },
      {
        "IT": "Completed"
      },
      {
        "BG": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-003364-21"
  },
  {
    "EudraCT Number": "2007-003370-26",
    "Sponsor Protocol Number": "CLAF237ADE03",
    "Sponsor Name": "Charite Universit\u00e4tsmedizin Berlin",
    "Full Title": "A prospective, single center, double blind, placebo controlled study of adipocytokines, adipose tissue gene expression and hepatic insulin clearance in the therapeutic response to vildagliptin in man",
    "Start Date": "2007-11-15",
    "Medical condition": [
      "This is a single center",
      "randomized",
      "double-blind pilot study on patients with Type 2 diabetes. The purpose of this study is to test the effects of vildagliptin (as add-on to metformin) on hepatic ..."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-003370-26"
  },
  {
    "EudraCT Number": "2008-001687-37",
    "Sponsor Protocol Number": "LEX/001/C",
    "Sponsor Name": "Novosis AG",
    "Full Title": "An open label, parallel group phase III clinical study in patients with prostate cancer to demonstrate the non-inferiority of a new Novosis Leuprorelin 10.72 mg implant versus the reference product...",
    "Start Date": "2008-07-08",
    "Medical condition": [
      "Male patients with carcinoma of the prostate aged 18 years and more and suitable for hormonal manipulation"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10060862, Term: Prostate cancer, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-001687-37"
  },
  {
    "EudraCT Number": "2008-001705-42",
    "Sponsor Protocol Number": "CRB-MNX-08-01",
    "Sponsor Name": "L'OREAL",
    "Full Title": "ETUDE TRANSCRIPTOMIQUE DE LA REPONSE AU MINOXIDIL CHEZ L'HOMME ALOPECIQUE",
    "Start Date": "2008-06-04",
    "Medical condition": [
      "alop\u00e9cie androg\u00e9n\u00e9tique"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10001760, Term: Alopecia, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "FR": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-001705-42"
  },
  {
    "EudraCT Number": "2004-000211-26",
    "Sponsor Protocol Number": "D5890L00007",
    "Sponsor Name": "AstraZeneca AB",
    "Full Title": "A comperative, placebo-controlled, doubleblind, double dummy, cross over, single center phase IIIb study between formoterol alone and the fixed combination of formoterol and budesonide on airway re...",
    "Start Date": "2004-08-04",
    "Medical condition": [
      "Patient with stable and mild allergic asthma."
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "SE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2004-000211-26"
  },
  {
    "EudraCT Number": "2007-004754-82",
    "Sponsor Protocol Number": "V59P22",
    "Sponsor Name": "Novartis Vaccines and Diagnostics S.r.l.",
    "Full Title": "A Phase 3, Open-Label, Randomized, Multi-Center Study to Evaluate the Safety and Immunogenicity after One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine Administered to Healthy Infan...",
    "Start Date": "2008-01-03",
    "Medical condition": [
      "Novartis Meningococcal ACWY Conjugate  Vaccine is intended for prevention of meningitidis and septicemia caused by Neisseria meningitidis serogroups A",
      "C",
      "W-135 and Y."
    ],
    "Disease": "",
    "Population Age": [
      "Infants and toddlers",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-004754-82"
  },
  {
    "EudraCT Number": "2006-007018-39",
    "Sponsor Protocol Number": "Persephone",
    "Sponsor Name": "Cambridge Hospitals NHS Foundation Trust and Cambridge University",
    "Full Title": "Persephone : Duration of Trastuzumab with Chemotherapy in patients with early breast cancer : Six months versus twelve",
    "Start Date": "2007-08-09",
    "Medical condition": [
      "HER2 positive early breast cancer"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-007018-39"
  },
  {
    "EudraCT Number": "2006-007021-32",
    "Sponsor Protocol Number": "CRAD001ADE13",
    "Sponsor Name": "Novartis Pharma GmbH",
    "Full Title": "Multi-center, open-label, prospective, randomized, parallel group, long-term study investigating a standard regimen in de novo kidney transplant patients versus a CNI-free regimen and a CNI-low dos...",
    "Start Date": "2007-05-29",
    "Medical condition": [
      "de novo kidney transplant patients"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10023439, Term: Kidney transplant rejection, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-007021-32"
  },
  {
    "EudraCT Number": "2006-007036-95",
    "Sponsor Protocol Number": "CSOM230BDE01",
    "Sponsor Name": "Universit\u00e4tsklinikum Essen - Zentrum f\u00fcr Innere Medizin - Klinik f\u00fcr Endokrinologie",
    "Full Title": "Monocenter, double blinded, exploratory, randomized, study investigating the influence of Pasireotide on the hormonal activity of Prolactinomas - proof of concept study",
    "Start Date": "2008-07-02",
    "Medical condition": [
      "Prolactinoma"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10036832, Term: Prolactinoma, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-007036-95"
  },
  {
    "EudraCT Number": "2006-007053-51",
    "Sponsor Protocol Number": "003/APR06",
    "Sponsor Name": "Gloucestershire Hospitals NHS Foundation Trust",
    "Full Title": "Diamorphine or alfentanil for subcutaneous use in hospice in-patients",
    "Start Date": "2007-07-02",
    "Medical condition": [
      "Palliative Care"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10059513, Term: Palliative care, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-007053-51"
  },
  {
    "EudraCT Number": "2006-007073-75",
    "Sponsor Protocol Number": "07-01/DPI Fluticason_250",
    "Sponsor Name": "mibe GmbH Arzneimittel",
    "Full Title": "Randomised, double-blind, double-dummy, parallel trial comparing a novel DPI with 250 \u00b5g fluticasone versus Flutide\u00ae 250 Diskus\u00ae in patients with persistent asthma",
    "Start Date": "2008-01-30",
    "Medical condition": [
      "Persistent Asthma in adults"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10049106, Term: Asthma chronic, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-007073-75"
  },
  {
    "EudraCT Number": "2006-007087-28",
    "Sponsor Protocol Number": "RV-MM-PI-210",
    "Sponsor Name": "FONDAZIONE NEOPLASIE SANGUE ONLUS",
    "Full Title": "A PHASE II, MULTI-CENTER, OPEN LABEL STUDY OF LENALIDOMIDE, MELPHALAN, PREDNISONE AND THALIDOMIDE   R-MPT  IN ADVANCED, RELAPSED, REFRACTORY MULTIPLE MYELOMA PATIENTS.",
    "Start Date": "2007-02-23",
    "Medical condition": [
      "Patients with Multiple Myeloma"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10028228, Term: Multiple myeloma, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IT": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-007087-28"
  },
  {
    "EudraCT Number": "2006-007091-15",
    "Sponsor Protocol Number": "CSTI571ENL18",
    "Sponsor Name": "ErasmusMC",
    "Full Title": "Glivec (imatinib mesylate) in systemic sclerosis, a pilot study",
    "Start Date": "2007-09-03",
    "Medical condition": [
      "systemic sclerosis"
    ],
    "Disease": "Version: 9.1, SOC Term: , Classification Code: 10039710, Term: Scleroderma, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-007091-15"
  },
  {
    "EudraCT Number": "2005-000192-17",
    "Sponsor Protocol Number": "GO-80, V1 18 Mar 05",
    "Sponsor Name": "Barts & The London NHS Trust",
    "Full Title": "Gemcitabine and Oxaliplatin in the treatment of locally advanced or metastatic transitional cell carcinoma of the urinary tract in patients with impaired renal function  and patients who have progr...",
    "Start Date": "2005-05-18",
    "Medical condition": [
      "Locally advanced or metastatic  transitional cell carcinoma of the urinary tract"
    ],
    "Disease": "",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-000192-17"
  },
  {
    "EudraCT Number": "2007-001881-33",
    "Sponsor Protocol Number": "AEO-2007-01",
    "Sponsor Name": "Medicinsk gastroenterologisk afdeling, Aalborg sygehus S.",
    "Full Title": "Unders\u00f8gelse af opioiders effekt p\u00e5 eksperimentel hyperalgesi i spiser\u00f8r og hud samt p\u00e5 en isk\u00e6misk muskelmodel, inklusiv et eksplorativt studie af morfins \u00e6ndringer i hjernens smerte processering.",
    "Start Date": "2007-05-21",
    "Medical condition": [
      ""
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-001881-33"
  },
  {
    "EudraCT Number": "2018-004835-56",
    "Sponsor Protocol Number": "GEMCAD-1703",
    "Sponsor Name": "Grupo espa\u00f1ol mutidisciplinar en c\u00e1ncer digestivo (GEMCAD)",
    "Full Title": "Phase II study of Durvalumab (MEDI4736) plus Total Neoadjuvant Therapy (TNT) in locally advanced rectal cancer",
    "Start Date": "2019-08-13",
    "Medical condition": [
      "Locally advanced rectal cancer"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10038038, Term: Rectal cancer, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-004835-56"
  },
  {
    "EudraCT Number": "2015-000608-24",
    "Sponsor Protocol Number": "15102014",
    "Sponsor Name": "Aarhus University Hospital",
    "Full Title": "TMS Electrochemotherapy for Glioblastoma Multiforme",
    "Start Date": "2015-04-09",
    "Medical condition": [
      "Glioblastoma Multiforme (WHO grade IV brain tumor)"
    ],
    "Disease": "Version: 17.1, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10018336, Term: Glioblastoma, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-000608-24"
  },
  {
    "EudraCT Number": "2016-003109-32",
    "Sponsor Protocol Number": "1",
    "Sponsor Name": "University of Oxford",
    "Full Title": "An investigation of Levetiracetam in Alzheimer\u2019s Disease (ILiAD): a proof of concept study",
    "Start Date": "2017-11-23",
    "Medical condition": [
      "Alzheimer's disease"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004852, Classification Code: 10001896, Term: Alzheimer's disease, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003109-32"
  },
  {
    "EudraCT Number": "2019-000171-16",
    "Sponsor Protocol Number": "KCH-PRO:19/001",
    "Sponsor Name": "King's College Hospital NHS Foundation Trust",
    "Full Title": "Comparison between Propofol and Inhalational Anaesthetic Agents on Cardiovascular Outcomes following Cardiac Surgery - a Randomised Controlled Feasibility Trial",
    "Start Date": "2019-08-02",
    "Medical condition": [
      "Cardiopulmonary bypass (CPB) and revascularisation-induced ischaemic reperfusion injury"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004865, Classification Code: 10018061, Term: General anesthesia, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-000171-16"
  },
  {
    "EudraCT Number": "2015-000857-19",
    "Sponsor Protocol Number": "D2210C00014",
    "Sponsor Name": "AstraZeneca AB",
    "Full Title": "A Multicentre, Randomized, Double-blind, Parallel Group, Placebo Controlled, 12-Week, Phase 2 Study to Evaluate the Effect of Tralokinumab on Airway Inflammation in Adults with Asthma Inadequately ...",
    "Start Date": "2015-08-06",
    "Medical condition": [
      "Asthma"
    ],
    "Disease": "Version: 18.1, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10003553, Term: Asthma, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-000857-19"
  },
  {
    "EudraCT Number": "2015-004711-21",
    "Sponsor Protocol Number": "20130287",
    "Sponsor Name": "Amgen Inc.",
    "Full Title": "Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Evolocumab (AMG 145) on LDL-C in Subjects With Type 2 Diabetes Mellitus and Hyperch...",
    "Start Date": "2016-06-06",
    "Medical condition": [
      "Type 2 Diabetes Mellitus and Hypercholesterolemia/Mixed Dyslipidemia"
    ],
    "Disease": "Version: 19.1, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10058110, Term: Dyslipidemia, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "PL": "Completed"
      },
      {
        "BE": "Completed"
      },
      {
        "ES": "Completed"
      },
      {
        "IT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004711-21"
  },
  {
    "EudraCT Number": "2018-001471-20",
    "Sponsor Protocol Number": "MET35",
    "Sponsor Name": "Sanofi Pasteur Inc.",
    "Full Title": "Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age",
    "Start Date": "2018-07-10",
    "Medical condition": [
      "Healthy volunteers (active immunization against invasive meningogoccal"
    ],
    "Disease": "Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10027274, Term: Meningococcal infection, Level: PT",
    "Population Age": [
      "Children",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-001471-20"
  },
  {
    "EudraCT Number": "2014-000484-41",
    "Sponsor Protocol Number": "PROMISE",
    "Sponsor Name": "Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge",
    "Full Title": "A Non-Randomised, Open Label, Pilot Trial of Sirolimus Therapy for Segmental Overgrowth Due to PIK3CA Related Overgrowth",
    "Start Date": "2015-11-04",
    "Medical condition": [
      "Segmental overgrowth caused by somatic PI3K hyperactivation"
    ],
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-000484-41"
  },
  {
    "EudraCT Number": "2020-001805-21",
    "Sponsor Protocol Number": "RA486120",
    "Sponsor Name": "University Hospital Coventry & Warwickshire",
    "Full Title": "Prospective, Randomized, Parallel-Group, Open-Label Study to Evaluate the Efficacy and Safety of IMU-838, in Combination with Oseltamivir, in Adults with Coronavirus Disease COVID-19",
    "Start Date": "2020-05-15",
    "Medical condition": [
      "Sars-Cov-2"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001805-21"
  },
  {
    "EudraCT Number": "2019-004085-17",
    "Sponsor Protocol Number": "19IC5548",
    "Sponsor Name": "Imperial College London",
    "Full Title": "Treating severe paediatric asthma; a randomised controlled trial of mepolizumab and omalizumab (TREAT trial)",
    "Start Date": "2020-03-18",
    "Medical condition": [
      "Asthma"
    ],
    "Disease": "Version: 20.0, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10003553, Term: Asthma, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-004085-17"
  },
  {
    "EudraCT Number": "2020-005111-51",
    "Sponsor Protocol Number": "20170199",
    "Sponsor Name": "Amgen Inc.",
    "Full Title": "A Multicenter, Open-label, Single-arm, Study to Evaluate Safety and Tolerability of Repatha in Patients with Homozygous Familial Hypercholesterolemia (HoFH) in India",
    "Start Date": "2020-11-05",
    "Medical condition": [
      "Homozygous Familial Hypercholesterolemia (HoFH)"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004850, Classification Code: 10057080, Term: Homozygous familial hypercholesterolemia, Level: LLT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005111-51"
  },
  {
    "EudraCT Number": "2018-002597-41",
    "Sponsor Protocol Number": "O321",
    "Sponsor Name": "Adamed Pharma S.A.",
    "Full Title": "A multi-centre clinical trial evaluating patients\u2019 ability to independently and safely use the medicinal product indicated in the treatment of erectile dysfunction",
    "Start Date": "2018-11-14",
    "Medical condition": [
      "Erectile dysfunction"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004872, Classification Code: 10052003, Term: Erectile dysfunction NOS, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-002597-41"
  },
  {
    "EudraCT Number": "2019-000690-22",
    "Sponsor Protocol Number": "VAC52150EBL2002",
    "Sponsor Name": "Janssen Vaccines & Prevention B.V.",
    "Full Title": "A Randomized, Observer-blind, Placebo-controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Immunogenicity of Different Prime-boost Regimens of the Candidate Prophylactic Vaccines for ...",
    "Start Date": "2019-04-25",
    "Medical condition": [
      "Prevention of Ebola virus disease"
    ],
    "Disease": "Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10014071, Term: Ebola disease, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-000690-22"
  },
  {
    "EudraCT Number": "2019-000691-42",
    "Sponsor Protocol Number": "VAC52150EBL3001",
    "Sponsor Name": "Janssen Vaccines & Prevention B.V.",
    "Full Title": "A Staged Phase 3 Study, Including a Double-Blinded Controlled Stage to Evaluate the Safety and Immunogenicity of Ad26.ZEBOV and MVA-BN-Filo as Candidate Prophylactic Vaccines for Ebola",
    "Start Date": "2019-04-25",
    "Medical condition": [
      "Prevention of Ebola virus disease"
    ],
    "Disease": "Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10014071, Term: Ebola disease, Level: PT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-000691-42"
  },
  {
    "EudraCT Number": "2014-005424-97",
    "Sponsor Protocol Number": "CIGE025EFR02",
    "Sponsor Name": "NOVARTIS PHARMA SAS",
    "Full Title": "A phase IV, multicenter, single-arm and open-label study to explore the impact on quality of life of omalizumab (Xolair\u00ae) in patients with chronic spontaneous urticaria (CSU) who remain symptomatic...",
    "Start Date": "2015-01-28",
    "Medical condition": [
      "chronic spontaneous urticaria"
    ],
    "Disease": "Version: 18.0, SOC Term: 10040785 - Skin and subcutaneous tissue disorders, Classification Code: 10072757, Term: Chronic spontaneous urticaria, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-005424-97"
  },
  {
    "EudraCT Number": "2019-003542-32",
    "Sponsor Protocol Number": "SCOPE",
    "Sponsor Name": "Dr. Jos\u00e9 Manuel Porcel P\u00e9rez",
    "Full Title": "Randomised clinical trial: saline washouts versus standard treatment in complicated parapneumonic pleural effusion or empyema. SCOPE study.",
    "Start Date": "2020-02-28",
    "Medical condition": [
      "Treatment of complicated parapneumatic pleural effusion or empyema"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-003542-32"
  },
  {
    "EudraCT Number": "2019-001878-28",
    "Sponsor Protocol Number": "307-201",
    "Sponsor Name": "BioMarin Pharmaceutical Inc.",
    "Full Title": "A Phase 1/2 Open-Label, Dose Escalation Study to Determine the Safety and Efficacy of BMN 307, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Phenylalanine Hydroxylase in Subjects...",
    "Start Date": "2019-12-17",
    "Medical condition": [
      "Phenylketonuria"
    ],
    "Disease": "Version: 20.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10034872, Term: Phenylketonuria, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-001878-28"
  },
  {
    "EudraCT Number": "2016-004954-13",
    "Sponsor Protocol Number": "E2090-AS886-202",
    "Sponsor Name": "Eisai Taiwan Inc.",
    "Full Title": "A Multi-center, Randomized, Open-label, Parallel-group, Dose-titration, Add-on, Comparative Study in Evaluating the Efficacy and Safety of Zonisamide (Zonegran) and Lamotrigine (Lamictal) for Subje...",
    "Start Date": "2017-04-24",
    "Medical condition": [
      "Epilepsy"
    ],
    "Disease": "",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004954-13"
  },
  {
    "EudraCT Number": "2018-002446-36",
    "Sponsor Protocol Number": "BP40635",
    "Sponsor Name": "F. Hoffmann-La Roche Ltd",
    "Full Title": "AN OPEN LABEL PHASE 2A TRIAL ASSESSING THE CLINICAL EFFICACY AND SAFETY OF RO5459072 IN MODERATE TO SEVERE PSORIASIS",
    "Start Date": "2018-11-05",
    "Medical condition": [
      "Psoriasis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10040785 - Skin and subcutaneous tissue disorders, Classification Code: 10037153, Term: Psoriasis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-002446-36"
  },
  {
    "EudraCT Number": "2019-000736-25",
    "Sponsor Protocol Number": "IB3M.2019",
    "Sponsor Name": "Universidad Complutense de Madrid",
    "Full Title": "Efficacy of Non-Steroidal Anti-Inflammatory (Ibuprofen) Chronotherapy in Healing After Mandibular Third Molar Surgical Extraction \u2013 A Randomized Clinical Trial",
    "Start Date": "2019-09-05",
    "Medical condition": [
      "The clinical trial will try to understand if the elimination  of the ibuprofen dosage in resting phase after surgical third molar extraction not jeopardize the postoperative period ."
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-000736-25"
  },
  {
    "EudraCT Number": "2015-003490-15",
    "Sponsor Protocol Number": "CACZ885D2308",
    "Sponsor Name": "Novartis Pharmaceuticals",
    "Full Title": "An Open-label, Efficacy and Safety Study of Canakinumab (Anti-interleukin-1\u03b2 Monoclonal Antibody) Administered for 6 Months (24 Weeks) in Japanese Patients With the Following Cryopyrin-associated P...",
    "Start Date": "2016-04-14",
    "Medical condition": [
      "Cryopyrin-associated Periodic Syndromes"
    ],
    "Disease": "Version: 19.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10064569, Term: Muckle-Wells syndrome, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003490-15"
  },
  {
    "EudraCT Number": "2016-002657-38",
    "Sponsor Protocol Number": "RLY5016-207",
    "Sponsor Name": "Relypsa, Inc",
    "Full Title": "A Randomized, Double-Blind, Placebo controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients with Resistant Hypertension and Chr...",
    "Start Date": "2017-01-09",
    "Medical condition": [
      "Resistant Hypertension and Chronic Kidney Disease"
    ],
    "Disease": "Version: 20.0, SOC Term: 10047065 - Vascular disorders, Classification Code: 10020772, Term: Hypertension, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "HR": "Completed"
      },
      {
        "BG": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002657-38"
  },
  {
    "EudraCT Number": "2017-002008-28",
    "Sponsor Protocol Number": "2017-002008-28",
    "Sponsor Name": "Region Sk\u00e5ne",
    "Full Title": "A prospective open label study to evaluate treatment of chronic HCV infection with glecaprevir/pibrentasvir in PWID attending a needle exchange program",
    "Start Date": "2017-12-21",
    "Medical condition": [
      ""
    ],
    "Disease": "Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10019744, Term: Hepatitis C, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "SE": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002008-28"
  },
  {
    "EudraCT Number": "2015-001438-46",
    "Sponsor Protocol Number": "A3921104",
    "Sponsor Name": "Pfizer Inc.",
    "Full Title": "EFFICACY, SAFETY AND TOLERABILITY OF TOFACITINIB FOR TREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS (JIA) IN CHILDREN AND ADOLESCENT SUBJECTS",
    "Start Date": "2018-03-27",
    "Medical condition": [
      "JUVENILE IDIOPATHIC ARTHRITIS (JIA)"
    ],
    "Disease": "Version: 20.0, SOC Term: 10028395 - Musculoskeletal and connective tissue disorders, Classification Code: 10059176, Term: Juvenile idiopathic arthritis, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "BE": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "ES": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-001438-46"
  },
  {
    "EudraCT Number": "2019-001020-36",
    "Sponsor Protocol Number": "MS301",
    "Sponsor Name": "Ipsen Pharma",
    "Full Title": "RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR-1 (rhIGF-1) TREATMENT OF PREPUBERTAL CHILDREN WITH GROWTH FAILURE ASSOCIATED WITH PRIMARY IGF-1 DEFICIENCY: A PHASE 3, RANDOMIZED, OPEN LABEL, OBSERVATI...",
    "Start Date": "2019-05-31",
    "Medical condition": [
      "Children with growth failure associated with primary insulin-like growth factor deficiency (IGFD)."
    ],
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-001020-36"
  },
  {
    "EudraCT Number": "2019-002836-10",
    "Sponsor Protocol Number": "C3291002",
    "Sponsor Name": "Pfizer Inc.",
    "Full Title": "A Phase 4, Multicenter, Open Label Safety Study Of Crisaborole Ointment 2% In Children Aged 3 Months To Less Than 24 Months With Mild To Moderate Atopic Dermatitis",
    "Start Date": "2019-08-22",
    "Medical condition": [
      "Atopic Dermatitis"
    ],
    "Disease": "",
    "Population Age": [
      "Infants and toddlers",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002836-10"
  },
  {
    "EudraCT Number": "2019-002991-15",
    "Sponsor Protocol Number": "SOLTI-1804",
    "Sponsor Name": "SOLTI",
    "Full Title": "HER2-PREDICT: Estudio Traslacional De Muestras De Tumor Procedentes De Los Ensayos Ds8201-A-U301 y Ds8201-A-U302",
    "Start Date": "2019-11-04",
    "Medical condition": [
      "Her2\u2011positive",
      "unresectable and/or metastatic breast cancer."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002991-15"
  },
  {
    "EudraCT Number": "2015-001929-17",
    "Sponsor Protocol Number": "E7080-M000-213",
    "Sponsor Name": "EISAI LIMITED",
    "Full Title": "This is an Open-Label, Single-Arm, Multicenter, Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC).",
    "Start Date": "2017-01-18",
    "Medical condition": [
      "Anaplastic Thyroid Cancer (ATC)"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10002240, Term: Anaplastic thyroid cancer, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IT": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-001929-17"
  },
  {
    "EudraCT Number": "2016-002071-96",
    "Sponsor Protocol Number": "I4X-MC-JFCP",
    "Sponsor Name": "Lilly, S.A.",
    "Full Title": "A Single-Arm, Multicenter, Open-Label, Phase 2 Study of nab\u00ae-Paclitaxel (Abraxane\u00ae) and Carboplatin Chemotherapy plus Necitumumab (LY3012211) in the First-Line Treatment of Patients with Stage IV S...",
    "Start Date": "2016-11-03",
    "Medical condition": [
      "Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)"
    ],
    "Disease": "Version: 19.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10029522, Term: Non-small cell lung cancer stage IV, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "GR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002071-96"
  },
  {
    "EudraCT Number": "2016-001135-12",
    "Sponsor Protocol Number": "204812",
    "Sponsor Name": "GlaxoSmithKline Biologicals",
    "Full Title": "A Phase II, randomised, observer-blind, controlled, multi-country study to rank different formulations of GSK Biologicals\u2019 investigational RSV vaccine (GSK3003891A), based on immunogenicity, reacto...",
    "Start Date": "2016-10-27",
    "Medical condition": [
      "Respiratory Syncytial Virus"
    ],
    "Disease": "Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10061603, Term: Respiratory syncytial virus infection, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "EE": "Completed"
      },
      {
        "BE": "Completed"
      },
      {
        "FR": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001135-12"
  },
  {
    "EudraCT Number": "2016-003893-42",
    "Sponsor Protocol Number": "AUTO2-MM1",
    "Sponsor Name": "Autolus Limited",
    "Full Title": "A Single Arm, Open-Label, Multi-Centre, Phase I/II Study Evaluating the Safety and Clinical Activity of AUTO2, a CAR T Cell Treatment Targeting BCMA and TACI, in Patients with Relapsed or Refractor...",
    "Start Date": "2017-03-28",
    "Medical condition": [
      "Relapsed or Refractory Multiple Myeloma"
    ],
    "Disease": "Version: 16.1, SOC Term: 100000004851, Classification Code: 10028229, Term: Multiple myelomas, Level: HLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Prematurely Ended"
      },
      {
        "NL": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003893-42"
  },
  {
    "EudraCT Number": "2016-004753-33",
    "Sponsor Protocol Number": "CSLCT-QIV-15-03",
    "Sponsor Name": "Seqirus GmbH",
    "Full Title": "A Phase 3, Randomized, Multicenter, Observer-blinded, Noninferiority Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Inactivated Influenza Virus Vaccine (Seqirus QIV) with a US-li...",
    "Start Date": "2016-12-15",
    "Medical condition": [
      "Prophylaxis for influenza virus infection"
    ],
    "Disease": "Version: 19.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10022000, Term: Influenza, Level: PT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004753-33"
  },
  {
    "EudraCT Number": "2016-003990-17",
    "Sponsor Protocol Number": "54135419SUI3001",
    "Sponsor Name": "Janssen-Cilag International NV",
    "Full Title": "A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Sympto...",
    "Start Date": "2017-05-18",
    "Medical condition": [
      "Major Depressive Disorder with Imminent Risk of Suicide"
    ],
    "Disease": "Version: 20.0, SOC Term: 10037175 - Psychiatric disorders, Classification Code: 10065604, Term: Suicidal behaviour, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "SK": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "HU": "Completed"
      },
      {
        "ES": "Completed"
      },
      {
        "BG": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003990-17"
  },
  {
    "EudraCT Number": "2017-004316-18",
    "Sponsor Protocol Number": "2006-05",
    "Sponsor Name": "Jazz Pharmaceuticals",
    "Full Title": "Defibrotide for Patients with Hepatic Veno-occlusive Disease (VOD): A Treatment IND Study",
    "Start Date": "2017-11-21",
    "Medical condition": [
      "Hepatic Veno-Occlusive Disease"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004871, Classification Code: 10047207, Term: Veno-occlusive liver damage, Level: LLT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004316-18"
  },
  {
    "EudraCT Number": "2016-004521-17",
    "Sponsor Protocol Number": "BIT-001",
    "Sponsor Name": "BIT Pharma GmbH",
    "Full Title": "A Phase IIa: single ascending dose safety, tolerability and pharmacokinetic study of NicaPlant\u00ae in aneurysmal subarachnoid haemorrhage patients undergoing aneurysm clipping",
    "Start Date": "2018-02-19",
    "Medical condition": [
      "Aneurysmal subarachnoid haemorrhage"
    ],
    "Disease": "Version: 20.1, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10008111, Term: Cerebral haemorrhage, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "AT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004521-17"
  },
  {
    "EudraCT Number": "2017-002223-25",
    "Sponsor Protocol Number": "NL60891.091.17",
    "Sponsor Name": "Radboud University Medical Center",
    "Full Title": "Pilot study on the effect of prophylactic versus therapeutic treatment with coal tar and vaseline lanette ointment on the skin barrier repair mechanisms in absence of a chronic inflammatory compone...",
    "Start Date": "2018-05-25",
    "Medical condition": [
      "Atopic dermatits"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004858, Classification Code: 10003640, Term: Atopic dermatitis and related conditions, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002223-25"
  },
  {
    "EudraCT Number": "2018-000028-33",
    "Sponsor Protocol Number": "D-FR-01070-003",
    "Sponsor Name": "Ipsen Pharma",
    "Full Title": "A non-randomised, phase II study to evaluate the optimal uptake time of 68Ga-OPS202 as a sstr2 positive PET imaging agent in subjects with newly diagnosed breast cancer. (Sub-study of Master Protoc...",
    "Start Date": "2018-07-17",
    "Medical condition": [
      "Breast Cancer"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10057654, Term: Breast cancer female, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "AT": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-000028-33"
  },
  {
    "EudraCT Number": "2018-003518-41",
    "Sponsor Protocol Number": "2018-4765",
    "Sponsor Name": "Radboudumc",
    "Full Title": "Efficacy of Diltiazem to improve coronary microvascular dysfunction: A randomized clinical trial",
    "Start Date": "2019-10-03",
    "Medical condition": [
      "Coronary Microvascular Dysfunction (CMD). In CMD",
      "ischemia is caused by impaired endothelial and/or non-endothelial coronary vasoreactivity resulting in the coronary microvasculature not dilating p..."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-003518-41"
  },
  {
    "EudraCT Number": "2016-000592-24",
    "Sponsor Protocol Number": "MR308-3501",
    "Sponsor Name": "Mundipharma Research GmbH & Co. KG",
    "Full Title": "A Randomized, Double-Blind, Multicenter, Placebo- and active Comparator-Controlled Study to evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Third Molar Tooth Extraction (...",
    "Start Date": "2017-03-15",
    "Medical condition": [
      "Acute pain after third molar tooth extraction; dental procedure must have involved extraction of at least two impacted third molars requireing bone removal. If only two impacted third molars are ex..."
    ],
    "Disease": "Version: 20.0, SOC Term:  100000023314, Classification Code: 10066714, Term: Acute pain, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "PL": "Completed"
      },
      {
        "IT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000592-24"
  },
  {
    "EudraCT Number": "2016-004702-34",
    "Sponsor Protocol Number": "CLS001-CO-PR-015",
    "Sponsor Name": "Cutanea Life Sciences",
    "Full Title": "A randomized, evaluator-blinded, vehicle-controlled study to explore the pharmacodynamic effects of omiganan and omiganan in combination with imiquimod in healthy volunteers.",
    "Start Date": "2017-01-09",
    "Medical condition": [
      "None"
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004858, Classification Code: 10062249, Term: Skin inflammation, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004702-34"
  },
  {
    "EudraCT Number": "2015-002034-47",
    "Sponsor Protocol Number": "AF219-014",
    "Sponsor Name": "Afferent Pharmaceuticals, Inc.",
    "Full Title": "A Study to Assess the Effect of AF-219 on Cough Reflex Sensitivity in Both Healthy and Chronic Cough Subjects",
    "Start Date": "2015-10-12",
    "Medical condition": [
      "Chronic cough"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002034-47"
  },
  {
    "EudraCT Number": "2015-005845-30",
    "Sponsor Protocol Number": "Td506-LT",
    "Sponsor Name": "Sanofi Pasteur Limited",
    "Full Title": "One-, Three-, Five-, and Ten-Year Data on the Long-Term Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap) in Adults and Adolescents (11-64 ...",
    "Start Date": "2016-01-26",
    "Medical condition": [
      "Active immunization against tetanus",
      "diphtheria and pertussis"
    ],
    "Disease": "Version: 18.1, SOC Term: 10042613 - Surgical and medical procedures, Classification Code: 10054131, Term: Tetanus immunisation, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005845-30"
  },
  {
    "EudraCT Number": "2016-001833-29",
    "Sponsor Protocol Number": "202152",
    "Sponsor Name": "GlaxoSmithKline Research & Development Ltd",
    "Full Title": "A multicentre, randomised, double-blind (sponsor-unblinded), placebo-controlled study with open label extension to investigate the safety and tolerability, pharmacokinetics, pharmacodynamics, and...",
    "Start Date": "2016-09-07",
    "Medical condition": [
      "Active ulcerative colitis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10017947 - Gastrointestinal disorders, Classification Code: 10017969, Term: Gastrointestinal inflammatory conditions, Level: HLGT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "SE": "Completed"
      },
      {
        "GB": "Completed"
      },
      {
        "PL": "Completed"
      },
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001833-29"
  },
  {
    "EudraCT Number": "2016-001373-33",
    "Sponsor Protocol Number": "2016-3",
    "Sponsor Name": "Region Ostergotland",
    "Full Title": "Clinical Study Protocol  An open phase IV,RCT, evaluating patient controlled sedation, in three different dosages of propofol in healthy subjects undergoing  elective gynaecological out-patient su...",
    "Start Date": "2017-02-17",
    "Medical condition": [
      "Gynecological outpatient surgery"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "SE": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001373-33"
  },
  {
    "EudraCT Number": "2016-000454-36",
    "Sponsor Protocol Number": "VX15-440-101",
    "Sponsor Name": "Vertex Pharmaceuticals Incorporated",
    "Full Title": "A Phase 2, Randomized, Double-blind, Controlled Study to Evaluate the Safety and Efficacy of VX-440 Combination Therapy in Subjects Aged 12 Years and Older With Cystic Fibrosis",
    "Start Date": "2017-01-10",
    "Medical condition": [
      "Cystic fibrosis"
    ],
    "Disease": "Version: 19.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10011762, Term: Cystic fibrosis, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "AT": "Completed"
      },
      {
        "DK": "Prematurely Ended"
      },
      {
        "DE": "Completed"
      },
      {
        "BE": "Completed"
      },
      {
        "ES": "Prematurely Ended"
      },
      {
        "NL": "Completed"
      },
      {
        "IT": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000454-36"
  },
  {
    "EudraCT Number": "2016-003002-14",
    "Sponsor Protocol Number": "203162",
    "Sponsor Name": "GlaxoSmithKline Research & Development Limited",
    "Full Title": "An escalating dose, randomized, placebo-controlled incomplete block, 2-period cross-over study to assess the dose response for topical efficacy via airway responsiveness to adenosine-5'-monophospha...",
    "Start Date": "2017-01-24",
    "Medical condition": [
      "Asthma"
    ],
    "Disease": "Version: 20.0, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10003553, Term: Asthma, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003002-14"
  },
  {
    "EudraCT Number": "2016-004834-11",
    "Sponsor Protocol Number": "CR6086-2-02",
    "Sponsor Name": "Rottapharm Biotech S.r.l.",
    "Full Title": "A randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy, safety and pharmacokinetics of oral CR6086 administered at the doses of 30, 90 o...",
    "Start Date": "2017-07-06",
    "Medical condition": [
      "Rheumatoid Arthritis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10028395 - Musculoskeletal and connective tissue disorders, Classification Code: 10039073, Term: Rheumatoid arthritis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      },
      {
        "BG": "Completed"
      },
      {
        "PL": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004834-11"
  },
  {
    "EudraCT Number": "2017-001149-28",
    "Sponsor Protocol Number": "207608",
    "Sponsor Name": "GlaxoSmithKline Research & Development Limited",
    "Full Title": "A Phase IV, 12-week, randomised, double-blind, triple dummy study to compare single inhaler triple therapy, fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) with multiple inhaler therapy (b...",
    "Start Date": "2018-08-22",
    "Medical condition": [
      "Chronic obstructive pulmonary disease (COPD)"
    ],
    "Disease": "Version: 20.0, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10009033, Term: Chronic obstructive pulmonary disease, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-001149-28"
  },
  {
    "EudraCT Number": "2018-001339-33",
    "Sponsor Protocol Number": "SCITVITD3",
    "Sponsor Name": "Academisch medisch centrum Amsterdam",
    "Full Title": "A randomized, double-blind, placebo-controlled, study to determine the added value of vitamin D3 to treatment with subcutaneous immunotherapy in patients with moderate to severe allergic rhinitis/ ...",
    "Start Date": "2018-07-05",
    "Medical condition": [
      "subcutaneous immunotherapy in allergic rhinitis (AR) patients with allergies to birchpollen"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-001339-33"
  },
  {
    "EudraCT Number": "2014-004924-23",
    "Sponsor Protocol Number": "P04500",
    "Sponsor Name": "Schering-Plough Research Institute, a Division of Schering Corporation",
    "Full Title": "Efficacy and Safety of Concurrent Administration of Mometasone Furoate Nasal Spray (MFNS) and Oxymetazoline Nasal Spray Administered Once Daily (QD) vs.  Oxymetazoline Twice Daily (BID), Mometasone...",
    "Start Date": "2015-02-24",
    "Medical condition": [
      "Seasonal Allergic Rhinitis"
    ],
    "Disease": "",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-004924-23"
  },
  {
    "EudraCT Number": "2016-000758-37",
    "Sponsor Protocol Number": "NO18517",
    "Sponsor Name": "F. Hoffmann-La Roche AG",
    "Full Title": "A Phase I Trial of Capecitabine Rapidly Disintegrating Tablets and Concomitant Radiation Therapy in Children with Newly Diagnosed Brainstem Gliomas and High Grade Gliomas",
    "Start Date": "2016-08-23",
    "Medical condition": [
      "High Grade Glioma"
    ],
    "Disease": "Version: 19.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10018338, Term: Glioma, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000758-37"
  },
  {
    "EudraCT Number": "2017-003724-79",
    "Sponsor Protocol Number": "17SM4152",
    "Sponsor Name": "Imperial College London",
    "Full Title": "IL-1 Signal Inhibition in Alcoholic Hepatitis (Isaiah)",
    "Start Date": "2018-07-10",
    "Medical condition": [
      "Alcoholic Hepatitis"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004871, Classification Code: 10001624, Term: Alcoholic hepatitis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003724-79"
  },
  {
    "EudraCT Number": "2019-000258-76",
    "Sponsor Protocol Number": "2019-PRO/CAP/006-BE",
    "Sponsor Name": "Proveca Ltd.",
    "Full Title": "A single-dose, open-label, randomised, three-way crossover study to assess the comparative bioavailability of Captopril oral solution 5 mg/mL relative to captopril tablets and to investigate the ef...",
    "Start Date": "2019-11-21",
    "Medical condition": [
      "Captopril 5 mg/mL oral solution is a new oral pharmaceutical formulation intended for the treatment of congestive heart failure in male and female paediatric patients from birth to 18 years."
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-000258-76"
  },
  {
    "EudraCT Number": "2019-002643-23",
    "Sponsor Protocol Number": "STH19966",
    "Sponsor Name": "Sheffield Teaching Hospitals NHS Foundation Trust",
    "Full Title": "Validation of a novel composite of skin biomarkers as a primary outcome measure for evaluating the safety of treatments for atopic dermatitis: a randomized controlled trial (phase 2) comparing the ...",
    "Start Date": "2020-03-23",
    "Medical condition": [
      "atopic eczema (synonym atopic dermatitis) and the adverse treatment side effect epidermal atrophy"
    ],
    "Disease": "Version: 21.0, SOC Term: 10040785 - Skin and subcutaneous tissue disorders, Classification Code: 10040799, Term: Skin atrophy, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002643-23"
  },
  {
    "EudraCT Number": "2020-001044-26",
    "Sponsor Protocol Number": "MB05-P-01-20",
    "Sponsor Name": "mAbxience Research S.L.",
    "Full Title": "A Double-Blind, Randomised, Placebo-Controlled Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated with Respiratory Syncytial Virus (RSV)",
    "Start Date": "2020-05-12",
    "Medical condition": [
      "Respiratory Syncytial Virus Infection"
    ],
    "Disease": "Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10021881, Term: Infections and infestations, Level: SOC",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001044-26"
  },
  {
    "EudraCT Number": "2016-002503-26",
    "Sponsor Protocol Number": "X16082",
    "Sponsor Name": "Fundaci\u00f3n P\u00fablica Andaluza para la Gesti\u00f3n en Salud de Sevilla (FISEVI)",
    "Full Title": "Phase Ib/II trial to evaluate safety and efficacy of oral ixazomib in combination with sirolimus and tacrolimus in the prophylaxis of chronic graft-versus-host disease",
    "Start Date": "2017-03-14",
    "Medical condition": [
      "Adult patiens after allogeneic stem cell transplantation"
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004865, Classification Code: 10067859, Term: Allogenic stem cell transplantation, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002503-26"
  },
  {
    "EudraCT Number": "2018-003281-14",
    "Sponsor Protocol Number": "FCR173011/ResToP",
    "Sponsor Name": "Fundaci\u00f3n CRIS contra el C\u00e1ncer",
    "Full Title": "Multicenter, Open-Label, Single Arm, Phase II Exploratory Study to Evaluate the Reinduction and second stop of TKI with Ponatinib in CML in Molecular Response (ResToP)",
    "Start Date": "Information not available in EudraCT",
    "Medical condition": [
      "Chronic myelogenous leukemia"
    ],
    "Disease": "Version: 21.0, SOC Term: 100000004864, Classification Code: 10009012, Term: Chronic myelogenous leukemia, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-003281-14"
  },
  {
    "EudraCT Number": "2020-001891-14",
    "Sponsor Protocol Number": "Heparin-SARS-CoV2",
    "Sponsor Name": "Fundaci\u00f3n Neumosur",
    "Full Title": "Impact of the use of low molecular weight heparins (LMWH), at prophylactic versus intermediate doses, on SARS-CoV2 infection (COVID-19)",
    "Start Date": "2020-05-04",
    "Medical condition": [
      "COVID-19"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001891-14"
  },
  {
    "EudraCT Number": "2020-000875-20",
    "Sponsor Protocol Number": "C3291028",
    "Sponsor Name": "Pfizer Inc.",
    "Full Title": "A Phase 2b, Multi Center, Randomized, Double-Blind, Vehicle-Controlled, Intra-Participant Study, to Evaluate Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Pediatric and...",
    "Start Date": "2020-05-14",
    "Medical condition": [
      "Atopic Dermatitis"
    ],
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000875-20"
  },
  {
    "EudraCT Number": "2015-005064-42",
    "Sponsor Protocol Number": "AF219-012",
    "Sponsor Name": "Afferent Pharmaceuticals, Inc.",
    "Full Title": "A 12-Week Study to Assess the Efficacy and Safety of AF-219 in Subjects with Treatment Refractory Chronic Cough",
    "Start Date": "2016-02-26",
    "Medical condition": [
      "Chronic Cough"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005064-42"
  },
  {
    "EudraCT Number": "2008-006649-18",
    "Sponsor Protocol Number": "08/0214",
    "Sponsor Name": "University College London",
    "Full Title": "CMV TCR Gene Therapy: A Phase I Safety, Toxicity and Feasibility Study of Adoptive Immunotherapy with CMV TCR-transduced Donor-derived T cells for Recipients of Allogeneic Haematopoietic Stem Cell ...",
    "Start Date": "2011-11-16",
    "Medical condition": [
      "CMV reactivation/infection in post allogeneic haematopoietic stem cell transplant recipients. Allo-HSCT being performed for underlying haematological malignancy (eg",
      "AML",
      "ALL",
      "NHL",
      "Hodgkin Lymphoma..."
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004865, Classification Code: 10067859, Term: Allogenic stem cell transplantation, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-006649-18"
  },
  {
    "EudraCT Number": "2008-002768-32",
    "Sponsor Protocol Number": "MM03",
    "Sponsor Name": "Freistaat Bayern",
    "Full Title": "A prospective phase I/II, one-arm, one-stage multi-center, open label study of lenalidomide in combination with pioglitazone, dexamethasone and metronomic low-dose chemotherapy with treosulfan in p...",
    "Start Date": "2009-06-08",
    "Medical condition": [
      "Multiple myeloma"
    ],
    "Disease": "Version: 21.0, SOC Term: 100000004864, Classification Code: 10028228, Term: Multiple myeloma, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-002768-32"
  },
  {
    "EudraCT Number": "2010-022400-53",
    "Sponsor Protocol Number": "NLH-01",
    "Sponsor Name": "K\u00f8ge Hospital",
    "Full Title": "Intracoronary administration of melatonin for patients with acute myocardial infarction: a placebo controlled randomized study.",
    "Start Date": "2011-01-13",
    "Medical condition": [
      "Acute Myocardial Infarction"
    ],
    "Disease": "Version: 18.1, SOC Term: 10007541 - Cardiac disorders, Classification Code: 10000891, Term: Acute myocardial infarction, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-022400-53"
  },
  {
    "EudraCT Number": "2008-003174-18",
    "Sponsor Protocol Number": "PACET-CUP",
    "Sponsor Name": "Universit\u00e4tsklinikum Heidelberg",
    "Full Title": "Open-labeled, randomized multi-center phase II study evaluating the efficacy and safety of Paclitaxel/ Carboplatin with and without Cetuximab as first-line treatment of adeno- and undifferentiated ...",
    "Start Date": "2009-12-18",
    "Medical condition": [
      "adeno- and undifferentiated Carcinoma of Unknown Primary (CUP)"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-003174-18"
  },
  {
    "EudraCT Number": "2006-001095-21",
    "Sponsor Protocol Number": "A5I16",
    "Sponsor Name": "Sanofi Pasteur Inc.",
    "Full Title": "Immunogenicity and Safety of PEDIACEL\u00ae, a Combined Diphtheria, Tetanus, Five Component Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed),...",
    "Start Date": "2016-04-19",
    "Medical condition": [
      "Pertussis",
      "adsorbed diphtheria and tetanus toxoids",
      "inactivated poliomyelitis and polysaccharide of H. influenza type b bound to tetanus toxoid"
    ],
    "Disease": "",
    "Population Age": [
      "Infants and toddlers",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-001095-21"
  },
  {
    "EudraCT Number": "2006-000653-22",
    "Sponsor Protocol Number": "GART1013",
    "Sponsor Name": "Moorfields Eye Hospital",
    "Full Title": "The UK Glaucoma Treatment Study",
    "Start Date": "2006-07-26",
    "Medical condition": [
      "Primary open-angle Glaucoma Pseudoexfoliation Glaucoma"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004853, Classification Code: 10037118, Term: Pseudoexfoliation glaucoma, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-000653-22"
  },
  {
    "EudraCT Number": "2008-000581-23",
    "Sponsor Protocol Number": "CSPP100A2244",
    "Sponsor Name": "Novartis Pharma AG",
    "Full Title": "A randomized, double-masked, placebo-controlled add on study to assess the efficacy of oral aliskiren 300 mg once daily for diabetic macular edema",
    "Start Date": "2008-07-28",
    "Medical condition": [
      "Diabetic Macular Edema (DME) in hypertensive patients"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004853, Classification Code: 10057915, Term: Diabetic macular oedema, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-000581-23"
  },
  {
    "EudraCT Number": "2007-001058-16",
    "Sponsor Protocol Number": "V00147GL202",
    "Sponsor Name": "PIERRE FABRE MEDICAMENT",
    "Full Title": "A PHASE II DOUBLE-BLIND VEHICLE-CONTROLLED CROSSOVER SINGLE DOSE (400 \u00b5G) V0147 GEL EFFECT AND TOLERANCE STUDY IN SPINAL CORD INJURED PATIENTS WITH ERECTILE DYSFUNCTION",
    "Start Date": "2007-04-30",
    "Medical condition": [
      "Erectile dysfunction"
    ],
    "Disease": "Version: 21.1, SOC Term: 10038604 - Reproductive system and breast disorders, Classification Code: 10052004, Term: Organic erectile dysfunction, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "FR": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-001058-16"
  },
  {
    "EudraCT Number": "2008-007225-39",
    "Sponsor Protocol Number": "CareRA",
    "Sponsor Name": "University Hospitals Leuven",
    "Full Title": "A 2 year prospective multicentre randomised controlled trial comparing effectiveness in daily practice of different treatment strategies for early RA",
    "Start Date": "2009-01-06",
    "Medical condition": [
      "early active Rheumatoid Arthritis",
      "previously untreated with DMARDS"
    ],
    "Disease": "Version: 20.0, SOC Term: 10028395 - Musculoskeletal and connective tissue disorders, Classification Code: 10039073, Term: Rheumatoid arthritis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "BE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-007225-39"
  },
  {
    "EudraCT Number": "2010-023062-40",
    "Sponsor Protocol Number": "PRP-001",
    "Sponsor Name": "Medivation, Inc.",
    "Full Title": "A Phase 1/2, First in Human, Single-arm, Open-label Study of Once a Day, Orally Administered Talazoparib (BMN 673) in Patients with Advanced or Recurrent Solid Tumors",
    "Start Date": "2011-04-19",
    "Medical condition": [
      "Advanced or recurrent solid tumors for which there is no accepted standard treatment or for which standard treatment has failed.  Patients may also be eligible if they are unable or decline to unde..."
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004864, Classification Code: 10065147, Term: Malignant solid tumor, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-023062-40"
  },
  {
    "EudraCT Number": "2009-016877-14",
    "Sponsor Protocol Number": "H1N1-2009",
    "Sponsor Name": "COPSAC",
    "Full Title": "H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A-H1N1v Vaccination in Pregnant Women",
    "Start Date": "2009-11-04",
    "Medical condition": [
      "Protection against Influenza A H1N1v disease"
    ],
    "Disease": "",
    "Population Age": [
      "In utero",
      "Preterm newborn infants",
      "Newborns",
      "Infants and toddlers",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2009-016877-14"
  },
  {
    "EudraCT Number": "2011-002044-28",
    "Sponsor Protocol Number": "HGT-MLD-070",
    "Sponsor Name": "Shire Human Genetics Therapies Inc",
    "Full Title": "A Phase I/II, Multicenter, Open-label, Dose Escalation Study of HGT-1110 Administered Intrathecally in Children with Metachromatic Leukodystrophy",
    "Start Date": "2012-06-14",
    "Medical condition": [
      "Treatment of Metachromatic Leukodystrophy"
    ],
    "Disease": "Version: 19.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10067609, Term: Metachromatic leukodystrophy, Level: PT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      },
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-002044-28"
  },
  {
    "EudraCT Number": "2013-001048-73",
    "Sponsor Protocol Number": "BAY41-6551/13084",
    "Sponsor Name": "Bayer AG",
    "Full Title": "A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of BAY 41-6551 as Adjunctive Therapy in Intubated and Mechanically-Ventilated Pati...",
    "Start Date": "2013-07-25",
    "Medical condition": [
      "Gram-negative pneumonia"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004862, Classification Code: 10035701, Term: Pneumonia gram-negative bacterial NOS, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "CZ": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-001048-73"
  },
  {
    "EudraCT Number": "2012-001650-26",
    "Sponsor Protocol Number": "AnticholiumperSeIII",
    "Sponsor Name": "Ruprecht-Karls-University Heidelberg, Med Faculty represented by Universit\u00e4tsklinikum Heidelberg and its Commercial D",
    "Full Title": "A randomised, placebo-controlled, double-blind, monocentre study on the application of physostigminsalicylate (Anticholium\u00ae) as adjunctive measure in perioperative sepsis/septic shock",
    "Start Date": "2014-04-28",
    "Medical condition": [
      ""
    ],
    "Disease": "Version: 19.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10040047, Term: Sepsis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-001650-26"
  },
  {
    "EudraCT Number": "2012-000447-27",
    "Sponsor Protocol Number": "USKH_VL1",
    "Sponsor Name": "Universit\u00e4tsklinikum Schleswig-Holstein, Campus Kiel",
    "Full Title": "Open Label Study for the Functional Characterization of Drug Metabolism and Transport in patients before routine visceral surgery",
    "Start Date": "2012-07-25",
    "Medical condition": [
      "Pharmacokinetic trial in patients",
      "with a good general condition before standard abdominal surgery"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Temporarily Halted"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-000447-27"
  },
  {
    "EudraCT Number": "2011-005066-38",
    "Sponsor Protocol Number": "CINC424AGB02",
    "Sponsor Name": "Novartis Pharmaceuticals UK Ltd",
    "Full Title": "A UK open-label, multicentre, exploratory Phase II study of INC424 for patients with primary myelofibrosis (PMF) or post polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelof...",
    "Start Date": "2012-03-09",
    "Medical condition": [
      "primary myelofibrosis (PMF)",
      "post polycythemia vera myelofibrosis (PPV MF) or Post essential thrombocythemia myelofibrosis (PET-MF)"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-005066-38"
  },
  {
    "EudraCT Number": "2011-005082-21",
    "Sponsor Protocol Number": "Uni-Koeln-1491",
    "Sponsor Name": "University of Cologne",
    "Full Title": "Targeted BEACOPP variants in patients with newly diagnosed advanced classical Hodgkin Lymphoma",
    "Start Date": "2012-09-25",
    "Medical condition": [
      "newly diagnosed advanced classical Hodgkin Lymphoma"
    ],
    "Disease": "Version: 20.0, SOC Term:  100000004851, Classification Code: 10025319, Term: Lymphomas Hodgkin's disease, Level: HLGT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-005082-21"
  },
  {
    "EudraCT Number": "2012-004439-22",
    "Sponsor Protocol Number": "CAIN457F2312",
    "Sponsor Name": "Novartis Pharma Services AG",
    "Full Title": "A Phase III randomized, double-blind, placebo-controlled multicenter study of subcutaneous secukinumab in prefilled syringes to demonstrate the efficacy at 24 weeks and to assess the long term effi...",
    "Start Date": "2013-04-08",
    "Medical condition": [
      "Psoriatic arthritis"
    ],
    "Disease": "Version: 19.1, SOC Term: 100000004859, Classification Code: 10037160, Term: Psoriatic arthritis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      },
      {
        "BE": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-004439-22"
  },
  {
    "EudraCT Number": "2012-002786-35",
    "Sponsor Protocol Number": "12/0246",
    "Sponsor Name": "University College London",
    "Full Title": "A randomised double-blind controlled phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose with placebo in patients with anaemia undergoing major open abdominal su...",
    "Start Date": "2012-11-05",
    "Medical condition": [
      "Anaemia"
    ],
    "Disease": "Version: 19.0, SOC Term: 10005329 - Blood and lymphatic system disorders, Classification Code: 10022972, Term: Iron deficiency anaemia, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-002786-35"
  },
  {
    "EudraCT Number": "2012-005629-65",
    "Sponsor Protocol Number": "RG_12-269",
    "Sponsor Name": "University of Birmingham",
    "Full Title": "Management of Transformed Chronic myeloid leukaemia: Ponatinib and Intensive chemotherapy: a dose finding study",
    "Start Date": "2014-01-15",
    "Medical condition": [
      "Chronic Myeloid Leukaemia (CML) in Blast Phase"
    ],
    "Disease": "Version: 20.1, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10009013, Term: Chronic myeloid leukaemia, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-005629-65"
  },
  {
    "EudraCT Number": "2017-002127-16",
    "Sponsor Protocol Number": "UCAB-CT-03",
    "Sponsor Name": "Umecrine Cognition AB",
    "Full Title": "A phase IIa study of GR3027 in patients with idiopathic hypersomnia (IH) involving an open-label part to assess safety, tolerability and pharmacokinetics (PK) of a single oral GR3027 dose in female...",
    "Start Date": "2017-08-24",
    "Medical condition": [
      "Idiopathic hypersomnia (IH)"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004852, Classification Code: 10028714, Term: Narcolepsy and hypersomnia, Level: HLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "FI": "Completed"
      },
      {
        "DK": "Completed"
      },
      {
        "SE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002127-16"
  },
  {
    "EudraCT Number": "2017-003555-35",
    "Sponsor Protocol Number": "PAT-DEU-402",
    "Sponsor Name": "Fresenius Medical Care Nephrologica Deutschland GmbH",
    "Full Title": "A Multicentre, Randomised, Open-label, Parallel-Group Pilot Study to Evaluate the Efficacy of Patiromer in Optimising Mineralocorticoid Receptor Antagonist Therapy in Heart Failure Subjects with Hy...",
    "Start Date": "2017-11-17",
    "Medical condition": [
      "Heart Failure with reduced ejection fraction (HFrEF) subjects with hyperkalaemia"
    ],
    "Disease": "Version: 20.1, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10020646, Term: Hyperkalaemia, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003555-35"
  },
  {
    "EudraCT Number": "2017-003636-36",
    "Sponsor Protocol Number": "UCL/17/0396",
    "Sponsor Name": "University College London",
    "Full Title": "A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients with performance status 2 with recurrent or metastatic squamous cell carcinoma of the head and neck",
    "Start Date": "2019-01-08",
    "Medical condition": [
      "Recurrent/metastatic head and neck squamous cell cancer"
    ],
    "Disease": "Version: 21.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10060121, Term: Squamous cell carcinoma of head and neck, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003636-36"
  },
  {
    "EudraCT Number": "2020-001736-95",
    "Sponsor Protocol Number": "ACCORD-2-001,Sub002,003,006",
    "Sponsor Name": "University Hospital Southampton NHS Foundation Trust",
    "Full Title": "ACCORD 2: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID 19 in Hospitalised Patients",
    "Start Date": "2020-04-28",
    "Medical condition": [
      "COVID 19"
    ],
    "Disease": "Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001736-95"
  },
  {
    "EudraCT Number": "2015-004867-35",
    "Sponsor Protocol Number": "ADA109057",
    "Sponsor Name": "GlaxoSmithKline Research and Development Ltd.",
    "Full Title": "A 52-week, Randomized, Double-Blind, Parallel-Group Study of Fluticasone Propionate/Salmeterol DISKUS Combination Product (FSC) 250/50 mcg BID and Fluticasone Propionate (FP) DISKUS 250 mcg BID in ...",
    "Start Date": "2016-12-21",
    "Medical condition": [
      "Asthma"
    ],
    "Disease": "",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004867-35"
  },
  {
    "EudraCT Number": "2016-003870-41",
    "Sponsor Protocol Number": "EC_10/2016",
    "Sponsor Name": "Fundaci\u00f3n para la Investigaci\u00f3n Biom\u00e9dica del Hospital Universitario Pr\u00edncipe de Asturias",
    "Full Title": "Comparison of treatment of diabetic macular edema with Ozurdex\u00ae versus Ozurdex\u00ae plus laser in areas of peripheral non-perfusion",
    "Start Date": "2017-02-07",
    "Medical condition": [
      "Diabetic macular edema"
    ],
    "Disease": "Version: 19.0, SOC Term: 100000004853, Classification Code: 10057934, Term: Diabetic macular edema, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Restarted"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003870-41"
  },
  {
    "EudraCT Number": "2017-000501-20",
    "Sponsor Protocol Number": "A1501082",
    "Sponsor Name": "Pfizer, Inc.",
    "Full Title": "Voriconazole In High-Risk Patients With Invasive Fungal Infections In Slovakia. An Open, Prospective, Non-comparative Study",
    "Start Date": "2017-03-09",
    "Medical condition": [
      "Invasive Fungal Infections"
    ],
    "Disease": "Version: 19.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10017533, Term: Fungal infection, Level: PT",
    "Population Age": [
      "In utero",
      "Infants and toddlers",
      "Children",
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000501-20"
  },
  {
    "EudraCT Number": "2015-000172-98",
    "Sponsor Protocol Number": "",
    "Sponsor Name": "The University of Leicester",
    "Full Title": "An Open Label Oxygen Enhanced Imaging Biomarker Study to Assess the Role of Fluticasone/Formoterol upon Airway Function in Moderate to Severe Persistent Asthma.",
    "Start Date": "2015-03-24",
    "Medical condition": [
      "Asthma"
    ],
    "Disease": "Version: 20.0, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10003553, Term: Asthma, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-000172-98"
  },
  {
    "EudraCT Number": "2019-003468-27",
    "Sponsor Protocol Number": "PiNCv.1.1",
    "Sponsor Name": "Homerton University Hospital NHS Trust",
    "Full Title": "A Randomised Controlled trial investigating the effects of Progesterone for luteal phase support in Natural Cycles for unexplained infertility",
    "Start Date": "2019-11-29",
    "Medical condition": [
      "Unexplained infertility"
    ],
    "Disease": "Version: 20.1, SOC Term: 10014698 - Endocrine disorders, Classification Code: 10049513, Term: Luteal phase deficiency, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-003468-27"
  },
  {
    "EudraCT Number": "2010-019466-81",
    "Sponsor Protocol Number": "LPA114255",
    "Sponsor Name": "GlaxoSmithKline Research & Development",
    "Full Title": "A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Treatment, Four 6-Week Period Cross-Over, Multi-Center Study to Evaluate the Effect of Adding GSK2190915 100 mg, GSK2190915 300 mg...",
    "Start Date": "2016-12-12",
    "Medical condition": [
      "Asthma"
    ],
    "Disease": "",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-019466-81"
  },
  {
    "EudraCT Number": "2017-001205-33",
    "Sponsor Protocol Number": "V503-017",
    "Sponsor Name": "Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.",
    "Full Title": "A Phase III Open-label Safety and Immunogenicity Study of GARDASIL\u21229 Administered to 9- to 26-Year-Old Females and Males in Vietnam",
    "Start Date": "2019-03-14",
    "Medical condition": [
      "Prevention of cervical",
      "vulvar",
      "vaginal",
      "and anal cancers and related precancers",
      "and anogenital warts caused by HPV Types 6",
      "11",
      "16",
      "18",
      "31",
      "33",
      "45",
      "52",
      "and 58."
    ],
    "Disease": "Version: 20.1, SOC Term: 100000004862, Classification Code: 10063001, Term: Human papilloma virus infection, Level: LLT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-001205-33"
  },
  {
    "EudraCT Number": "2018-004279-11",
    "Sponsor Protocol Number": "B7471007",
    "Sponsor Name": "Pfizer Inc., 235 East 42nd Street, New York, NY 10017",
    "Full Title": "A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PNEUMOCOCCAL VACCINE\u2013NA\u00cfVE ADULTS 18 YEARS OF AGE AND OLDER",
    "Start Date": "2019-02-27",
    "Medical condition": [
      "Pneumococcal Infections"
    ],
    "Disease": "Version: 20.0, SOC Term: 10042613 - Surgical and medical procedures, Classification Code: 10069578, Term: Pneumococcal immunisation, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "SE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-004279-11"
  },
  {
    "EudraCT Number": "2018-001983-49",
    "Sponsor Protocol Number": "UX023-CL205",
    "Sponsor Name": "Ultragenyx Pharmaceutical Inc",
    "Full Title": "An Open-Label, Phase 2 Study to Assess the Safety, Pharmacodynamics, and Efficacy of KRN23 in Children from 1 to 4 Years Old with X-linked Hypophosphatemia (XLH)",
    "Start Date": "2019-10-10",
    "Medical condition": [
      "XLH is a disorder of hypophosphatemia",
      "renal phosphate wasting",
      "and the most common inheritable form of rickets. In XLH patients",
      "excess circulating fibroblast growth factor (FGF23) impair phosphat..."
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004850, Classification Code: 10016206, Term: Familial hypophosphataemic rickets, Level: LLT",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-001983-49"
  },
  {
    "EudraCT Number": "2019-002045-38",
    "Sponsor Protocol Number": "SGMCLM",
    "Sponsor Name": "Leiden University Medical Center",
    "Full Title": "AN OPEN-LABEL, EXPLORATORY STUDY ASSESSING THE FEASIBILITY OF SGM-101, A FLUOROCHROME-LABELED ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY FOR THE INTRAOPERATIVE DETECTION OF LUNG METASTASIS I...",
    "Start Date": "2020-03-23",
    "Medical condition": [
      "Colorectal lung metastases"
    ],
    "Disease": "Version: 21.1, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10050017, Term: Lung cancer metastatic, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002045-38"
  },
  {
    "EudraCT Number": "2016-001963-35",
    "Sponsor Protocol Number": "MET50",
    "Sponsor Name": "Sanofi Pasteur Inc.",
    "Full Title": "A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents",
    "Start Date": "2016-05-06",
    "Medical condition": [
      "Healthy volunteers (active immunization against invasive meningococcal disease (IMD) caused by Meningococcal serogroups A",
      "C",
      "Y or W"
    ],
    "Disease": "",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001963-35"
  },
  {
    "EudraCT Number": "2019-001277-93",
    "Sponsor Protocol Number": "EC03/2019-MacroCOL",
    "Sponsor Name": "\"Pr\u00edncipe de Asturias\" University Hospital",
    "Full Title": "Usefulness of strengthering the bowel-cleansing preparation with Macrogol 3350 in patients with weak previous colonoscopy preparation",
    "Start Date": "2019-09-27",
    "Medical condition": [
      "Colorectal cancer"
    ],
    "Disease": "Version: 21.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10061451, Term: Colorectal cancer, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-001277-93"
  },
  {
    "EudraCT Number": "2015-002387-16",
    "Sponsor Protocol Number": "SI-C-060",
    "Sponsor Name": "Solvotrin Innovations Ltd",
    "Full Title": "The Role of Tetracyclines in the Personalised Management of MMP-9 and Cardiovascular Function in Type 2 Diabetes",
    "Start Date": "2015-11-16",
    "Medical condition": [
      "Type II diabetes mellitus"
    ],
    "Disease": "Version: 18.1, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10067585, Term: Type 2 diabetes mellitus, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "IE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002387-16"
  },
  {
    "EudraCT Number": "2015-004442-25",
    "Sponsor Protocol Number": "CFAM810B2304",
    "Sponsor Name": "Novartis Pharmaceuticals",
    "Full Title": "A multicenter, open-label, single-arm, two-step study to evaluate the safety and single-dose pharmacokinetics of famciclovir and multiple-dose safety after administration of famciclovir oral pediat...",
    "Start Date": "2016-04-12",
    "Medical condition": [
      "Chickenpox"
    ],
    "Disease": "",
    "Population Age": [
      "Infants and toddlers",
      "Children",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004442-25"
  },
  {
    "EudraCT Number": "2015-003527-57",
    "Sponsor Protocol Number": "CACZ885DTR01",
    "Sponsor Name": "Novartis Pharmaceuticals",
    "Full Title": "An Open-label, Exploratory Study to Establish the Safety and Efficacy of 3 Months Treatment With Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever",
    "Start Date": "2016-04-14",
    "Medical condition": [
      "Familial Mediterranean Fever"
    ],
    "Disease": "Version: 19.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10016207, Term: Familial mediterranean fever, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003527-57"
  },
  {
    "EudraCT Number": "2007-002135-83",
    "Sponsor Protocol Number": "ML20951",
    "Sponsor Name": "Roche Romania SRL",
    "Full Title": "An open label study to evaluate the effect of first line treatment with Tarceva in combination with Gemcitabine on disease progression in patients with unresectable advanced and/or metastatic non-s...",
    "Start Date": "2007-11-28",
    "Medical condition": [
      "unresectable",
      "advanced and/or metastatic non-small cell lung cancer"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "RO": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-002135-83"
  },
  {
    "EudraCT Number": "2017-004684-12",
    "Sponsor Protocol Number": "iNO_Protocol_V1.1_16.07.17",
    "Sponsor Name": "Lady Cilento Children's Hospital",
    "Full Title": "Nitric Oxide during Cardio Pulmonary Bypass during surgery for congenital heart defects: A Randomised Controlled Trial.",
    "Start Date": "2019-05-16",
    "Medical condition": [
      "Congenital heart disease ranks still within the top causes of infant mortality in industrialized countries. Despite considerable advances over the past decade",
      "the exposure to cardiopulmonary bypas..."
    ],
    "Disease": "",
    "Population Age": [
      "Newborns",
      "Infants and toddlers",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004684-12"
  },
  {
    "EudraCT Number": "2014-003997-18",
    "Sponsor Protocol Number": "GTI1408",
    "Sponsor Name": "Grifols Therapeutics Inc.",
    "Full Title": "A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/ Chromatography Purified (IGIV -C) in Symptomatic Su...",
    "Start Date": "2015-07-07",
    "Medical condition": [
      "Myasthenia Gravis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10028417, Term: Myasthenia gravis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "LT": "Completed"
      },
      {
        "EE": "Completed"
      },
      {
        "HU": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "BE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-003997-18"
  },
  {
    "EudraCT Number": "2016-000446-56",
    "Sponsor Protocol Number": "CRT076",
    "Sponsor Name": "Crist\u00e1lia Produtos Qu\u00edmicos Farmac\u00eauticos Ltda.",
    "Full Title": "Clinical study to compare recombinant human growth hormone Cristalia (r-hGH Cristalia) versus Genotropin\u00ae in prepubertal children with growth deficiency due to deficiency of growth hormone.",
    "Start Date": "2016-03-07",
    "Medical condition": [
      "Growth deficiency due to growth hormone deficiency"
    ],
    "Disease": "Version: 18.1, SOC Term: 10014698 - Endocrine disorders, Classification Code: 10056438, Term: Growth hormone deficiency, Level: PT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000446-56"
  },
  {
    "EudraCT Number": "2015-005211-32",
    "Sponsor Protocol Number": "DS1040-B-U107",
    "Sponsor Name": "Daiichi Sankyo, Inc.",
    "Full Title": "A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Single Ascending Dose Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of DS-1040b when Added to ...",
    "Start Date": "2017-03-08",
    "Medical condition": [
      "DS-1040b is an inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor (TAFIa) intended to be used for the treatment of thrombotic diseases including Pulmonary Embolism (PE)"
    ],
    "Disease": "Version: 20.0, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10037377, Term: Pulmonary embolism, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005211-32"
  },
  {
    "EudraCT Number": "2016-002160-14",
    "Sponsor Protocol Number": "20160516",
    "Sponsor Name": "St. Antonius Hospital",
    "Full Title": "68Ga-DOTA-NOC PET/CT for the imaging of disease activity in neurologic and cardiac sarcoidosis.",
    "Start Date": "2016-11-22",
    "Medical condition": [
      "Sarcoidosis."
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002160-14"
  },
  {
    "EudraCT Number": "2016-001163-37",
    "Sponsor Protocol Number": "CNTO1959PSA3001",
    "Sponsor Name": "Janssen-Cilag International N.V.",
    "Full Title": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Subjects with Active Psoriatic Arthritis i...",
    "Start Date": "2017-07-25",
    "Medical condition": [
      "Active Psoriatic Arthritis"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004859, Classification Code: 10037160, Term: Psoriatic arthritis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "HU": "Completed"
      },
      {
        "CZ": "Completed"
      },
      {
        "ES": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001163-37"
  },
  {
    "EudraCT Number": "2017-004753-16",
    "Sponsor Protocol Number": "HEH-SF-02",
    "Sponsor Name": "Department of Surgery, Herlev Hospital",
    "Full Title": "Intraperitoneal administration of fosfomycin, metronidazole and molgramostim versus intravenous conventional antibiotics for perforated appendicitis \u2013 a pivotal quasi-randomized controlled trial",
    "Start Date": "2018-02-01",
    "Medical condition": [
      "We wish to investigate if intraoperative intraperitoneal administration of fosfomycin",
      "metronidazole and rhGM-CSF followed by oral antibiotic for three days is as effective as the current intraveno..."
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004862, Classification Code: 10000680, Term: Acute appendicitis without mention of peritonitis, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DK": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004753-16"
  },
  {
    "EudraCT Number": "2018-004450-24",
    "Sponsor Protocol Number": "PHIX-IT",
    "Sponsor Name": "Tergooi Hospital, dep of internal medicine",
    "Full Title": "A pharmacokinetic study of edoxaban in patients with breast cancer using the P-glycoprotein inhibitor tamoxifen",
    "Start Date": "2019-08-01",
    "Medical condition": [
      "If there are increased plasma levels of edoxaban when used concomitantly with the P-glycoprote\u00efne inhibitor tamoxifen for the treatment of venous thromboembolism in patients with breast cancer."
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Female"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-004450-24"
  },
  {
    "EudraCT Number": "2015-003737-95",
    "Sponsor Protocol Number": "Samba-V",
    "Sponsor Name": "Dance Biopharm Inc.",
    "Full Title": "A Randomized, Open-Label, 4-Period Cross-Over Study to Investigate the Inter- and Intra-subject Variability of Dance 501 (Human Insulin Inhalation Solution and Inhaler) in Subjects with Type 1 Diab...",
    "Start Date": "2018-11-27",
    "Medical condition": [
      "Type 1 Diabetes Mellitus"
    ],
    "Disease": "Version: 20.0, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10067584, Term: Type 1 diabetes mellitus, Level: PT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003737-95"
  },
  {
    "EudraCT Number": "2018-004401-79",
    "Sponsor Protocol Number": "00000000",
    "Sponsor Name": "University of Oxford, Clinical Trials and Research Governance",
    "Full Title": "The use of Benralizumab, an interleukin-5 receptor-\u03b1 monoclonal antibody as treatment of acute exacerbations of airways disease",
    "Start Date": "2020-04-15",
    "Medical condition": [
      "Asthma and COPD exacerbations."
    ],
    "Disease": "Version: 21.1, SOC Term: 100000004855, Classification Code: 10015575, Term: Exacerbation of asthma, Level: LLT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-004401-79"
  },
  {
    "EudraCT Number": "2019-003150-86",
    "Sponsor Protocol Number": "V1.0",
    "Sponsor Name": "Royal Cornwall Hospitals NHS Trust",
    "Full Title": "A Study to Investigate the Effect of Different Durations of Ameluz Application on Response to Treatment of Acral Actinic Keratoses",
    "Start Date": "2019-09-20",
    "Medical condition": [
      "Actinic keratoses"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-003150-86"
  },
  {
    "EudraCT Number": "2015-002669-45",
    "Sponsor Protocol Number": "ICL-23-ABSSSI1",
    "Sponsor Name": "Motif BioSciences Inc.",
    "Full Title": "A Phase 3, randomized, double-blind, multicenter study to evaluate the safety and efficacy of intravenous iclaprim versus vancomycin in the treatment of acute bacterial skin and skin structure infe...",
    "Start Date": "2016-02-18",
    "Medical condition": [
      "Acute bacterial skin and skin structure infections (ABSSSIs) suspected or confirmed to be due to Gram-positive pathogens."
    ],
    "Disease": "Version: 19.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10040872, Term: Skin infection, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "LV": "Completed"
      },
      {
        "DE": "Completed"
      },
      {
        "BG": "Completed"
      },
      {
        "PL": "Completed"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002669-45"
  },
  {
    "EudraCT Number": "2015-005398-18",
    "Sponsor Protocol Number": "W15-679",
    "Sponsor Name": "AbbVie Deutschland GmbH & Co. KG",
    "Full Title": "Treating patients with early axial spondyloarthritis to target \u2013 a 1 year randomized controlled study taking an intense treatment approach versus routine treatment (STRIKE)",
    "Start Date": "2016-07-12",
    "Medical condition": [
      "Axial spondyloarthritis"
    ],
    "Disease": "Version: 20.0, SOC Term: 10028395 - Musculoskeletal and connective tissue disorders, Classification Code: 10071400, Term: Axial spondyloarthritis, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "DE": "Prematurely Ended"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005398-18"
  },
  {
    "EudraCT Number": "2016-003345-29",
    "Sponsor Protocol Number": "3568",
    "Sponsor Name": "Kings College Hospital NHS Foundation Trust",
    "Full Title": "Safety of tenofovir alafenamide (TAF) in patients with a history of tubulopathy on tenofovir disoproxil fumarate (TDF)",
    "Start Date": "2016-11-16",
    "Medical condition": [
      "HIV infection"
    ],
    "Disease": "Version: 20.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10020161, Term: HIV infection, Level: PT",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003345-29"
  },
  {
    "EudraCT Number": "2019-000581-38",
    "Sponsor Protocol Number": "17/0894",
    "Sponsor Name": "University College London Comprehensive Clinical Trials Unit",
    "Full Title": "ASEPTIC: Primary Antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis",
    "Start Date": "2019-07-29",
    "Medical condition": [
      "Spontaneous bacterial peritonitis infection in patients with advanced liver disease"
    ],
    "Disease": "Version: 20.1, SOC Term: 100000004862, Classification Code: 10061135, Term: Spontaneous bacterial peritonitis, Level: LLT",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-000581-38"
  },
  {
    "EudraCT Number": "2020-001622-64",
    "Sponsor Protocol Number": "TAC-COVID19",
    "Sponsor Name": "Dra Ana Pueyo Bastida",
    "Full Title": "OUTPATIENT TREATMENT OF COVID-19 WITH EARLY PULMONARY CORTICOSTEROIDS AS AN OPPORTUNITY TO MODIFY THE COURSE OF THE DISEASE",
    "Start Date": "2020-04-19",
    "Medical condition": [
      "COVID-19"
    ],
    "Disease": "",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001622-64"
  },
  {
    "EudraCT Number": "2020-001228-32",
    "Sponsor Protocol Number": "COV002",
    "Sponsor Name": "CTRG",
    "Full Title": "A phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19",
    "Start Date": "2020-05-04",
    "Medical condition": [
      "SARS-CoV-2"
    ],
    "Disease": "Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT",
    "Population Age": [
      "Adults",
      "Elderly"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "GB": "GB - no longer in EU/EEA"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001228-32"
  },
  {
    "EudraCT Number": "2019-002562-12",
    "Sponsor Protocol Number": "ENDOS2019",
    "Sponsor Name": "HOSPITAL GENERAL DE CATALUNYA",
    "Full Title": "PRAGMATIC, COMPARATIVE AND RANDOMIZED CLINICAL TRIAL OF THE NEW SOLUTION OF 1 LITER POLYETHYLENE GLYCOL VERSUS SODIUM PICOSULFATE WITH MAGNESIUM CITRATE  IN THE EFFECTIVENESS OF SCREENING AND SURVE...",
    "Start Date": "2019-09-09",
    "Medical condition": [
      "Screening and surveillance colonoscopy"
    ],
    "Disease": "",
    "Population Age": [
      "Adults"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "ES": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002562-12"
  },
  {
    "EudraCT Number": "2019-001910-40",
    "Sponsor Protocol Number": "0305070107",
    "Sponsor Name": "Radboud University",
    "Full Title": "Combining emotion recognition training with oxytocin administration: A psychobiological approach",
    "Start Date": "2020-06-09",
    "Medical condition": [
      "We examine whether oxytocin administration can improve the effectiveness of emotion recognition training compared to placebo in residential youth with antisocial behavior"
    ],
    "Disease": "",
    "Population Age": [
      "Adolescents",
      "Under 18",
      "Adults"
    ],
    "Gender": [
      "Male"
    ],
    "Trial protocol": [
      {
        "NL": "Ongoing"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-001910-40"
  },
  {
    "EudraCT Number": "2020-003972-42",
    "Sponsor Protocol Number": "A1281198",
    "Sponsor Name": "Pfizer, Inc.",
    "Full Title": "A PHASE 3, MULTICENTER, FOUR-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP EFFICACY AND SAFETY TRIAL OF FLEXIBLE DOSES OF ORAL ZIPRASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPO...",
    "Start Date": "2020-08-21",
    "Medical condition": [
      "Bipolar Disorder"
    ],
    "Disease": "Version: 20.0, SOC Term: 100000004873, Classification Code: 10004938, Term: Bipolar disorders, Level: HLT",
    "Population Age": [
      "Children",
      "Adolescents",
      "Under 18"
    ],
    "Gender": [
      "Male",
      "Female"
    ],
    "Trial protocol": [
      {
        "Outside EU/EEA": "Unknown"
      }
    ],
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003972-42"
  }
]